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In the process of intracellular trafficking, fidelity of delivering proteins and lipids 
across the secretory pathway is of critical importance. Any failure in this highly regulated 
event could have severe consequences to the cell. Various human diseases arise from 
mutations affecting membrane trafficking. In this regard, vesicle tethering complexes 
serve as key factors for the maintenance of cellular function. The transport protein 
particle (TRAPP) is one such factor which provides specificity in delivering proteins and 
lipids. TRAPP is found in three related complexes sharing core subunits, each 
governing different transport steps. TRAPPC2, a mammalian ortholog of yeast TRS20, 
is an essential gene that codes for a protein that exists in all forms of the TRAPP 
complexes. My research has focused on elucidating the cellular function of TRAPPC2 
and proteins that associate with it.  
Substitution of an aspartic acid residue at position 47 of TRAPPC2 to tyrosine 
has been shown to cause a skeletal disorder known as spondyloepiphyseal dysplasia 
tarda (SEDT), a disorder which is believed to be due to a defect in collagen secretion. In 
Chapter 2 I demonstrate that aspartic acid residue 47 is absolutely invariant across taxa 
suggesting that this amino acid plays an important role in the function of the TRAPP 
complex.  Even though TRAPPC2 is ubiquitously expressed the SEDT phenotype is 
manifested in only in specific tissue. Thus, we rationalised a search for homologs of 
TRAPPC2/Trs20p, hoping to provide an answer to the tissue-specificity of SEDT. We 
identified two novel proteins; TRAPPC2L and its yeast counterpart Tca17p.  The 
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position for the novel TRAPPC2L protein is postulated to be opposite to the region 
where TRAPPC2/Trs20p incorporates into the TRAPP complex. 
In Chapter 3 I demonstrate a direct interaction between the TRAPP complex and 
the SNARE fusion machinery. This binding is lost in the pathogenic TRAPPC2D47Y 
mutant. Subsequently, we revealed that an SEDT-analogous mutation in Trs20p 
(trs20D46Y) resulted in deficiency in autophagy rather than defects in endoplasmic 
reticulum to Golgi trafficking. Chapter 4 describes the discovery of the association 
between TRAPP and the tethering factor p115. By using the TRAPPC2D47Y mutant I 
showed that p115 could not efficiently dissociate from membranes, thereby showing 
that a TRAPP-p115 interaction is critical for p115 membrane recognition. Furthermore, I 
provide evidence that TRAPP associates with p115 and SNAREs in a Brefeldin A-
resistant manner.  I propose placing this association at the ER-Golgi intermediate 
compartment (ERGIC) membranes, a compartment that lacks in lower eukaryotic cells, 
at the very early stage of the secretory pathway.  
Previous work by our laboratory found several novel mammalian TRAPP 
components including TRAPPC11. Chapter 5 discusses our discoveries into the 
function of TRAPPC11, a TRAPPC2 protein partner. The genetic component of this 
work was conducted by our collaborators from Alberta who used homozygosity mapping 
in combination with exome sequencing in two siblings from a Hutterite family. They 
found that the candidate gene mutation affects the foie gras domain of TRAPPC11 in 
these brothers. The deletion mutation accounts for the array of phenotypes including 
myopathy, ataxia, and intellectual disability (ID) that is observed in these patients. I 
demonstrated that this mutation disrupts TRAPPC11 binding to multiple TRAPP 
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subunits including TRAPPC2 and compromises the integrity of the Golgi apparatus. I 
also showed that this mutation causes a dramatic delay in trafficking from the Golgi to 
the plasma membrane. Moreover, this mutation dramatically affects the localization of 
lysosomal membrane glycoprotein 1 (LAMP1). This is the first study to investigate the 
function of the foie gras domain of TRAPPC11 in humans. Finally, in Chapter 6 I 
discuss the implications of all of the studies performed in the preceding chapters and 
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1.1 Introduction to intracellular transport 
1.1.1 Background  
Organellar compartmentalization is a hallmark in all eukaryotic cells and relies on an 
elaborate network of endomembrane systems. These systems are composed of distinct 
organelles such as the endoplasmic reticulum (ER), the Golgi, endosomes and lysosomes 
(vacuoles in yeast). Several trafficking pathways have been established to develop 
communication among these organelles including the secretory pathway described by Nobel 
Prize winner George Palade. Palade defined protein secretion in exocrine pancreatic cells with a 
combination of pulse-chase, autoradiographic and electron microscopy techniques (Caro and 
Palade, 1964). He found that proteins to be secreted begin synthesis at the ER and traverse 
towards the Golgi apparatus. In the Golgi, the proteins are packaged into secretory vesicles and 
subsequently transported to the plasma membrane where they are released into the 
extracellular matrix (ECM) (Palade, 1975). 
 
Significant insight into the molecular mechanism of vesicular trafficking was later 
obtained through the work of recent Nobel Prize winners Randy Schekman and James 
Rothman using yeast and mammalian systems, respectively (Balch et al., 1984; Novick et al., 
1980). Schekman and his associate Peter Novick used genetic studies, specifically, 
complementation-based yeast screens, for the isolation of conditional mutants that display 
blocks in secretion. This led to the discovery of 23 genes required for secretion (Novick et al., 
1981) and the further characterization of their corresponding gene products. Rothman’s group 
developed a biochemical in vitro vesicle transport reconstitution system using isolated Golgi 
membranes from wild type and mutants that were lacking the glycosylation enzyme N-
acetylglucosamine (GlcNAc) transferase.  Mutant cells that were transfected with a secretory 
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pathway marker, the vesicular Stomatitis-Virus-Glycoprotein (VSV-G) in combination with a 
radiolabelled GlcNAc were shown to be properly glycosylated, thus leading to the discovery that 
vesicles containing VSV-G bud from mutant membranes and are transported across the stacks 
of the Golgi to fuse with the wild type membranes. The development of this assay allowed the 
researchers to purify cytosolic components required for budding and fusion in the secretory 
pathway e.g. components of the fusion machinery (Sollner et al., 1993a) (see section 1.2.4.1 for 
detail). 
 
1.1.2 Secretory (biosynthetic) pathway of intracellular trafficking 
The movement of proteins and lipids between different compartments in a eukaryotic cells is 
known as membrane trafficking and is mediated by membrane-bound transport carriers. These 
transport carriers may be round in shape or resemble more of a tubulo-vesicular structure. 
Transport intermediates (vesicles) bud from a donor compartment and subsequently fuse to 
a specific recipient organelle thus, interconnecting the endomembrane systems (Bonifacino and 
Glick, 2004). Regardless of the shape of the vesicles, vesicular transport can be classified into 
five events with partial overlapping steps between formation at donor and delivery to recipient 
organelles: (i) budding, (ii) motility, (iii) tethering, (iv) docking and (v) fusion. During the budding 
(vesicle biogenesis) process, selective incorporation of cargo into the growing vesicle is 
achieved by the collaborative action of small GTP-binding proteins, coat protein complexes 
COPI and COPII and accessory factors (described in later sections). The vesicles then move 
along cytoskeletal tracks in mammalian cells and during certain steps in yeast, with motor 
proteins usually facilitating their trafficking. The vesicles then tether and dock to the recipient 
membranes via the action of a diverse group of coiled-coil and multisubunit tethering complexes 
(MTCs) collectively known as tethering factors. These tethering factors are needed for vesicle 
grasping and establishing the first “loose” interaction between vesicles and their respective 
compartments, which is subsequently followed by tighter engagements of the vesicle with its 
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target membrane. During this docking event the two lipid bilayers undergo molecular 
rearrangement, presumably as a prerequisite step triggering subsequent membrane fusion.  
Ultimately during fusion, the soluble N-ethylmaleimide-sensitive factor attachment protein 
receptors (SNAREs) (see section 1.2.4) are key to allow for the merging of the bilayers thereby 
leading to the release of the vesicle contents into the lumen of the target organelle. The precise 
regulation of the biosynthetic pathway from vesicle budding to fusion ensures efficient cargo 
transfer to a target organelle, yet  maintains the integrity of organelle identity; all this occurring 
while there are thousands of proteins and lipids moving through various pathways. 
 
The complex network of endomembranes in the secretory system includes the ER, flat 
stacks (cisternae) of the Golgi apparatus, the trans-Golgi network (TGN), plasma membrane and 
some cell-specific secretory granules, and is evolutionarily conserved. Intracellular membrane 
trafficking incorporates two major routes to facilitate the transport of lipids and proteins. The 
secretory (anterograde) pathway operates to secrete proteins and lipids outside of the cell or to 
deliver them to other intracellular tragets while the endocytic pathway is devoted towards the 
uptake of proteins and materials from the extracellular milieu to intracellular destinations. Both 
pathways are finely tuned to ensure maintenance of the composition and function of the 
organelles.   
 
The secretory pathway is initiated by the synthesis of many proteins destined for 
secretion and commences at the ER. Newly synthesized proteins must be properly folded, and 
in some cases proteins may undergo a series of post-translational modification (PTMs), usually 
N-glycosylation, prior to exit from the ER (Schegg et al., 2009). Proteins that are not folded 
correctly are retained in the ER and degraded. Once this initial quality control is imposed, 
proteins leave the ER via COPII-coated vesicles (described in 1.2.1). In mammals, COPII 
vesicles can fuse with each other to form an ER-Golgi intermediate compartment (ERGIC) prior 
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to moving to the Golgi.  The vesicular-tubular structures of ERGIC (known as VTC) are the first 
post-ER sorting organelle in higher eukaryotes (Szul and Sztul, 2011). Although controversial, it 
has been suggested that COPI takes over the responsibilities for ferrying the cargo to 
downstream pathways and for recycling back to the ER (Martinez-Menarguez et al., 2001; Orci 
et al., 2000). 
 
Highly dynamic cytoskeleton microtubules (MT), in part, are responsible for bidirectional 
movement of proteins between intracellular organelles. Two extremities of MTs are labelled the 
minus end, which is found in a perinuclear region called the microtubule organizing center (MTOC) 
and the plus end, which is found near the cell periphery.  The position and movement of organelles 
and vesicles along these microtubules is achieved through the coordinated function of MTs with 
another group of proteins known as motor proteins.  There are two classes of motor proteins, both 
with an intimate association with MTs: dynein-dynactin and kinesin.  Dynein-dynactin delivers cargo 
in a retrograde fashion towards the MTOC region and is thus called a minus end directed motor 
protein, while kinesin is a plus end directed motor protein moving  in an anterograde fashion, and 
thereby transporting cargos to the cell periphery (Soppina et al., 2009). 
 
Microtubules assist COPI vesicles en route to the Golgi complex in higher eukaryotes 
(Appenzeller-Herzog and Hauri, 2006). This is followed by vectorial shuttling across the Golgi 
apparatus where the proteins can pass through the distinct cis, medial and trans sub-
compartments called cisternae. The proteins once again may be subject to additional 
glycosylation or other PTMs such as palmitoylation (Fukuda et al., 1988; Turnbull et al., 2005). 
The modifications imposed on the proteins enable them to mature prior to being distributed to 
their final destination. Similar to endocytic trafficking, the highly dynamic TGN is a major sorting 
station receiving numerous transport carriers from the biosynthetic pathway and receiving those 
derived from the cell surface via the endocytic pathway. The TGN is responsible for packaging and 
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sorting cargo to ensure that the contents of the vesicle reach its specified target membrane.  
Finally, the TGN also plays a role in recycling transport materials that originated from 
endosomal compartments (Riederer et al., 1994). 
 
Depending on the cargo’s final fate, proteins can take either the constitutive or regulated 
secretory pathway after exiting the TGN. In the case of the constitutive pathway, vesicles 
harboring proteins are targeted to the cell surface where they can discharge their contents in a 
non-regulated fashion. In the regulated pathway, cargo proteins are stored in secretory vesicles 
(granules). Secretion of the contents of this vesicle is fine-tuned and triggered in response to an 
appropriate stimulus. Regulated secretion is observed in dedicated secretory cells of the 
endocrine and neuronal systems which release hormones and neurotransmitters, respectively 
(Bonifacino and Glick, 2004). Alternatively, some TGN-packaged cargos move toward organelles 
such as early/late endosomes, where the proteins can ultimately make their way to vacuoles 
(lysosomes). For instance, lysosomal membrane proteins LAMP1 and LAMP2 can be 
transported via either a direct or indirect route on their way to endosomal compartments. In the 
direct route, LAMP proteins use the endosomal system prior to their delivery to the lysosome. 
On the other hand, the indirect pathway involves the cycling of proteins to the cell surface prior 
to their subsequent delivery to the endosomal compartments and finally to lysosomal 
membranes (Janvier and Bonifacino, 2005; Kornfeld and Mellman, 1989).  
 
1.1.3 Endocytic pathway of intracellular trafficking 
The second fundamental route of intracellular trafficking is the endocytic pathway, and it 
is composed of three main populations of endosomes; (1) early, late and recycling endosomes, 
(2) lysosomes and (3) lysosome-related organelles (LROs). Like the biosynthetic pathway, 
endocytic transport involves multiple processes of cargo recognition which promotes vesicle 
formation, and then vesicle release followed by transport towards and fusion with the target 
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destination. While there is a flux of proteins moving towards the cell membrane in the 
biosynthetic pathway, the endocytic pathway involves the trafficking of material in the opposite 
direction. Proteins at the cell surface are collected into vesicles called endosomes which bud off 
from the plasma membrane via endocytosis. The endocytic pathways consist of specific sets of 
protein machinery and vesicles that cycle between endosomes and the TGN. Protein retrieval 
from endosomal organelles back to the TGN can take place either from early/recycling 
endosomes or from late endosomes to the Golgi.  For example, the transmembrane protein 
TGN46 (human ortholog of rat TGN38) has an unknown function but cycles through the cell 
surface, early endosome and TGN. However, Shiga toxin utilizes the early/recycling endosomes 
subsequent to its internalization but the toxin then leaves the endocytic pathway and takes a 
route known as the retrograde pathway all the way towards the ER, which ultimately poisons the 
host cell (Johannes et al., 1997; Mallard et al., 1998). In yeast, numerous cargo proteins are 
directed to the endosome and the TGN via the vacuolar receptor known as Vps10p, which is a 
receptor for carboxypeptidase Y (CPY) (Seaman et al., 1997) (Figure 1.1).  Finally, chitin 
synthase-III (Chs3) in yeast is another example of a cargo that exploits the retrograde pathway 
from the plasma membrane to the early endosome and then to the TGN (Valdivia et al., 2002). 
            
Figure 1.1 Highly coordinated bidirectional (forward and reverse) trafficking systems 
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interconnecting intracellular organelles. Cargo sorting from the tubular network of the trans-Golgi 
in budding yeast: Vps10p, like its mammalian counterpart mannose 6-phosphate receptor, 
constantly traffics from the TGN to the endosome thus, delivering its cargo. The empty receptor 
recycles back to the TGN for another round of biosynthetic cargo transport (Duncan and Kornfeld, 
1988). In the case of the vacuolar hydrolase CPY, the cargo is secreted from the cells when its 
receptor Vps10p is defective (Lewis et al., 2000). Two cargo proteins Snc1p and the CPY receptor 
Vps10p, follow distinct recycling routes from early and late endosomes to the late Golgi, 
respectively. 
 
1.2 Membrane trafficking machinery and the specificity of vesicle fusion with its appropriate 
compartment 
In membrane trafficking, distribution of the proteins to their proper target compartments 
is of crucial importance and is assured by the coordination between the following cellular 
factors: (1) coat proteins, required to coordinate the production of transport vesicles with the 
selection of specific cargo; (2)  tethering factors, essential for initial recognition between a 
vesicle and target destination, (Sztul and Lupashin, 2006); (3) GTP-binding proteins that define 
and localize vesicles to their appropriate organelle (Pfeffer, 2001); and (4)  SNAREs (Sollner et 
al., 1993a), key factors for fusion of vesicles to their  correct organellar destinations.  
 
1.2.1 Coat proteins    
There are three different types of well-studied coat protein complexes that are vital to 
membrane trafficking. The first is the COPII coat protein complex, which is involved in the early 
stages of the secretory pathway for transport of vesicles between the ER to either the 
ERGIC/VTC or the Golgi (Barlowe et al., 1994). The second is the heptameric complex COPI, 
also known as coatomer, that takes part in multiple transport steps including bidirectional 
trafficking from the VTC to the Golgi (Aridor et al., 1995), retrograde transport between Golgi 
cisternae and from the Golgi to the ER (Letourneur et al., 1994), and endocytic transport 
(Whitney et al., 1995). Finally, the clathrin protein complex acts at two distinct sites; one 
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emanating from the post-Golgi network to generate intermediate clathrin-coated vesicles (CCVs) 
en route  to the endosomal systems, and the second CCVs originates at the cell surface and coats 
vesicles that travel to early endosomes (Bonifacino and Lippincott-Schwartz, 2003). 
 
Generation of a COPII vesicle requires three main components: the small Ras-like GTPase 
Sar1p, the membrane-proximal layer Sec23p-Sec24p heterodimer and a second layer, 
membrane-distal sub-complex Sec13p-Sec31p (Figure 1.2). The formation of COPII-coated 
vesicles is initiated by the recruitment of the Sar1 GTPase to specialized regions of the ER 
membrane called ER-exit sites (ERES) (Amessou et al., 2007) also known as transitional-ER 
(tER) where Sar1 then becomes activated by the action of the ER-localized guanine 
nucleotide exchange factor (GEF) Sec12 (Figure 1.2). Following the activation of Sar1p, there 
is sequential recruitment of cytosolic inner and outer COPII coat proteins (Lee et al., 2005). 
GTP-bound Sar1p also triggers membrane curvature and fission of COPII vesicles (Bielli et 
al., 2005; Lee et al., 2005). Once these components of the coat have been assembled, 
selection and concentration of properly folded cargo, coat polymerization, membrane 





Figure 1.2 Vesicle biogenesis mediated by COPII coat protein machinery.  
 
Typical COPII coated vesicles are estimated to be between 50-100 nm in diameter. 
Occasionally there are some large cargos that must exit the ER (Bachinger et al., 1982). Thus it is 
possible that there is an alternative mechanism for packaging these macro-cargos into vesicles 
destined for downstream compartments, or alternatively, the COPII coat itself is flexible enough to 
accommodate larger cargos.  A number of laboratories recently demonstrated that the secretion of 
procollagen (PC), a cargo of approximately 300 nm in length, is COPII- dependent (Townley et al., 
2008;O'Donnell et al., 2011) and accommodation of the large PC cargo is achieved by longer 
activation of Sar1 GTPase and thus longer settlement of COPII proteins on the membrane which is 
a requirement for PC packaging (Venditti et al., 2012).  
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1.2.2 Tethering factors  
The initial interaction between a vesicle and its cognate membrane is a critical step 
for proper cell functioning. The specificity of the interaction is achieved by the action of tethers 
that act to initially tether (or capture) the transport vesicles to their target membrane. This 
occurs subsequent to the vesicle budding event. Tethering factors are localized to distinct 
intracellular regions where they can act upon those organelles (see Figure 1.3). Tethers can 
be divided into two different classes: coiled-coil proteins and multisubunit tethering 
complexes (MTCs) (Whyte and Munro, 2002). From a structural point of view, the elongated 
nature of coiled-coil tethers may allow these tethers to interact with incoming vesicles and 
bring them closer to the membrane on which the tether is attached. In mammals, one example 
of a coiled-coil tether is p115 (the mammalian homolog of yeast Uso1p) which interacts with 
two Golgi-localized tethers called GM130 and giantin (Beard et al., 2005).  
 
1.2.2.1 Coiled-coil tethers 
Long coiled-coil tethering factors are responsible for capturing transport intermediates in 
a process known as loose tethering. This is followed by vesicle docking which involves tighter 
interaction (Whyte and Munro, 2002). Coiled-coil proteins mostly exist in cytosolic and 
membrane-bound forms.  This family of proteins is usually in direct contact with numerous 
components of the cellular trafficking machinery. One such interaction is with Ras-related 
GTPase which allows them to associate with the membrane. Coiled-coil tethering factors in part 
confer fidelity by participating in the delivery of vesicles, through the formation of physical links at 
relatively long-distances from the target membrane (Gillingham and Munro, 2003; Yu and 
Hughson, 2010). Genetic and physical interactions have been documented between a cis- 
Golgi tethering factor Uso1p/p115 and Ypt1p/Rab1 in yeast and mammalian cells enabling 




1.2.2.2 Multisubunit tethering complexes (MTCs) 
In contrast to the coiled-coil family of tethering factors, multisubunit complexes mediate 
short-distance tethering events (Yu and Hughson, 2010). MTCs have been proposed to play roles 
at distinct trafficking steps. Some tethering factors that exist as multisubunit complexes such as 
TRAPP (transport protein particle) have been shown to act as Rab-activators. Other MTCs 
include HOPS, DSL1, COG, GARP, Exocyst and CORVET (Figure 1.3), and some these 
associate with and regulate the function of Rab GTPases. Tethering factors are implicated in every 
aspect of vesicle transport and more specifically MTCs are emerging as positive regulators of 
SNARE assembly (Perez-Victoria and Bonifacino, 2009;Ren et al., 2009; Shorter et al., 2002). 
There will be a section devoted to the TRAPP complex (see section 1.3). 
 
Figure 1.3 Intracellular localization of MTCs in yeast. To date, nine MTCs have been 





1.2.3 Small GTPases as master regulators of intracellular transport 
Rab GTPases are members of the Ras superfamily and are master regulators of 
vesicular budding, motility and fusion. These small GTPases are involved in virtually every 
trafficking pathway (Woollard and Moore, 2008). In eukaryotic cells, intracellular vesicle 
trafficking is controlled by Rab GTPases in both the secretory and endocytic pathways. In terms 
of vesicular trafficking events Rab GTPases are involved in vesicle biogenesis, transport, tethering 
and fusion events.   
 
Once Rab proteins are activated they can then specifically interact with certain proteins 
or lipids referred to as effector molecules. This interaction facilitates membrane transport as 
the newly formed interaction can act as a scaffold for the sequential recruitment of proteins 
and lipids that are required in that specific process. Rab proteins cycle between an active and 
inactive state: the GTP- and GDP-bound forms, respectively. A general feature observed in 
all the GTPases is the intrinsic rates of GDP dissociation and GTP hydrolysis are slow, thus the 
switch between active and inactive Rab proteins requires accessory proteins (Figure 1.4). 
These accessory factors are collectively called guanine nucleotide exchange factors (GEFs) and 
GTPase activating proteins (GAPs), which stimulate activation and deactivation of Rab proteins, 
respectively. In addition to GEFs and GAPs, GDP-dissociation inhibitor (GDI) and GDI displacement 
factor (GDF) are also part of the protein machinery required for cycling of small GTPases between 
membrane compartments by facilitating extraction from and recruitment to specific membranes, 




Figure 1.4 Widely accepted model of the Rab/Ypt cycle. GEFs and GAPs are responsible for the 
active (GTP-bound) and inactive (GDP-bound) states of small GTPases. The active form of the 
GTPase is competent to bind to downstream effectors. GDI extracts the GTPase from 
membranes while GDF mediates the dissociation of the GTPase from GDI.  
 
 
1.2.4 SNARE proteins mediate intracellular fusion 
SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) proteins 
are key to one of the fundamental processes in the fusion of eukaryotic cell membranes.  In 
Saccharomyces cerevisiae, there are 25 genes encoding SNARE proteins and alternative 
splicing in SNARE primary transcripts in humans increases the SNARE numbers to 36 (Jahn 
and Scheller, 2006). All mammalian SNARE proteins of the Syntaxin family, except Syntaxin 11, 
are type II integral membrane proteins that are thought to be essential in anchoring the proteins 
by their C-terminal region. SNAREs have a broad range of protein partners within the vesicular 





1.2.4.1 Discovery of SNARE proteins 
As noted before, an in vitro intra-Golgi trafficking assay used in the Rothman lab during 
the 1980s led to the identification of a soluble protein called NSF (mammalian ortholog of 
Sec18p) and shortly after that, the identification of its adaptor molecule α-soluble NSF 
attachment protein (α-SNAP)/ Sec17p (Sollner et al., 1993a). Subsequently SNAREs, the 
receptors for α-SNAP were also discovered using methods similar to those used for NSF and α-
SNAP detection. NSF and α-SNAP are important proteins in intracellular membrane fusion since 
four helical coiled-coil bundles of cis-SNARE complexes are disassembled through the action 
of the ATPase NSF (N-ethyl-maleimide-sensitive fusion) protein in complex with α-SNAP.  
 
1.2.4.2 SNARE hypothesis and specificity 
The three SNARE proteins that were discovered as receptors for the NSF-α-SNAP 
complex are Syntaxin, SNAP-25 and Synaptobrevin, which had been localized to either 
synaptic vesicles or to presynaptic membranes (Sudhof et al., 1989). Shortly thereafter, SNARE 
subcellular localization studies demonstrating that distinct SNAREs are found in specific 
compartments led to the SNARE hypothesis that was proposed by Rothman and colleagues 
(Sollner et al., 1993a). It postulated that there were two different classes of SNARES: (v) - 
vesicle SNAREs and (t) - target SNAREs (generally corresponds to another nomenclature 
R- (arginine) and Q- (glutamine) SNAREs, respectively). According to this hypothesis, each v-
SNARE pairs up with its unique cognate t-SNARE at the proper target membrane and this 
interaction is the determinant of specificity that ensures that a vesicle will fuse with its 
correct target membrane. Current knowledge has indicated that there is no doubt that 
SNAREs contribute to the specificity of membrane transport. However, it has been realized 
that SNAREs are not the exclusive determinants of specificity in vesicle transport. It is more 
likely that the specificity is defined at earlier stages upstream of SNARE complex formation per 
se, at points such as membrane targeting and vesicle tethering events where primary recognition 
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between vesicles and their appropriate target compartment is mediated by Rabs and tethering 
factors.  
 
1.2.4.3 SNARE complex formation  
Because of the similarity between eukaryotic SNAREs and viral fusion proteins 
(Hughson, 1999), it has been postulated that membrane fusion is caused by forcing two 
opposing bilayers to overcome the repulsive energy that normally keeps the two leaflets 
separate. Based on the zipper up model, trans-assembly formation (so-called SNARE-pin 
formation) is formed from three t-SNAREs on one membrane and one v-SNARE on the 
opposing membrane (Figure 1.5). The proteins initially are largely unfolded but then form a 
highly stable four helix bundle as the vesicle gradually approaches its target membrane (Liu 
and Parpura, 2010). The energy produced by the formation of a highly stable complex most 
likely overcomes the energy barrier that normally prevents the fusion of two separate 
membranes, thereby inducing fusion (Margittai et al., 2001). The nucleated trans-complexes 
arise from a so called loose form in which zipper up has just started at the N-terminal region. 
Once the SNARE-pin structure is completed, this then leads to pore formation and transition to a 
remarkably stable cis-SNARE complex (Otto et al., 1997), suggesting that the fusion process is 
associated with the release of energy. Once the fusion event takes place NSF and its adaptor α-




Figure 1.5 Schematic representation of the SNARE protein cycle. The cycle begins with 
conversion of a SNARE (t/Q-SNARE) from a closed to open conformation. Free t-SNAREs with 
the assistance of an SM protein (discussed in 1.2.4.4) generates clusters of three SNAREs 
(indicated in pink, dark and light green) that wait for an incoming vesicle. The fourth SNARE 
(v/R-SNARE) resides on the vesicle (depicted in blue). Transition from loose tethering of the 
vesicle to the docking stage allows the assembly of a four-helix bundle zipper that drives the 
membrane fusion (Jahn et al., 2003).The cis-SNARE complex disassembly is achieved by ATP 
hydrolysis by NSF together with its protein partner α-SNAP allowing for the SNAREs to 
participate in the next cycle of membrane fusion (Pratelli et al., 2004). 
 
 
1.2.4.4 Sec1/Munc18 (SM) family proteins facilitate SNARE complex assembly 
The evolutionarily conserved family of SM proteins has only four members: 
Sec1/Munc18-1, Vps45, Sly1 and Vps33, which are, thought to function in conjunction with 
distinct sets of SNARE proteins. All SM proteins seem to interact directly with Q-SNAREs; 
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however, the mode of the interaction is surprisingly diverse. For instance, neuronal Munc18-1 
binds to Syntaxin 1 when the protein adopts a closed conformation, therefore preventing the 
exposure of the SNARE motif (60-70 amino acids near the transmembrane domain of SNAREs 
that participates in SNARE complex formation) and blocking its participation in SNARE complex 
assembly, thus negatively regulating fusion events (Dulubova et al., 1999). In contrast, other 
researchers have observed that Munc18-1 is essential for neurotransmitter secretion, since this 
process is blocked in mice lacking Munc18-1 (Verhage et al., 2000). On the other hand, the yeast 
homolog Sec1p interacts with the Q-SNARE Syntaxin homolog Sso1p when Sso1p is assembled 
in a SNARE complex as opposed to in the closed configuration (Carr et al., 1999). This second 
mode of SM protein binding activates SNARE-pin formation (Shen et al., 2007) (Figure 1.6).  
 
 
Figure 1.6 Different modes of interaction of Syntaxin and SNARE complexes with SM proteins. 
(a) Binding of an SM protein to an N-terminal region of Syntaxin adaptable with SNARE 
complex formation. (b, c) SM protein associates with SNARE complexes located in two (trans) 
or one (cis) membrane(s). (d) SM protein interacts with closed conformation of Syntaxin and 
prevents other SNARE proteins from binding. (a,d) Open and closed conformation adopted by 





1.3 The TRAPP complex 
1.3.1 Discovery of the TRAPP multisubunit complexes  
The TRAPP complex in yeast is one of the best characterized multisubunit protein 
complexes and exists in three different compositions: TRAPP I, TRAPP II, and TRAPP III. Each 
of these complexes controls distinct trafficking events. TRAPP I, with seven subunits, acts in 
ER-to-Golgi vesicle trafficking, while TRAPP II, with its 11 subunits, governs multiple trafficking 
steps including intra-Golgi (Sacher et al., 2001), endosome-to-late Golgi (Cai et al., 2005), as 
well as autophagy (Zou et al., 2013). TRAPP III with 8 subunits also acts in autophagy (Lynch-
Day et al., 2010). TRAPP III is discussed along with its unique subunit specific to TRAPP III, 
Trs85p, in section 1.4. 
 
The first component of the yeast TRAPP complexes was identified by a synthetic lethal 
genetic screen designed to identify protein partners of the SNARE protein Bet1p, an ER-to-
Golgi transport protein. In this screen blocked early in transport 3 protein (Bet3p) was identified 
(Rossi et al., 1995). Subsequently, BET5 was isolated as a high copy suppressor of the 
temperature-sensitive (ts) growth phenotype of a bet3-1 (Rossi et al., 1995). The conserved 
multisubunit tethering complex of TRAPP (Koumandou et al., 2007) was discovered and 
characterized by metabolic labelling with 35S-methionine combined with immunoprecipitation of 
Protein A-tagged Bet3p and column chromatography techniques using Saccharomyces 
cerevisiae (Sacher et al., 1998).  The TRAPP (transport protein particle) complex, at this point 
believed to represent a single complex, was introduced to the scientific community in Susan 
Ferro-Novick‘s laboratory and shown to contain 10 proteins (Table 1.1) (Sacher et al., 1998). 
 
Subsequent studies made it clear that there was more than one species of TRAPP. The 
first clue that there were multiple forms of the complex came from biochemical fractionation 
studies that initially revealed two forms of the complex: TRAPP I, with seven subunits (Bet5p, 
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Trs20p, two copies of Bet3p, Trs23p, Trs33p, and Trs85p,and TRAPP II, which is comprised of 
ten subunits including all of the subunits of TRAPP I and three TRAPP II specific subunits 
(Trs65p, Trs120p and Trs130p) (Sacher et al., 2001). Thus there are core subunits (Bet3p, 
Bet5p, Trs20p, Trs23p, Trs31p, and Trs33p) that are shared between TRAPP I and TRAPP II. 
Much later Tca17p was discovered in our laboratory and other laboratories through 
bioinformatic analysis and a genetic screen for defective SNARE recycling, respectively 
(Scrivens et al., 2009; Montpetit and Conibear, 2009).   
 
Mammalian orthologs of TRAPP subunits have also been identified (Sacher et al., 
1998,2000) Table 1.1. In a proteomic-based analysis using mammalian TRAPPC2 (hereafter 
the prefix “TRAPP” is eliminated for simplicity from the mammalian proteins) and C2L as bait, 
novel components of the mammalian TRAPP complex were identified. The protein partners that 
were identified included ones that had been previously characterized as bona fide TRAPP 
subunits including C3, C4, and C5 with the two yeast TRAPP II-specific orthologs C9 and C10. 
Also identified were novel proteins including the mammalian ortholog of Trs85p, C8, two 
proteins that are absent in the budding yeast that were named C11 and C12 (Scrivens et al., 




      
  
Table 1.1 Nomenclature of yeast and mammalian subunits. C11 and C12 are specific to higher 
eukaryotes and the star indicates that they have not been assigned to any specific complex, 
although one study reported that they might be part of the mammalian TRAPP III (Bassik et al., 
2013). The subunits written in bold are the main focus of my research. 
 
1.3.2 The architecture of TRAPP 
The TRAPP complexes are the best-described tethering factors at the structural level, 
both in terms of its subunits and holocomplexes. The following sections will describe what is 
known to date regarding these features. 
 
1.3.2.1 Structure of the C2 subunit  
Since the identification of the TRAPP complexes, one mammalian subunit, C2, has 
come under scrutiny because mutations in this homolog of the yeast Trs20 protein are 
responsible for a skeletal disorder referred to as SEDT (spondyloepiphysealdysplasia tarda) 
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(Gedeon et al., 1999). The single longin domain crystal structure of C2 was the first to be 
determined among the TRAPP subunits (Jang et al., 2002). Later it was revealed that other 
subunits of the TRAPP complex such as C1 and C4 (mammalian orthologs of Bet5p and 
Trs23p) adopt similar folds, although C4 also contains a PDZ-like domain not seen in C2 nor C1 
(Kim et al., 2006). A surprising structural similarity to the N-terminal regulatory domain of two 
SNARE proteins was also noted, suggesting C2 may directly interact with SNARE proteins, a 
notion explored in Chapter 3 of this thesis. 
 
1.3.2.2 Structure of the C3 subunit  
Dimeric mouse C3 (the mammalian homolog of Bet3p) was the second subunit to have 
its structure determined (Kim et al., 2005b). Interestingly, C3 exhibits unique features such as a 
hydrophobic channel and a flat, positively charged surface. The latter characteristic appears to 
be critical for the membrane attachment of the Bet3p/C3 protein (Kim et al., 2005b). The 
monomer of C3 is composed of four β–strands on one side and five helices on the other 
side.The four β–strands are arranged in a twisted, antiparallel format. Interestingly the Bet3p/C3 
fold is also seen in the TRAPP subunits Trs31p/C5 and Trs33p/C6 (Kim et al., 2006).  
 
1.3.2.3 Structure of the C3-C6 heterodimer  
In vitro studies using yeast subunits mapped out the various protein partners within the 
TRAPP complexes (Kim et al., 2005a). This ultimately led to the crystallization of the 
mammalian C3-C6 heterodimer. Although there is no homology between these proteins at the 
amino acid level, unexpectedly C6 adopts a similar fold to that of C3. Subsequently the structure 
of human C6 as a homodimer or heterodimer in a complex with C3 was determined (Kummel et 
al., 2005). The C3-C6 heterodimer was the starting point towards assembly of the TRAPP I 




1.3.2.4 Heterotrimeric and heterotetrameric structures of TRAPP 
In vitro pull down experiments were used to examine the network of interactions within 
the yeast TRAPP complex. This was used to guide the recombinant co-expression of individual 
subunits. Subsequent work allowed for the co-expression of multiple (>2) subunits. Ultimately it 
was revealed that trimeric and tetrameric sub-complexes of TRAPP are composed of Bet3p-
Trs31p-Trs20p and Bet3p-Trs33p-Bet5p-Trs23p. The crystal structures of the mammalian 
homologs of these complexes (C3-C5-C2 and C3-C6-C1-C4) were then solved. C3-C5-C2 
showed that C2 interacts with the C3-C5 heterodimer in a shoulder to shoulder fashion and 
generates a flat sub-complex., Similarly, C3-C6-C1-C4 also associated into a flat sub-complex. 
(Kim et al., 2006).  
 
1.3.2.5 Pentameric structure of yeast TRAPP complex   
In yeast, the structure of the heteropentameric Bet3p-Trs33p-Trs23p-Trs31p in 
association with the small GTPase Ypt1p was solved (Cai et al., 2008). The structure exhibited 
a direct interaction between small GTPase Ypt1p with yeast Bet3p, Bet5p and Trs23p, three out 
of the four minimum components required for activation of Ypt1p. It was postulated that the 
mechanism of nucleotide exchange is obtained with the above interaction between TRAPP and 
Ypt1p resulting in stabilization of the Ypt1p nucleotide-binding pocket in an open conformation, 
followed by protrusion of the C-terminal region of Bet3p into the pocket. 
 
1.3.3 The architecture of TRAPP I 
Components of TRAPP were purified from yeast (Bet3p, Bet5p, Trs23p, Trs31p, and 
Trs33p) and experiments showed that Trs23p (the homolog of C4) united the two sub-
complexes (Bet3p-Bet5p-Trs33p and Bet3p-Trs31p-Trs20p) together (Figure 1.7). The subunits 
of TRAPP I, when co-expressed in bacteria, spontaneously formed a functional TRAPP I 
complex (Kim et al., 2006). This complex was purified and subjected to single particle electron 
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microscopy to determine its low-resolution structure. This revealed a flat and elongated 
structure with a length of 180 A° (Kim et al., 2006) (Figure 1.8). Subsequently, the mammalian 
sub-complexes mentioned above were docked into this low-resolution map to generate a 
pseudo-atomic resolution structure of the TRAPP I complex. The fact that the yeast (electron 
microscopy) EM map perfectly accommodated the mammalian subunits indicates that the core 
of yeast and mammalian complexes are highly similar to each other. This structure has been 
used to elucidate the structure of TRAPP II (see below). 
       
 
Figure 1.7 Schematic representations of two yeast heterotrimers linked together via a central 
Trs23p subunit.  
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Figure 1.8 Crystal structure and subunit organization of mammalian sub-complexes and EM 
map of yeast TRAPP I complex. (a) Mammalian sub-complexes viewed from the putative 
cytosolic face. The dashed line highlighted in gray designates the minimal Ypt1 GEF. (b) The 
two mammalian sub-complexes docked into the EM map generated from yeast subunits (Kim et 
al., 2006). 
 
Bacterially co-expressed subunits of the yeast TRAPP I led to proper assembly of a 
functional TRAPP I complex (Kim et al., 2006) although this was not the case for mammalian 
TRAPP homologs. These results suggested that there may be other protein partners, either 
TRAPP subunit(s) and/or unrelated protein(s) required for proper assembly of the mammalian 
(m)TRAPP complex. This notion formed the basis of a search for novel protein partners of 
mTRAPP and is presented in Chapter 2. 
 
1.3.4 The EM structure of yeast TRAPP II 
The architecture of yeast TRAPP II was predicted using the EM structure of the TRAPP 
I.  The TRAPP II complex forms a dimer of the TRAPP I core with Trs120p and Trs130p at the 
ends of the core and the dimers are linked together by a central layer composed of Trs65p 
(Figure 1.9) (Yip et al., 2010). Indeed, deletion of Trs65p causes a shift in the components of 





Figure 1.9 Architecture of TRAPP II in Saccharomyces cerevisiae (Yip et al., 2010). The shared 
core TRAPP I and TRAPP II components arrange side by side and generate a flat, elongated 
shape at the center of each monomer, consistent with Kim et al, 2006. Two specific TRAPP II 
components, Trs120p and Trs130p are accommodated at the extremities of the flat surface with 
Trs130p being adjacent to Trs20p. The dimer interface is depicted as a green dashed line 
where Trs65p is proposed to mediate the dimerization of TRAPP II (Choi et al., 2011; Yip et al., 
2010). 
 
1.3.5 The number and composition of yeast and mammalian TRAPP complexes 
Given the limitation of using Superdex-200 to separate TRAPP complexes from cell 
lysates, TRAPP initially appeared as one single peak in both yeast and mammalian lysates.  
Co-immunoprecipitation studies showed that the mammalian homologs of the TRAPP II- (C2L 
and C13) and TRAPP III- (C8) specific subunits co-purified in the same complex and prompted 
speculation that mTRAPP might exist as a single complex (Choi et al., 2011; Scrivens et al., 
2011). Recent data have strongly suggested that mTRAPP actually forms two distinct 
complexes. One complex, mTRAPP II, contains the core with C9 and C10 and the other 
complex, mTRAPP III contains the core complex plus C8, C11, C12, and C13 subunits (Figure 





Figure 1.10 Schematic representations of mammalian TRAPP complexes. Currently identified 
components of the mTRAPP II and TRAPP III complexes based on Bassik et al., 2013, and 
yeast two-hybrid binary interactions (Scrivens et al., 2011). 
 
All forms of yeast TRAPP contain the proteins found in TRAPP core. The structure of 
TRAPP II (except for the positions of Trs120p and Trs130p) has been depicted according to Yip 
et al., 2010, as two layers of core subunits capped by Trs120p, and Trs130p at both ends, with 
Trs65p in the joining part. Trs65p has been shown to interact with both Trs120p and Trs130p 
(Choi et al., 2011; Liang et al., 2007). Interestingly the architecture of TRAPP III was deciphered 
based on our Y2H analysis which is in fair agreement with very recent report on EM structure of 
TRAPP III (Figure 1.11). 
 
Figure 1.11 Schematic representations of the three different TRAPP complexes found in yeast.  
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1.3.6 Functions of the TRAPP complexes  
A significant body of work has shown that TRAPP complexes cooperate with 
components of both the early and late secretory machinery and the mode of interaction is 
conserved between yeast and mammals. The two most prominent functions of the TRAPP 
complexes are tethering vesicles and acting as guanine nucleotide exchange factors (GEFs).  
 
1.3.6.1 TRAPP as a GEF in yeast and mammals 
Since TRAPP genes displayed genetic interactions with the gene encoding the ER-to-
Golgi small GTPase Ypt1p (Rossi et al., 1995; Jiang et al. 1998) a physical interaction was 
between TRAPP and Ypt1p was explored. This revealed that the complex has a preference for 
binding to a nucleotide free form of Ypt1p which is a characteristic of nucleotide exchange 
factor(s). It was subsequently shown that all three forms of the TRAPP complexes stimulated 
the exchange of GDP for GTP on Ypt1p (Jones et al., 2000;Wang et al., 2000;Lynch-Day et al., 
2010). The catalytic surfaces of TRAPP at the Ypt1p interface encompasses four subunits 
(Bet5p, Bet3p (A and B), Trs23p and Trs31p) common to all three forms of the complex (Kim et 
al., 2006).  A subsequent study provided a mechanism for TRAPP-catalysed Ypt1p nucleotide 
exchange that involved the C-terminus of the Bet3p subunit (Cai et al., 2008). Another example 
of a GEF involving multiple subunits is Mon1-CCZ as a GEF for Ypt7p (Nordmann et al., 2010; 
Zhu et al., 2009). 
 
Since the GEF activity is confined to the TRAPP I core, which is shared amongst all 
three yeast TRAPP complexes, one would suspect that all three complexes would act as Ypt1p 
GEFs and this has been demonstrated (Jones et al., 2000; Wang et al., 2000; Chen et al., 2011; 
Yamasaki et al., 2009;Lynch-Day et al., 2010). However, one group has claimed that TRAPP II 
acts as a GEF on Ypt31p-Ypt32p, a Rab GTPase functioning in the trans-Golgi (Jones et al., 
2000). In contrast to the yeast controversy, mTRAPP GEF activity has been reported for Rab1 
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(Yamasaki et al., 2009), the mammalian homolog of Ypt1p, and not Rab11, the mammalian 
homologs of Ypt31p-Ypt32p. 
 
1.3.6.2 TRAPP function as a tether in yeast and mammals 
In the early secretory pathway in yeast, the TRAPP I complex, via the Bet3p core 
subunit, interacts physically with Sec23p, an inner layer component of the COPII coat (Cai et al., 
2007b). Interestingly, Bet3p has been shown to be stably associated with the Golgi apparatus 
(Sacher et al., 2000), suggesting that Bet3p facilitates tethering of ER-derived vesicles to the 
Golgi target membrane. A recent study revealed that during the coat -TRAPP I interaction, a 
Golgi-associated kinase, Hrr25p, competes with TRAPP I for a Sec23p-binding site thus 
displacing TRAPP I. Subsequent phosphorylation of Sec23p triggers vesicle uncoating (Lord et 
al., 2011; Sharpe et al., 2011). Therefore phosphorylation of Sec23p by Hrr25p assures spatial 
and temporal regulation of vesicle transport events. While COPII vesicles are tethered to and 
interacted with TRAPP I, but not TRAPP II (Sacher et al., 2001;Cai et al., 2007a), COPI-coated 
vesicles are captured and bound to TRAPP II-specific subunits (Cai et al. 2005;Yamasaki et al., 
2009). Consistent with these findings, the phenotypes of core TRAPP mutants differ from 
mutants defective in genes specific to TRAPP II (Cai et al., 2005; Mahfouz et al., 2012;Scrivens 
et al., 2009;Jian et al., 1998).   
 
The coat-TRAPP association in the early and late biosynthetic pathways is not limited to 
budding yeast cells.  Unlike in yeast cells, however, nascent vesicles in higher eukaryotes first 
fuse together to generate the intermediate ERGIC compartment prior to fusion with the Golgi. 
The TRAPP I subunit, C3, is necessary for homotypic fusion of COPII-coated vesicles crucial for 
formation of ERGIC (Yu et al., 2006). In addition, the structural integrity of both the ERGIC and 
Golgi apparatus is impaired upon depletion of C3. The fragmented Golgi and perturbed ERGIC 
structures are phenotypes that are also observed when several TRAPP subunits are mutated 
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(Choi et al., 2011; Scrivens et al.,2009 and 2011). The tethering action of mTRAPP is not 
restricted to C3; other subunits such as C9 can bind p150, a component of a microtubule (MT) 
motor, and C9 competes with p150 for binding to Sec23 and displace its interaction to Sec23 
through tethering the vesicle toward the ERGIC (Zong et al., 2012). This consecutive process is 
reminiscent of the regulation of Sec23p by Hrr25p observed in yeast, which is mediated through 
the TRAPP I complex. The newly identified members of mTRAPP (C11 and C12) (Scrivens et 
al., 2011) have been found in the ERGIC as is seen with C3, suggesting its implication is 
consistent with the generally accepted ER-Golgi trafficking role of the yeast TRAPP I complex. 
 
Furthermore, genome-wide studies have been implicated the TRAPP complex in 
membrane traffic.  For example, the Golgi t-SNARE protein Syntaxin 5, and the Drosophila 
ortholog of C11, Gryzun, have been shown to be essential for secretion (Wendler et al., 2010). 
Moreover, high throughput analysis has revealed multiple mTRAPP proteins (C8, C11, and 
C12) as being important for ricin retrograde transport (Bassik et al., 2013; Moreau et al., 2011).  
 
In addition to tethering and nucleotide binding activity, multiple subunits of mTRAPP 
have been identified in large-scale screens for genes involved in human autophagy (Behrends 
et al., 2010). Furthermore, numerous studies point to functions for the TRAPP complex in being 
a protein supplier and a membrane depositing factor at a very early stage of certain processes 
including the engagement of the Rab GEF, Rabin8  (Westlake et al., 2011), the C9-mediated 
recruitment of necessary components for cilia formation during ciliogenesis (Lee et al., 2012), 
biogenesis of melanosomes (a lysosomal-related organelle) by C6a (Gwynn et al., 2006), and 






1.3.7 C2/Trs20p function in membrane trafficking   
1.3.7.1 C2 function and its link to SEDT in mammals 
Sedlin also known as C2 is the human ortholog of Trs20p. It was reported to reside at 
one end of the TRAPP core. Biochemical studies have revealed that the 140 amino acid C2 
interacts with both the C3 and C5 subunits of TRAPP and possible interaction(s) with as yet to 
be discovered protein(s). Mutations in the C2 gene (also known as SEDL or SEDT) that encodes 
for C2 have been reported to be the cause of an X-linked recessive skeletal dysplasia affecting 
males in early adolescence known as SEDT (Gedeon et al., 1999).  SEDT patients have inhibited 
epiphyseal bone growth leading to reduced stature among other features.  The defect manifests 
only in skeletal tissue, suggesting an involvement of chondrocytes, cells that are involved in the 
synthesis of collagen for the cartilage tissue. Patients with this disease have been reported to 
exhibit shorter extracellular collagen fibrils compared to those of unaffected individuals. 
 
There are a number of mutations in C2 that are associated with the disease, one being a 
substitution of aspartic acid at position 47 for tyrosine (Figure 1.12). This residue is highly 
conserved throughout metazoans (Jang et al., 2002;Scrivens et al., 2009). In addition, the 
wild-type C2 can complement for the loss of yeast Trs20p, while mutant D47Y has lost this ability 
(Gecz et al., 2000). Finally, while this residue exhibits unique features such as being a surface 
exposed charged residue, unlike some other missense mutations,  the  D47Y  mutation  still  
folds  properly  and  more  or  less  maintains  the biophysical properties of the wild-type protein 
(Choi et al., 2009 and 2011; Scrivens et al., 2009). In light of the crystal structure of the TRAPP 
complex (Kim et al., 2006) and the mouse C2 subunit (Jang et al., 2002), researchers have 
suggested that the surface-exposed area of C2 is an ideal environment for protein-protein 
interactions with other component(s) of the membrane trafficking system (Sacher et al., 2008).    
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Figure 1.12 C2 structure (1H3Q). α-helix1 backbone is colored in pink using PyMOL and dark 
blue highlights the position of D47.  
 
We and others have determined that C2 and C9 physically interact. This interaction is also 
observed between the C2 and C9 counterparts in yeast, Trs20p and Trs120p, respectively (see 
Table 1.1 (Jang et al., 2002;Levine et al., 2013;Taussig et al.,2013;Zong et al.,2011); see 
Chapter 3). This finding is not in accordance with results from single particle EM analysis presented 
by Yip and colleagues in 2010 who showed that, with respect to the TRAPP core, Trs20p is 
adjacent to the TRAPP II-specific subunit Trs130p and distant from Trs120p. The discrepancy could 
be explained by the possibility that TRAPP achieves a different structure upon interaction occurring 
inside the cells.  
 
A recent publication suggests that C2 also acts as an adaptor for C8 and C9 (Zong et al., 
2011).  If C9 and C8 are in distinct sub-complexes as suggested above (Bassik et al., 2013; Zong 
et al., 2011) then the C2 subunit could operate as an adaptor for each of these proteins in distinct 
TRAPP complexes in mammals.  It was recently suggested that C2 is recruited to the collagen exit 
site by TANGO1, a putative collagen receptor. Upon recruitment of C2 to ER exit sites, C2 
regulates Sar1 GTPase activity allowing the newly formed COPII carrier to increase its size 
(Venditti et al., 2012).  Although this finding helps to unravel the key molecular players of collagen 
transport, it is not clear how this relates to the pathogenesis observed in SEDT. To date, in addition 
to C2 mutations linked to SEDT, components of TRAPP have been linked to specific human 
health conditions. The table below delineates a growing list of diseases that are associated with 
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TRAPPC1 Melanoma Chiari et al 1999 
TRAPPC2 Spondyloepiphyseal dysplasia tarda (SEDT) Gedeon et al 1999 
TRAPPC4 Colon cancer Zhao et al 2011 
TRAPPC6 Mosaic-hypopigmentation Gwynnn et al 2006 
TRAPPC9 Intellectual disability (ID); Human ciliopathy 
Mochida et al 2009 ; 
Lee et al 2012 
TRAPPC10 
Epilepsy holoprosencephaly candidate 1 protein 
(EHCO1) 
Yamakawa et al 1995 
TRAPPC11 
Hepatic steatosis; Limb girdle muscular dystrophy, 
myopathy with movement disorder, and ID 
Howarth et al 2011; 
Bogershausen et al 
2013 
 
Table 1.2 Diseases associated with disruption of normal TRAPP subunit function 
 
1.3.7.2 Trs20p function in yeast and its implication in SEDT patients 
TRS20 is an essential gene (Sacher et al.,1998 and 2000) and depletion of Trs20p 
results in the inhibition of trafficking from the ER to the Golgi (Sacher et al., 2001).The 
mammalian homolog of Trs20p (C2) can complement the lethality of the trs20 disrupted gene 
product, strongly suggesting a conserved function of the gene throughout evolution (Gecz et al., 
2003). In yeast, Trs20p was reported to be neither part of the GEF activity of TRAPP I nor a 
participant in the assembly of the complex. Although more recent work in yeast from our lab and 
others have suggested that Trs20p might not be critical for the assembly of TRAPP I, there is 
strong evidence that Trs20p is a critical component of TRAPP II and TRAPP III and could be 
important for the organization of these complexes (Jang et al., 2002; Levine et al., 2013; 
Taussig et al., 2013; Zong et al., 2011; see Chapter 3). The adaptor function might be lost along 
with the integrity of the TRAPP II complex in yeast harboring the D46Y mutation. The authors 
have shown the essential requirements for Trs20p in order for Trs120p to integrate into the 
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complex. The D46Y mutant was shown to prevent the normal trans-Golgi localization of TRAPP 
II components and the interaction with Trs120p is also disrupted, further supporting the 
conserved mode of action of C2 in the TRAPP complex from yeast to mammals (Jang et al., 
2002; Levine et al., 2013; Taussig et al., 2013; Zong et al., 2011). Assessment of TRAPP II GEF 
activity for two small GTPases of early and late Golgi trafficking, Ypt1p and Ypt32p in the 
context of trs20D46Yp indicated that TRAPP II, but not TRAPP I, GEF activity was lost (Taussig 
et al., 2013).  
 
 Synthetic genetic interaction between trs20 and multiple genes involved in the endocytic 
recycling pathway were reported (Mahfouz et al., 2012). Even though it has been reported that 
Trs20p links TRAPP I to the TRAPP II-specific subunit Trs130p (Yip et al., 2010), more recently 
it has been shown that Trs20p and Trs130p operate in distinct routes. Specifically, 
overexpression of Ypt32p rescues the temperature sensitivity of trs130-HA ts, but not trs20ts. 
Furthermore, different transport pathways including ER to Golgi, Golgi to vacuole and Golgi to 
cell surface monitored by Gos1p (ER-to-Golgi SNARE fusion protein), CPY (vacuolar 
carboxypeptidase Y), ALP (vacoular alkaline phosphatase), and Gap1p (general-amino-acid-
permease) were defective in trs130-HAts , but not trs20ts (Taussig et al., 2013). 
 
1.4 Autophagy    
1.4.1 General aspects of autophagy    
Two fundamental pathways can be used by eukaryotic cells for degradation of 
unnecessary intracellular proteins. The first is the ubiquitin-proteasome system (UPS), which 
degrades short-lived intracellular proteins, and the second pathway, lysosome-mediated 
autophagy, degrades long-lived intracellular proteins (Mizushima and Komatsu, 2011). 
Autophagy directly translates into self-digesting, a term coined by Christian de Duve in 1963. 
Autophagy is a catabolic event which is evolutionary conserved among plant, yeast and animal 
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cells (Klionsky, 2005). It is a tightly regulated mechanism by which obsolete components will be 
eliminated.Thus, at least in part, autophagy provides cellular and metabolic homeostasis 
through balance between synthesis and degradation of macromolecules in the cell (Komatsu et 
al., 2005; Shintani and Klionsky, 2004). There are three major types of autophagy in mammals 
that are classified based on the type of substrates targeted to lysosomes: macroautophagy, 
microautophagy and chaperon-mediated autophagy (Cuervo, 2004). 
 
In microautophagy, small materials are directly delivered to the lysosomes by inward 
invagination of the lysosomal membrane (Wang and Klionsky, 2003). Chaperon-mediated 
autophagy involves the translocation of cytosolic material by a heat shock protein that 
recognizes the cytosolic portion of its substrate and directs it to the surface-bound lysosomal 
receptor LAMP2A (Massey et al., 2006). Macroautophagy involves formation of a double-
membrane structure known as the autophagosome. The autophagosome removes bulk 
cytoplasmic material such as damaged organelles, aggregates and aberrant proteins and 
delivers them to the lysosome (equivalent to vacuole in yeast) for degradation via lysosomal 
enzymes.  
 
Macroautophagy (hereafter autophagy) has been extensively studied and can be 
subclassified as non-selective (induced) or selective (basal). “Induced autophagy” is activated in 
response to a number of external and internal stress conditions. More specifically, in yeast and 
mammalian cells, nitrogen and amino acid deprivation triggers the highest response of a non-
selective form of autophagy.  
 
1.4.2 Molecular mechanism of autophagy    
The molecular components involved in autophagy are known as autophagy-related genes 
(Atg). There are 35 ATG genes identified in yeast thus far (Rubinsztein et al., 2012; Xie and 
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Klionsky, 2007)  that can be grouped into three categories: (1) core machinery, (2) selective 
autophagy-specific and (3) non-selective autophagy specific genes (Lynch-Day and Klionsky, 
2010). These Atg proteins are classified based on their role in starvation and/or vegetative 
conditions. The core Atg machinery consists of 17 proteins that are shared in both selective and 
non-selective autophagy. Some Atg proteins have been shown to act as binding partners of the 
TRAPP complex. I will therefore focus on this subset of proteins as it relates to my current 
research.  
 
1.4.3 The Cytoplasm-to-vacuole (Cvt) pathway 
The cytoplasm-to vacuole-targeting (Cvt) pathway is one of the best characterized types of 
selective autophagy observed in budding yeast. The Cvt transport system is a biosynthetic 
process destined for cargo delivery of inactive precursor forms of vacuolar hydrolase such as α-
mannosidase (Ams1) and aminopeptidase I (Ape1), from cytosol to vacuole under log-phase 
growth conditions (Klionsky et al., 1992; Scott et al., 1997).  
 
In the case of Ape1, after synthesis, precursor Ape1 (prApe1) monomers can self-assemble 
into a large Ape1 complex (Shintani et al., 2002) (Figure 1.13). This occurs once the complex is 
recognized by its receptor, Atg19p (now termed Cvt complex) that can then bind to Atg11p 
before its final integration into the pre-autophagosomal structure or phagophore assembly site 
PAS (Lynch-Day and Klionsky, 2010).  In yeast, the PAS is found to be the region where most, if 
not all, of the Atg proteins gather (Suzuki et al., 2001). The PAS expands and generates a 
phagophore, which is found to be the initial sequestering site capable of enclosing the double 
membrane harbouring the Cvt complex. Once the ends of the phagophore are completely 
sealed, the Cvt complex converts into a Cvt vesicle and, in the case of bulk autophagy, 
becomes the autophagosome. Finally the Cvt vesicles, or the autophagosomes, fuse with the 
vacuole and release their contents (Cvt body or autophagic body) into the lumen. Acidic 
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exposure of the Cvt or autophagic bodies would then lead to the breakdown of these structures. 
The N-terminal cleavage of preApe1 leads to a mature form of Ape1 and the remaining non-
specific contents of the autophagic bodies are degraded. Finally, the active building blocks of 
macromolecular by-products are recycled back to the cytoplasm to maintain cellular 
homeostasis and turn over (Cheong and Klionsky, 2008). 
 
 
Figure 1.13 Schematic representation of Ape1 processing in selective and non-selective 
autophagy. 
 
1.4.4 Molecular description of autophagy 
1.4.4.1 Induction of phagophore 
Initiation of autophagy in mammals begins with the isolation membrane (IM).  Next, the 
generation of the autophagosome will arise through the elongation of the IM. In yeast, the 
phagophore is developed from the elongation of the PAS (Sztul and Lupashin, 2006), which 
later gives rise to the autophagosome (Suzuki et al., 2001). Commonly, Atg proteins are 
gathered in the PAS in a hierarchical fashion (Mizushima and Komatsu, 2011). To date, there 
are no findings demonstrating the existence of a single PAS in mammals (Young et al., 2006). 
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However, multiple PAS equivalents have been detected under starvation conditions (Itakura et 
al., 2012).  
In yeast, the initiation of autophagy is hallmarked by the recruitment of Atg9p to the PAS. 
Atg9p is a multispanning membrane protein and an evolutionarily conserved gene involved in 
both selective and non-selective autophagy (Itakura et al., 2012; Orsi et al., 2012) . Upon 
synthesis of Atg9p, the protein is translocated to new tubulo-vesicular structures called Atg9-
reservoirs in both fungi and mammals (Mari and Reggiori, 2010; Orsi et al., 2012).  
 
1.4.4.2 Lipidation of Atg8p (LC3) along with expansion of the phagophore 
The mammalian homolog of yeast Atg8p, Microtubule-associated protein 1light chain 3 
protein (MAP-LC3 or LC3), is the best-characterized and most extensively used marker. There 
are two pools of cytosolic and membrane bound LC3 (LC3-I and LC3-II).  
LC3 has been used as a marker for monitoring autophagosomes and autolysosomes by 
microscopy or western blot analysis mainly due to its unique biochemical features (Mizushima et 
al., 2010). Similarly in yeast, a construct of GFP fused to Atg8p has also been used. When 
GFP-Atg8p is recruited to the vacuole via autophagy, the GFP fragment is released from Atg8p 
and Atg8p itself undergoes degradation (Shintani and Klionsky, 2004). Conversely, this process 
of degradation is impaired in mutants that are blocked in autophagy and can be followed by 
microscopy or western blot analysis. 
 
1.4.4.3 Acquisition of components destined for degradation (autophagic 
cargos) 
The conjugation of Atg8p to the lipid phosphatidylethanolamine (PE) of the membrane 
generates Atg8p-PE, which connects cargos to the cup-shaped membrane of the 
autophagosomes. This is accomplished either directly or indirectly through a receptor/adaptor 
reaction involving Atg19p and Atg11p, respectively (Cao et al., 2008; Pankiv et al., 2007). The 
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size of transport intermediates are determined based on the acquisition of substrates sorted to 
transport the intermediates. Hence, it is feasible that in non-selective autophagy, 
autophagosomes can range from 300-900 nm (Baba et al., 1997). On the other hand, selective 
autophagy, which does not comprise bulk cytosolic material and only accommodates specific 
cargos, generates smaller vesicles of about 150 nm in size (Scott et al., 2001).  
 
1.4.4.4 Maturation of autophagosomes 
The maturation of autophagosomes is accomplished by the fusion of autophagosomes with 
late endosomes and/or lysosomes, late endosomes also known as multivesiular bodies (MVBs). 
It is worth mentioning that the two most prominent lysosomal proteins, LAMP1 and LAMP2, are 
necessary for autophagosome maturation (Huynh et al., 2007).  Maturation occurs by the 
incorporation of lysosomal/vacuolar enzymes into the autolysosomes with the aim of instigating 
degradative abilities for macromolecule breakdown. Finally, permeases allow the breakdown 
products to efflux into the intracellular milieu. 
 
Atg8p, a PE-conjugated protein, has been shown to function in tethering and hemifusion 
between two opposing membranes (Nakatogawa et al., 2007) thereby mediating an emergence 
of a membrane and the expansion of the autophagosomes. Nevertheless, another recent study 
in yeast claims that under physiological conditions, Atg8p does not have the ability to drive 
membrane fusion and that the exocytic SNAREs (mainly Sso1/2p and Sec9p) are essential for 
generation of tubulo-vesicular clusters, which is a preliminary stage of PAS organization (Nair et 
al., 2011).  
 
1.4.5 Autophagy implication in human disease 
A great deal of our knowledge in autophagy came from the molecular studies conducted 
in budding yeast and subsequent identification of their mammalian homolog ATG genes. 
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Autophagy must be strictly regulated because any malfunction in this degradation pathway can 
give rise to various human diseases ranging from neurodegeneration, such as Alzheimer’s and 
Parkinson disease, to cardiomyopathy, muscular dystrophy, inflammation and cancer (Choi et 
al., 2013; Komatsu et al., 2005). As a result, autophagy has received a great deal of attention 
over the past three decades, since it holds potential therapeutic strategies in recognizing and 
eliminating specific types of non-functional proteins and/or organelles. Selective autophagy acts 
by carefully removing specific protein aggregates through the function of mammalian Atg19 and 
p62, which can potentially fulfill an important role in preventing neurodegenerative disorders 
(Pankiv et al., 2007).  
 
1.4.6 TRAPP implication in Autophagy 
The first report indicating the involvement of the TRAPP complex in autophagy, via its 
growth-dispensable subunit Trs85p, came from studies conducted in S. cerevisiae. This study 
revealed that trs85Δ failed to transport GFP-Atg8p to and to process Ape1 in the vacuole 
(Meiling-Wesse et al., 2005; Nazarko et al., 2005). TRAPP complexes have been shown to bind 
GTP-binding proteins Ypt1p and Ypt31p-Ypt32p (Jones et al., 2000; Morozova et al., 2006). 
Both of these small GTPases are implicated in the process of autophagy. Given the putative link 
with a GEF and its corresponding GTPase, it was reasonable to ask whether the GEF could 
also function in autophagy. Answering this question led to the finding that yeast TRAPP II and 
TRAPP III are involved in both bulk and selective autophagy acting at early steps in the 
autophagy pathway (Lynch-Day et al., 2010; Zou et al., 2012). Interestingly, Ypt1p and Trs85p 
were identified in a mass spectrometry analysis of Atg9p-vesicles. Trs85p was shown to be 
localized at the PAS (Kakuta et al., 2012; Lynch-Day et al., 2010), the site that is highly enriched 
for Atg9p. Thus these results in conjunction with others led to the proposal that Trs85p is a 
component of Atg9p vesicles and recruits Ypt1p and TRAPP III to the PAS (Kakuta et al., 2012; 
Lynch-Day et al., 2010). More recently it was revealed that PAS targeting of Trs85p itself is 
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regulated by the scaffolding protein Atg17p (Wang et al., 2013), which is also responsible for 
PAS- targeting of Atg9p (Sekito et al., 2009) (Figure 1.14). In order to unravel the cross talk 
between TRAPP and core molecular machinery of autophagy, the PAS localization of Atg 
proteins during induction of autophagy was assessed using Ape1p as a marker for PAS or a 
cargo that utilises the Cvt pathway in a strain deleted of trs85 or atg genes (Lipatova et al., 
2012b). In trs85Δ, the defective processing of the Ape1p, assessed by the presence of the 
precursor form of Ape1p (prApe1p), was suppressed when YPT1 or ATG11 were 
overexpressed (Figure 1.14). Conversely, overproduction of TRS85 had no effect on the 
accumulation of unprocessed Ape1p in ypt1 or atg11 mutant strains. Collectively, this suggests 
that TRS85 functions upstream of ATG11, thus defining the Trs85p-Ypt1p-Atg11p module 
(Lipatova et al., 2012a).  
 
Furthermore, in yeast biochemical and genetic interactions place Trs130-containing 
TRAPP II  in both selective Cvt and non-selective bulk autophagy pathways acting through the 
GTPase Ypt31p-Ypt32p downstream of a Ubiquitin-like conjugating system Atg5p and upstream 
of Atg8p, Atg1p, Atg13p, Atg9p and Atg14p (Lynch-Day et al., 2010; Zou et al., 2012). 
Interestingly another study revealed the importance of Trs85p in the recruitment of Atg14p, a 
phosphotidylinositol 3-kinase (PI3K), to the PAS only in nutrient rich conditions but impairment 
of atg14 did not alleviate the PAS localization of Trs85p suggesting that Atg14p acts 
downstream of Trs85p (Kakuta et al., 2012). Furthermore, in addition to TRAPP III, Ypt1p has 
also shown specificity towards the downstream Atg proteins. For instance, while a nutrient-rich 
environment permits Ypt1p-GTP to be associated with Atg11p, an Atg protein that only acts in 
Cvt/selective autophagy (Lipatova et al., 2012a), under nutrient deprivation, Ypt1p-GTP binds to 
Atg1p and further recruits other Atg proteins that are known to function in non-selective 
autophagy (Wang et al., 2013). In contrast, nutrient deprivation links Ypt1p-GTP to the 
autophagy-induced Atg1p complex, essential for autophagosome formation and recruitment of 
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other components of the autophagy machinery such as the heterotrimeric complex consisting of 




Figure 1.14 Integration of Ypt1p and the TRAPP II- and TRAPPP III-specific proteins Trs130p 
and Trs85p into the hierarchy of yeast Atg proteins. Note how Ypt1p-GTP stands as a hub 
between Cvt/nutrient rich and non-selective/nutrient deprivation routes. 
 
 
Atg8p, an indicator of fusion of the autophagosome with the vacuole, is normally seen 
within the vacuole lumen after induction of autophagy. However, Atg8p failed to appear inside 
the vacuole in trs85Δ (Meiling-Wesse et al., 2005; Nazarko et al., 2005). In mammalian cells, 
the role for TRAPP in autophagy is not clearly understood. Nonetheless, components of the 
TRAPP complex, C11, C12, and the Trs85p homolog C8, were among the TRAPP subunits 
identified in a screen for components of the autophagy machinery (Behrends et al., 2010). The 
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C10 (mTrs130) subunit of mammalian TRAPP can activate the Ypt1p homolog Rab1. It has 
been suggested that C10 may tether COPI vesicles to the early Golgi membrane because 
depletion of C10 was shown to cause a delay in forward trafficking and resulted in an 
accumulation of vesicles in the Golgi membrane (Yamasaki et al., 2009). In brief, even though 
the small GTPase (either Ypt1p or Ypt31p-Ypt32p) upon which TRAPP II acts is controversial, 
the involvement of TRAPP II in autophagy in yeast and mammalian cells may be conserved. In 
this respect it is notable that Rab1 has also been shown to have a role in autophagosome 
formation in mammals.  
 
1.5 The overall objective of my PhD dissertation 
With respect to the study of multisubunit complexes of TRAPP, which are the focus in our 
laboratory, my PhD thesis work involved the elucidation of the cellular function of one the 
subunits that resides at one extremity of the core TRAPP I complex named TRAPPC2, or Sedlin, 
and its yeast ortholog Trs20p. In this dissertation, I have conducted experiments using two model 
systems, S. cerevisiae and human cells. I initially concentrated my efforts on understanding 
the function of TRAPPC2, which led to the identification of a novel TRAPPC2-related subunit 
that was present in both the yeast and mammalian TRAPP complexes called Tca17p and 
TRAPPC2L, respectively. One of the challenges in characterization of the role of TRAPPC2 is that 
TRAPPC2 is broadly expressed in multiple tissues, including brain, skeletal muscle and other 
tissues, yet the SEDT has a tissue-specific phenotype (cartilage). The rationale in searching 
for a protein related to TRAPPC2 was that presumably such a protein(s) may have a redundant 
function such that it could compensate for the loss of TRAPPC2 in the majority, but not all, 
tissues. This would be one possible explanation of why SEDT is tissue specific.The results of this 
study will be presented in Chapter 2 and were published in the journal Traffic in 2009.   
It was determined that TRAPPC2L and TRAPPC2 expression in primary cells taken from 
the cartilage of SEDT patients was similar to the expression found in healthy individuals indicating 
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TRAPPC2L and its yeast counterpart Tca17p do not complement for the loss of TRAPPC2 and 
Trs20p, respectively, in chondrocytes. Thus, to investigate the function of TRAPPC2, I screened 
six human SNAREs involved in ER-to-Golgi transport for their potential to interact with TRAPPC2 
and then continued this work in yeast. This study demonstrated that the yeast homolog of 
TRAPPC2, Trs20p, is not only involved in the assembly of the TRAPP III complex but is also 
involved in specific and non-specific autophagy. The data is presented in Chapter 3 and was 
published in Traffic in 2013.   
 
In Chapter 4, I then present some of my unpublished findings, using mammalian cell 
culture, concerning the interaction between TRAPPC2 and SNARE proteins with a predominant 
focus on Syntaxin 5. I also describe the discovery of a novel protein partner of the TRAPP 
complexes, the putative coiled-coil tethering factor, p115, and will discuss the effect of the TRAPP 
complex on membrane and cytosol cycling of p115. I have determined that both p115 and the 
TRAPP complex are associated with the membrane fusion machinery and I discuss the possible 
functional significance of these associations.  
 
Following the discovery of TRAPPC2L, our lab used TAP tagged TRAPPC2 and 
TRAPPC2L to identify novel TRAPP-associated proteins which led to the identification and 
characterization of other subunits including the TRAPPC11 protein.  After teaming up with a group 
of collaborators who discovered that TRAPPC11 is mutated in several Hutterite families, I began 
another project with a goal of examining the effect of this deletion mutation in the foie gras domain 
on TRAPPC11 function. Through biochemical and microscopic-based analyses I demonstrated for 
the first time in primary human cells that the TRAPP complex is involved in a trafficking step late in 
the secretory pathway.The data is described in Chapter 5 and some of these findings were 
published in the American Journal of Human Genetics in 2013. Finally Chapter 6 of this 
dissertation includes a general summary of my studies and future perspectives. 
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CHAPTER 2  
 
TRAPPC2L is a novel, highly conserved TRAPP-interacting protein 
Data presented in this chapter used both the budding yeast Saccharomyces cerevisiae 
and mammalian tissue culture to identify mammalian TRAPPC2L (hereafter the prefix “TRAPP” 
is eliminated for simplicity from the mammalian proteins) and its yeast counterpart encoded by 
the YEL048c gene, and was published in the journal of Traffic (Scrivens et al. 2009). I 
preformed the work in Figures 2.5-2.11, 2.14 and 2.19 and I am co-first author of this 
manuscript. A simultaneous report also identified the product of YEL048c as a TRAPP 
component  and named  the gene TCA17 (Montpetit and Conibear, 2009). I have adapted this 
nomenclature in subsequent chapters. 
 
2.1 Introduction  
Vesicle-mediated transport of proteins and lipids is critical to the maintenance of the 
distinct composition of most intracellular organelles. Many factors are required to ensure that 
each vesicle is recognized by and fuses with the appropriate compartment. Tethering factors 
are an evolutionarily conserved class of proteins that mediate the initial contact between 
vesicles and target membranes and are thus believed to impart the initial layer of specificity in 
this process (Sztul and Lupashin, 2006;Whyte and Munro, 2002;Koumandou et al., 2007). 
These factors can be subdivided into coiled-coil proteins and multisubunit complexes (Sztul and 
Lupashin, 2006;Whyte and Munro, 2002). How these two classes of tethering factors cooperate 
to tether a vesicle remains unclear.  
 
TRAPP I and TRAPP II are two related multisubunit complexes acting in the yeast 
secretory pathway (Sacher et al., 2008). In yeast, these complexes are involved in endoplasmic 
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reticulum (ER) -to-Golgi transport (TRAPP I) and a transport step at the trans-Golgi/endosome 
(TRAPP II) (Cai et al., 2005; Sacher et al., 1998; Sacher et al., 2001). The complexes contain 
seven subunits in common (Bet5p, Trs20p, Bet3p, Trs23p, Trs31p, Trs33p and Trs85p) but 
TRAPP II contains three unique subunits (Trs65p, Trs120p and Trs130p; see Table 2.1 for 
mammalian and yeast subunit nomenclature to be used throughout this chapter). TRAPP is 
well-conserved through evolution and a Bet3p-like protein has even been described in 
prokaryotes, underlining the ancient origins and fundamental nature of this complex (Podar et 
al., 2008). While the yeast TRAPP complexes are readily distinguished based on their different 
molecular sizes and on their subunit composition (Sacher et al., 2001), no such distinction has 
yet been reported for mammalian TRAPP. In the limited reports on mammalian TRAPP, only a 
single high molecular weight pool of subunits has been described (Sacher and Ferro-Novick, 
2001;Loh et al., 2005). The absence of the larger TRAPP II complex is particularly curious given 
that orthologs for the TRAPP II subunits Trs130p and Trs120p have been identified in mammals 
(Cox et al., 2007) and have been reported to co-precipitate with C3 (Gavin et al., 2002;Kummel 
et al., 2008).  
 
Yeast TRAPP subunit 
(size in kD) 
Mammalian TRAPP 
subunit (size in kD) 
Bet5p (18) TRAPPC1 (17) 
Trs20p (20) TRAPPC2 (16) 
Bet3p (22) TRAPPC3 (20) 
Trs23p (23) TRAPPC4 (24) 
Trs31p (31) TRAPPC5 (21) 
Trs33p (33) TRAPPC6a,b (18) 
Trs65p (65)  none 
Trs85p (85)  none 
Trs120p (120) TRAPPC9 (140) 
Trs130p (130) TRAPPC10 (142) 
     
Table 2.1 Nomenclature of yeast and mammalian TRAPP subunits. 
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The yeast TRAPP I complex has been shown to be necessary for ER-to-Golgi transport 
and sufficient to interact with ER-derived transport vesicles (Sacher et al., 2001). This 
interaction has been proposed to be mediated by an interaction between C3 and the vesicle 
coat protein Sec23 (Cai et al., 2007b). Other factors needed for tethering the vesicle to the Golgi 
are Uso1p and the GTPase Ypt1p, and perturbation of any of these proteins abrogates efficient 
tethering (Cao et al., 1998). Although the sequence in which these factors function is not clear, 
TRAPP I has been shown to have guanine nucleotide exchange factor (GEF) activity towards 
Ypt1p (Jones et al., 2000;Wang et al., 2000). The TRAPP II complex has been shown to interact 
with components of the COP I vesicle coat (Cai et al., 2005) and has GEF activity towards the 
GTPases Ypt31p-Ypt32p (Jones et al., 2000;Morozova et al., 2006). Given that TRAPP I and 
TRAPP II share a common core, how these two highly related complexes interact with distinct 
proteins to mediate different transport events is unclear. One possible explanation is that other 
proteins that interact with the complexes regulate their function. Identification of TRAPP-
interacting proteins is thus an important area of study to further our understanding of these 
complexes. 
 
TRAPP is one of the best-studied of the tethering complexes at the structural level. The 
structures of six of the mammalian subunits and five of the yeast subunits have been solved 
(Cai et al., 2008;Jang et al., 2002;Kim et al., 2005a and b;Kummel et al., 2005 and 
2006;Kummel et al., 2005;Turnbull et al., 2005). Interestingly, the subunits fall into two families 
based on their three-dimensional crystal structures: the Bet3 family containing Bet3p/C3, 
Trs31p/C5 and Trs33p/C6, and the Sedlin family containing Trs20p/C2, Bet5p/C1 and 
Trs23p/C4 (yeast/mammalian). The arrangement of the subunits within the complex produces 
two large, flat surfaces that may enable multiple protein-protein interactions (Kim et al., 2006). 
Many factors involved in vesicle-mediated transport events have been linked to disease 
(Aridor and Hannan, 2000 and 2002). Mutations in the human C2 subunit have been strongly 
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linked to the skeletal disorder spondyloepiphyseal dysplasia tarda (SEDT) (Gedeon et al., 
1999;Shaw et al., 2003). This disorder primarily affects the spine and epiphyses and has been 
suggested to be due to a defect in collagen secretion from chondrocytes (Sacher, 2003;Tiller et 
al., 2001). However, the fact that other collagen-secreting cells in SEDT patients have not been 
reported to be defective in the transport of this protein raises interesting questions about the 
specific function(s) of C2. 
 
Here, we identify and characterize a protein, C2L, that is related to C2 and interacts with 
TRAPP. The protein is broadly expressed and highly conserved. We also characterize the yeast 
ortholog of this protein encoded by the uncharacterized open reading frame YEL048c and show 
that its genetic interactions group it with genes encoding TRAPP II subunits. C2L is in TRAPP 
complexes that also contain C2 indicating that the two proteins bind to different sites within 
TRAPP, a notion supported by biochemical studies. While C2 is found on two distinct 
membranes, C2L is found only on one. Finally, although functionally distinct, knockdown of the 
mammalian C2L and C2 proteins indicates that both are involved in Golgi dynamics. This study 
provides the first report of a mammalian TRAPP-interacting protein that may preferentially 










2.2 Materials and methods 
 
2.2.1 Plasmids  
The C2L open reading frame was amplified from cDNA obtained from OpenBiosystems. 
C2 was amplified from existing DNA (Kim et al., 2006). All PCR products were inserted into 
pRS425, pRS415 or pRS413-ADH1 (Mumberg et al., 1995) for expression in yeast and pFLAG-
CMV6a (Sigma) for expression in mammalian cells. For recombinant protein expression in E.coli 
the PCR products were inserted into either pACYCDuet-1 or pRSFDuet-1 (Novagen). 
 
2.2.2 Reverse transcriptase-PCR 
Tissues were harvested and total RNA was extracted with the Nucleospin RNA II kit 
(Clontech). cDNA was synthesized from 1 µg of RNA using Moloney Murine Leukemia Virus 
reverse transcriptase (New England Biolabs). For polysome experiments, the polysomes were 
prepared essentially as described by Blower et al.(2007). Processing of the RNA was as 
described above. 
 
2.2.3 Tissue culture  
Cells were maintained in DMEM (Wisent) supplemented with 10% fetal bovine serum 
(FBS) in a humidified CO2 chamber. Transfections were performed in a 10 cm dish with 10 µg of 
DNA by the calcium phosphate method. Cells were harvested 48 hours post-transfection using 
RIPA buffer (150 mM NaCl, 50 mM Tris, pH7.2, 0.1% SDS, 1% Triton X-100, 1% deoxycholate) 
with protease inhibitors (Roche). For gradient fractionation transfected cells were harvested in 
150 mM NaCl, 50 mM Tris, pH7.2, 0.5 mM EDTA, 1 mM DTT with protease inhibitors. For size 
exclusion chromatography the transfected cells were harvested in RIPA without SDS and 
deoxycholate. A total of 30 µg of lysate was used for western analysis and detergent extraction. 
For size exclusion chromatography a total of 1.5 mg of lysate was fractionated and assayed by 
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western analysis. For purification of TAP-tagged proteins, two 15 cm dishes were transfected 
with 50 µg DNA each, expanded one day after transfection and purified using IgG-sepharose 
beads (GE Healthcare). 
 
2.2.4 Antibodies 
 Polyclonal antibodies recognizing C3 and C2 were raised in rabbits using His-tagged 
proteins as antigen. Antibody to C4 (2D10) was purchased from Abnova. Monoclonal anti-FLAG 
M2 antibody was purchased from Sigma. Antibodies were used at 1:1000 dilution for western 
analysis or 1:250-1:1000 for immunofluorescence unless otherwise indicated. Compartment-
specific markers for immunofluorescence and western analysis were: rabbit anti-Mannosidase II 
(Dr. Kelly Moreman, University of Georgia), mouse anti-ERGIC53 (G1/93, Cedarlane), rabbit 
anti-ERGIC53 (E1031, Sigma), mouse anti-GM130 (Dr. Martine Lowe, University of 
Manchester), mouse anti-β-COP (MAD, Sigma), rabbit anti-TAP tag (OpenBiosystems), rabbit 
anti-Sam68 (Dr. S. Richard). Secondary antibodies were anti-rabbit AlexaFluor 488 and anti-
mouse AlexaFluor 546 (Invitrogen) or anti-mouse-Rhodamine, a kind gift from J. Uniacke. 
 
2.2.5 Gradient fractionation  
Cells were harvested and lysed as described above. The membranes were collected 
from the lysates by centrifugation at 100,000g for 1 h. Membranes were resuspended in lysis 
buffer and layered on top of an OptiPrep (Sigma) gradient (2.5%-40%) and centrifuged in an 
SW41 rotor at 156,000g for 16 h. Fractions of 1mL were collected from the top of the tubes and 
30 µL of each fraction was used for western analysis. 
 
2.2.6 siRNA 
Small interfering RNA (siRNA) that targets either both versions of C2 (C2 and C2.19; #1: 
UCCAUUUUAUGAACCCAAUTT; #2: CAAUUCUCCUAUUCGAUCATT) or C2L (#1: 
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AGCCCUUCGAGACAACGAATT; #2: GCAUGUUCCGGAAGCUACATT) were purchased from 
Ambion and used at 60 nM. Introduction of the siRNA was accomplished using Oligofectamine 
(Invitrogen) in OptiMEM. After 24 hours the medium containing the siRNA was removed and 
replaced with fresh DMEM containing serum and no antibiotics. For immunofluorescence cells 
were first trypsinized and replated to coverslips. Cells were processed 48 hours after the 
medium change. Knockdown was assessed by either semi-quantitative RT-PCR (for C2L) or 
western analysis (for C2) as described above. The siRNAs for C3 were designed from published 
oligonucleotides (Yu et al., 2006). 
 
2.2.7 Immunofluorescence microscopy 
Cells were plated on coverslips in 6-well dishes.  For processing, coverslips were rinsed 
in PBS then fixed in pre-chilled methanol: acetone (4:1) for 10 min at -20°C.  Following fixation, 
coverslips were rinsed in PBS prior to blocking in 2% FBS, 2% BSA, and 0.2% fish skin gelatin 
in PBS.  Primary antibodies were diluted in blocking buffer and incubated in 40 µL volumes on 
coverslips. The wash buffer consisted of blocking buffer progressively diluted with PBS. 
Secondary antibody incubation was identical to primary, except for the addition of DAPI and the 
fact that the incubation was conducted in the dark. Washes were as above, with the final wash 
being PBS alone. Slips were mounted on slides using Antifade Gold (Invitrogen) mounting 
medium. Samples were visualized on a Zeiss LSM510 confocal microscope using a Zeiss 
Planapochromat 63X N.A. 1.4 oil immersion objective. Images were adjusted for brightness and 








2.3.1 Identification of yeast and mammalian C2-related proteins 
In order to understand the function of C2 and how it is involved in the tissue-specific 
disorder SEDT we undertook a BLAST search of yeast and mammalian databases for C2-
related proteins. Our initial hypothesis was that such proteins may compensate for a lack of C2 
function in some, but not all, tissues. A BLAST search of GenBank using the yeast S.cerevisiae 
subunit Trs20p (C2 ortholog) as a query revealed two different proteins: the well-characterized 
C2 (33% identity, 52% similarity) and a related protein that we will call C2-like (C2L; 27% 
identity, 47% similarity). Using C2L as a query we found that this subunit is present throughout 
metazoans and is highly conserved (Figure 2.1). Of particular note is the fact that a previously 
uncharacterized S.cerevisiae open reading frame, YEL048c, clusters with C2L orthologs (Figure 
2.1). In addition, the independent clustering of C2 and C2L indicate that these proteins are 
distinct and likely arose early in eukaryotic lineage. On the other hand, it appears that functional 
constraints may have limited the divergence of these proteins from each other as C2 and C2L 
display 28% identity and 50% similarity over ~100 residues. While related to C2L, the 
uncharacterized YEL048cp is more divergent from the mammalian protein (24% identity, 43% 
similarity) than is the yeast C2 ortholog from its mammalian counterpart (see above). 
Furthermore, YEL048cp and Trs20p are more divergent (23% identity, 43% similarity over 103 
residues) than are their mammalian counterparts (see above). YEL048c is non-essential in 
yeast, and its greater divergence from its mammalian ortholog may reflect lower selective 
pressure in this organism relative to that operating on Trs20p/C2. The presence of C2 and C2L 
pairs across species suggests a conserved functional divergence between the two proteins. 
A comparison between the various C2 and C2L proteins by multiple sequence alignment 
revealed only two invariant residues and several nearly invariant but similar residues (Figure 
2.1). The invariant residues Leu46-Asp47 (human numbering) are particularly noteworthy since 
these are found at the surface of the protein (Jang et al., 2002;Kim et al., 2006) (Figures 2.2 and 
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2.3) and since an Asp47→Tyr missense mutation in C2 has been noted for one SEDT patient 




Figure 2.1 C2L is highly conserved and related to C2. Full-length sequences of C2 (indicated 
with a red star) or C2L proteins (indicated with a blue star) or their budding yeast orthologs were 
aligned using ClustalW and a phylogram generated. The independent clustering of C2 and C2L 
indicates these are distinct proteins. Note the clustering of the uncharacterized S.cerevisiae 




HumTRAPPC2  R-HLNQFIAHAALDLVDEN---MW--LSNN 
PonTrappC2  R-HLNQFIAHAALDLVDEN---MW--LSNN 
PanTRAPPC2  R-HLNQFIAHAALDLVDEN---MW--LSNN 
MacTRAPPC2  R-HLNQFIAHAALDLVDEN---MW--LSNN 
RatTRAPPC2  R-HLNQFIAHAALDLVDEN---MW--LSNN 
MusTRAPPC2  R-HLNQFIAHAALDLVDEN---MW--LSNN 
DogTRAPPC2  R-HLNQFIAHAALDLVDEN---MW--LSNN 
CowTRAPPC2  R-HLNQFIAHAALDLVDEN---MW--LSNN 
EquTRAPPC2  R-HLNQFIAHAALDLVDEN---MW--LSNN 
ChkTRAPPC2  R-HLNQFIAHAALDLVDEN---MW--LSNN 
OppTRAPPC2  R-HLNQFIAHAALDLVDEN---MW--LSNN 
XenTRAPPC2  R-HLNQFIAHAALDLVDEN---MW--LSNN 
ZbfTRAPPC2  R-HLNQFIAHAALDLVDEN---MW--LSNN 
DroTRAPPC2  R-HLTQFIAHAALDLVDEH---KWKTA--- 
ElgTRAPPC2  R-HLNHYIGHAALDIVDEH------ALTTS 
CerTRS20P   K-ELNPFILHASLDIVEDL---QW-QINPT 
PomTrs20p   S-HLNQFIVHSSLDIVD-----QL-QWTSN 
PomSedFam   RY---QYLGELSLDVIND--------LVND 

















Figure 2.2 Multiple sequence alignments  of C2 and C2L  
 
When all identified C2 and C2L proteins are compared, only two amino acid residues show 
absolute conservation (highlighted in black). The Asp47 residue of C2 is mutated in some 
patients with SEDT. Residues showing 75% identity between C2 and C2L are highlighted in 
dark grey.  Residues showing 75% similarity between C2 and C2L are highlighted in light grey. 
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Abbreviations and accession numbers for the proteins used in this figure are: C2L- Chimpanzee 
(Pan), XP_001138135; Orangutan (Pon), NP_001125486; Human (Hum), NP_057293; Rhesus 
Macaque (Mac), XP_001090102.1; Mouse (Mus), AAI14969; Rat, AAI68734; Cow, AAI46229; 
Dog, XP_850022.1; Horse (Equ), XP_001488385.1; Chicken (Chk), XP_414207.1; X. laevis 
(Xen), NP_001011228.1; Zebrafish (Zbf), NP_001003506; D. melanogaster (Dro), 
NP_610662.1; C.elegans (Elg), NP_001033370.1; Opposum (Opp), XP_001366474.1; S. 
Cerevisiae (Cer), NP_010816.1; S. Pombe (Pom), NP_594299.1. C2- Chimpanzee, 
XP_001145048.1; Orangutan, NP_001124790.1; Human, NP055371.1; Rhesus Macaque, 
XP001092331.1; Mouse, NP_079595.1; Rat, NP_001020136.1; Cow, NP_001029968.1; Dog, 
XP_537957.1; Horse, XP_001489143; Chicken, NP_001006263.1; X. laevis, NP_001087961.1; 
Zebrafish, NP_001070243.1; D. melanogaster, NP_648841.1; C. elegans, NP_508272.1; 









Figure 2.3 Comparison of the structures of C2 and C2L. (A) An overlay of human C2L on the 
previously determined structure of C2 in complex with C3 and C5 suggests possible roles for 
conserved amino acids. Five human C2L residues (Pro14, Leu36, Asp37, Leu58, and Asn113) 
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are conserved in all Trs20p-related proteins examined, with the exception of Zebrafish C2, 
where only Leu46 and Asp47 are conserved and are indicated in yellow along with their 
positions in C2. A closer view of each of these residues is shown in (B). C2 residue Asn112 
(equivalent to Asn113 in C2L) was previously implicated in C3 interactions. The C2 residue 
Asp47 (equivalent to Asp37 in C2L) has previously been shown to be mutated in a case of 
spondyloepiphyseal dysplasia tarda (SEDT). The remaining residues, Pro16 (equivalent to 
Pro14 in C2L) and Leu61 (equivalent to Leu58 in C2L), are surface-exposed in this model 
suggesting a possible role in other molecular interactions. (C) YEL048C is non-essential in 
S.cerevisiae, and may therefore be less highly conserved than the essential Trs20p. An 
alignment of mammalian C2/C2L proteins versus S.cerevisiae Trs20p reveals a further region of 
homology in the carboxy-terminus. With the exception of the Asn-Pro-Phe-Tyr loop previously 
described to play a role in C3 interactions, these amino acids (shown in yellow) appear to be 
oriented towards the interior of the protein in this model, suggesting a structural role. C2 Val130 
(gold) is the site of a known SEDT missense mutation. 
 
2.3.2 Expression pattern of C2, C2L and C2.19 
To begin characterizing C2L and C2 we examined their expression in cells using semi-
quantitative reverse transcriptase (RT)-PCR. Included in these studies was the expression 
pattern of a gene encoded on human chromosome 19 that can potentially encode a protein 
identical to C2. This gene has been referred to as SEDLP1 and it was originally thought to be a 
pseudogene (Gecz et al., 2000) but here we refer to it as C2.19. A previous report suggested 
differential expression of C2 and C2.19 but the probe used was not exclusive to either of the 
genes (Ghosh et al., 2001). As shown in Figure 2.4 left panel, C2L, C2 and C2.19 were 
expressed in all cell lines examined. Of particular interest was the fact that all of these genes 
were expressed in primary cultures of human chondrocytes cells that are predominantly thought 
to be affected in SEDT patients (Figure 2.4 left panel). Previous studies demonstrated broad 
expression of C2 (Gedeon et al., 1999;Ghosh et al., 2003;Mumm et al., 2001) and we found that 
C2L was also broadly expressed (Figure 2.4 right panel top). These studies indicate that C2L 
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and C2 are broadly co-expressed and further provide the first evidence that both C2 and C2.19 
are co-expressed within the same cell. Interestingly, C2.19 was found in polysomes (Figure 2.4 
right panel bottom), suggesting that it is actively translated. The apparent broad co-expression 
of three Trs20p-related proteins further complicates the elucidation of the precise mechanism by 




Figure 2.4 Gene expression patterns of C2, C2.19 and C2L. Total RNA from the indicated cells 
or tissues was subjected to RT-PCR as described in Materials and Methods. The expression of 
C2L, C2 and C2.19 was examined in several cell lines (HeLa, HEK293, A549) as well as in 
primary human chondrocytes (left panel). The expression of C2L was examined in various 
mouse tissues (right panel top). The presence of C2 and C2.19 in polysomes was examined by 
RT-PCR after collecting polysomes through a sucrose gradient as described in Materials and 







2.3.3 YEL048c displays genetic interactions with TRAPP genes 
To begin characterizing the relationship between C2L and C2 we explored genetic 
interactions between the genes encoding their yeast orthologs YEL048c and TRS20, 
respectively. To this end we first compared suppression of temperature-sensitive alleles in 
genes encoding TRAPP subunits by overexpression of YEL048c or known TRAPP genes. For 
this analysis we used bet3-5, bet5-2, trs20-1 and trs130-1, the latter encoding a TRAPP II-
specific subunit. Overexpression of YEL048c suppressed the growth phenotype of each mutant 
except for bet3-5 (Figures 2.5 and 2.6). In the case of trs130-1, YEL048c and two other genes 
encoding TRAPP II-specific proteins (TRS65 and TRS120) were the only genes capable of 
suppressing the growth phenotype. These results clearly show genetic interactions between 




Figure 2.5 Genetic interactions between YEL048c and genes encoding TRAPP subunits. Yeast 
strains containing bet5-2, trs20-1 or trs130-1 were transformed with a pRS425-based plasmid 
containing either the wild type TRAPP subunit-encoding genes (BET5, TRS20, BET3, TRS23, 
TRS31, TRS33, TRS65, TRS85, TRS120 and TRS130) or YEL048c. Ten-fold serial dilutions 
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were spotted onto rich medium and grown either at permissive temperature (25°C) or restrictive 




Figure 2.6 Temperature sensitivity of bet3-5 can be suppressed by several TRAPP subunits but 
not with YEL048c. A yeast strain containing bet3-5 was transformed with a pRS425-based 
plasmid containing either the wild type TRAPP subunit-encoding genes (BET5, TRS20, BET3, 
TRS23, TRS31, TRS33, TRS65, TRS85, TRS120 and TRS130) or YEL048c. Ten-fold serial 
dilutions were spotted onto rich medium and grown either at 25°C or 30°C. 
 
As a further measure of genetic interactions between the genes encoding TRAPP 
subunits and YEL048c we asked whether the disruption of the latter (yel048cΔ) displayed 
synthetic genetic interactions in combination with the TRAPP mutants above or with disruptions 
of the non-essential TRAPP genes trs33Δ, trs65Δ and trs85Δ. As described in Table 2.2 and 
yel048cΔ did indeed display synthetic lethality in combination with trs20-1, bet3-5 and trs65Δ 
and synthetic sickness with trs33Δ. Interestingly, the lethality of a yel048cΔ /trs65Δ double 
disruption can be suppressed by overexpression of TRS130 (Figure 2.7). Overall our analysis 
implicates YEL048c as genetically interacting with six of the TRAPP genes tested. Notably, 
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there is a pronounced genetic link between YEL048c and the genes encoding TRAPP II 
subunits (TRS130, TRS120, TRS65) suggesting that the protein encoded by YEL048c may 
interact with or modulate the activity of TRAPP II. 
 
 
 synthetic lethality or sickness 
in a yel048cΔ crossa 
suppression of single TRAPP gene 
alleles by YEL048c overexpression 
bet5-2 No yes 
trs20-1 Lethal yes 
bet3-5 Lethal no 
trs33Δ sickb (not tested) 
trs65Δ Lethal (not tested) 
trs85Δ No (not tested) 
trs130-1 No yes 
 
Table 2.2 Summary of YEL048c – TRAPP genetic interactions in yeast. 
aA minimum of 20 dissected tetrads were examined for co-segregation of yel048cΔ (marked by 
G418 resistance) and either the temperature-sensitive phenotype (for bet5, trs20, bet3 and 
trs130) or the His+ phenotype (for trs33Δ, trs65Δ and trs85Δ). bAll 22 colonies that displayed co-





Figure 2.7 yel048c mutant (yel048cΔ /trs65Δ) is suppressed by TRS130. The double mutation 
yel048cΔ /trs65Δ strain was generated in which the chromosomal copy of YEL048c was deleted 
(yel048cΔ) and a copy of wild type YEL048c was maintained on a URA3-based plasmid. The 




2.3.4 YEL048cp and C2L physically interact with TRAPP 
Given the genetic interactions presented above we next asked if the gene product of 
YEL048c can interact with TRAPP. A yeast lysate containing TAP-tagged YEL048cp was 
fractionated by size exclusion chromatography and YEL048cp was detected with an anti-TAP 
tag antibody. We also probed the fractions for the presence of Trs33p, found in both TRAPP I 
(low molecular weight) and TRAPP II (high molecular weight). As shown in Figure 2.8, 
YEL048cp was found in a high molecular weight fraction that co-fractionated with the high 
molecular weight peak for Trs33p. This result suggested that YEL048cp might physically 
interact with TRAPP and preferentially with yeast TRAPP II. Indeed, an interaction was 
confirmed by detection of Trs33p co-precipitating with TAP-tagged YEL048cp from a total cell 
lysate (Figure 2.8). It should be noted that a second pool of YEL048cp is occasionally found if 
cells are disrupted using a more harsh glass bead lysis procedure. This second pool is smaller 
than the lower molecular weight TRAPP I complex (not shown) and may result from the 




Figure 2.8 YEL048cp co-fractionates with the TRAPP II peak in yeast. A yeast lysate was 
prepared from spheroplasts from a strain in which YEL048cp is modified with a carboxy-terminal 
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TAP tag. The lysate was fractionated on a Superdex-200 size exclusion column and 1 mL 
fractions were collected and analyzed by western blotting using anti-Trs33p serum or anti-TAP 
antibody. (Inset) Lysates from untagged (lane 1) or TAP-tagged YEL048cp (lane 2) were treated 
with IgG-sepharose and the precipitates were probed with anti-Trs33p serum. 
 
 
We surmised that if YEL048cp interacts with TRAPP and is related to Trs20p then it may 
interact with the same TRAPP subunits that interact with Trs20p. We have recently shown that 
the mammalian Trs20p ortholog, C2, interacts with an interface presented by the C3-C5 
heterodimer (Kim et al., 2006), equivalent to yeast Bet3p-Trs31p. Therefore we co-expressed 
YEL048cp with 6x histidine-tagged Bet3p and Trs31p and purified the proteins on a Ni2+-NTA 
column. We detected YEL048cp co-purifying with the Bet3p-Trs31p heterodimer (Figure 2.9, 
lanes 1 and 2) indicating that the protein can indeed interact in this recombinant system with the 




Figure 2.9 YEL048cp/C2L interacts with same interface that binds Trs20p/C2 in vitro. Lysates 
from various E.coli strains co-expressing yeast and mammalian TRAPP subunits were 
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subjected to purification over a Ni2+-NTA affinity column. The strains co-expressed: His-Bet3p, 
Trs31p and either Trs20p (lane 1) or YEL048cp (lane 2); His-C3, C5 and either C2 (lane 3) or 




To assess whether C2L was behaving in a similar fashion as its yeast ortholog we 
transfected HEK293 cells with C2L containing a FLAG tag (FLAG-C2L) and prepared total cell 
lysates that were fractionated by size exclusion chromatography. In this assay, FLAG-C2L, like 
endogenous C2 and C3, is found in both high molecular weight and lower molecular weight 
fractions (Figure 2.10), the latter likely representing unassembled subunits or small heteromeric 
sub-complexes of TRAPP. Note that, while typical of mammalian TRAPP fractionation profiles 
(Loh et al., 2005;Sacher and Ferro-Novick, 2001), these results contrast with the size 
fractionation observed in yeast, where discrete high molecular weight TRAPP I and TRAPP II 
complexes are readily visualized (Sacher et al., 2001). As with the yeast results above, these 
results showing similar fractionation profiles of C2L, -C3 and -C2 suggested that C2L may 
interact with TRAPP. As shown in Figure 2.9 (lane 4), like C2 (lane 3), recombinant C2L could 
indeed bind to the C3-C5 heterodimer. Interestingly, the ability of the yeast and mammalian 
proteins to interact across species is preserved as C2 and C2L could bind to yeast Bet3p-
Trs31p (Figure 2.9, lanes 5 and 6) strengthening our hypothesis of conservation of C2/Trs20p 






Figure 2.10 C2L co-fractionates with the high molecular weight peak of mammalian TRAPP. A 
lysate from HEK293 cells transfected with FLAG-C2L was fractionated on a Superdex-200 
column as above. Samples were analyzed by western blotting using antibodies to the FLAG 
epitope (C2L), C2 and C3. 
 
 
To examine whether C2L also interacts with TRAPP in vivo we tagged C2L and C2 with 
a TAP tag to allow for purification of the protein and associated proteins under native conditions. 
Both tagged proteins were indeed capable of co-precipitating with other TRAPP subunits 
(Figure 2.11). Interestingly, and somewhat unexpectedly, TAP-tagged C2L and C2 could 
precipitate each other (Figure 2.11). Together with the yeast results above, these results 
confirm that C2L/YEL048cp interact with TRAPP in vivo and suggests they are in the same 





Figure 2.11 C2L binds to TRAPP in vivo. HEK293 cells were transfected with plasmids 
expressing C2-TAP or C2L-TAP, and lysates were prepared and purified on IgG-sepharose 
beads. Bound proteins were eluted by TEV cleavage and analyzed by western blotting for the 
presence of TRAPP subunits. The top panel was probed with anti-C4, the middle panel with anti 
C3, and the lowest panel with anti-C2. Note that the anti-C2 used weakly cross-reacts with C2L 





The latter result also suggests that, although C2L can interact with the same 
heterodimer as C2 in vitro (namely, C3-C5; see Figure 2.9), this mode of interaction may not 
reflect the in vivo situation since both subunits are found in the same complex simultaneously, 
suggesting discrete binding sites. We and others have shown that the C3-C5 (the C2 binding 
subunits) portion of the complex is structurally related to the C3-C6 dimer (Kim et al., 2005a and 
2006 ;Kummel et al., 2006) found on the opposite side of the TRAPP complex (Kim et al., 
2006). The C3-C6 interface equivalent to the C3-C5 interface that binds C2 is unoccupied in the 
current model (Kim et al., 2006) and therefore represents a likely site of C2L binding. To directly 
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test this possibility we co-expressed C3, C6a and C2L in our recombinant protein expression 
system. When 6X histidine-tagged C3-C6a was purified on Ni2+-NTA beads, C2L, but not C2, 
co-purified (Figure 2.12) suggesting that C2L interacts with C3-C6a while C2 interacts with the 




Figure 2.12 C2L interacts with the interface opposite that to which C2 binds. Lysate from an 
E.coli strain co-expressing His-C3 and C6a with either C2 (lane 1) or C2L (lane 2) were 
subjected to Ni2+-NTA affinity purification followed by SDS-PAGE. Expression of C2 was verified 
by western analysis. 
 
 
A tentative model of TRAPP based on these results and previous structural data (Kim et 







Figure 2.13 The architecture of TRAPP in complex with the C2L subunit. The structure of C2L 
was modeled using the known crystal structure of C2 (Jang et al., 2002). The C2L protein was 
then manually docked onto the previously published structure of mammalian TRAPP (Kim et al., 
2006). Since C2L binds to C3-C6a (Figure 2.9) and C2 binds to C3-C5 (Kim et al., 2006), and 
since C2L and C2 are predicted to be structurally related, C2L was oriented to interact with C3-
C6a in the same fashion as C2 interacts with C3-C5. The actual orientation of C2L with respect 
to the complex is unknown and hence the model presented is highly speculative. 
 
 
2.3.5 Membrane distribution of C2 and C2L 
We next examined whether C2 and C2L were found on similar intracellular membranes. 
To address this, membranes from HEK293 cells were collected by high-speed centrifugation 
and subjected to equilibrium-gradient centrifugation in OptiPrep. Fractions were collected and 
probed for C2L and TRAPP subunits. As shown in Figure 2.14, C2L was found in a single peak 
of very low density membranes (VLDM, peak in fraction 2). C2 and other TRAPP subunits were 
also found in this fraction but were further found in a second peak of intermediate density 
membranes (IDM, fractions 5 and 6). In order to identify the membranes in each of these 
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fractions we probed the gradient fractions with antibodies to various early secretory pathway 
marker proteins. The IDM overlapped with markers for the Golgi including Mannosidase II and 
GM130 (fractions 5-6; Figure 2.14). The peak of ERGIC53, the marker used to identify the ER-
to-Golgi intermediate compartment (ERGIC), was separated from the peak of the Golgi markers 
suggesting that the IDM represents Golgi and that mammalian TRAPP is found on Golgi 
membranes in these cells as it is in yeast (Sacher et al., 1998;Barrowman et al., 2000). The 
yeast TRAPP II complex has been reported to play a role in endosome-to-Golgi trafficking (Cai 
et al., 2005). Since the VLDM fraction did not significantly overlap with Golgi or ERGIC markers, 
we asked whether this fraction contained the early endosome marker EEA1. Although partially 
overlapping, the peak of EEA1 was offset from the peak of C2L (Figure 2.14). The identity of the 
C2L-associated VLDM therefore remains unresolved at this time. 
 
The relationship between the TRAPP complexes found in the VLDM and IDM was 
further characterized by overexpression of C2L (using FLAG-C2L) in HEK293 cells and 
examination of the distribution of the protein on membranes. We found that overexpressed C2L 
appeared additionally in the IDM fraction (Figure 2.14, FLAG-C2L). These results suggest that 
C2L can readily interact with TRAPP in vivo and that C2L in the VLDM fraction may reflect its 









Figure 2.14 C2L resides on very low density membranes. C2L and C2 were fractionated by 
equilibrium gradient centrifugation. Membranes from HEK293 cells either transfected with 
FLAG-C2L or untransfected were subjected to equilibrium gradient centrifugation using 
OptiPrep for 16 h. Fractions of 1 mL were collected from the top of the gradient and analyzed by 
western blotting. Shown are the results for C2L, overexpressed C2L (FLAG-C2L), C2, C3 and 
the organelle markers GM130 and Mannosidase II for the Golgi, ERGIC53 for the ERGIC, EEA1 
for endosomes and Sam68 for the nucleus. 
 
 
2.3.6 C2L and C2 are required for Golgi dynamics 
To begin to address the function of C2L we examined the effects of knocking down its 
expression using small interfering RNA (siRNA) and compared it to a C2 knockdown. We first 
examined the effect of knockdowns on the localization of the Golgi enzyme Mannosidase II and 
the Golgi matrix protein GM130 since C2L and C2 fractionate with Golgi markers (Figure 2.16) 
and since yeast TRAPP is implicated in Golgi dynamics (Sacher et al., 1998 and 
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2001;Barrowman et al., 2000). Small interfering RNA directed against C2 and C2.19 efficiently 
reduced the levels of the protein by 75-90% while siRNA directed against C2L drastically 




Figure 2.15 Demonstration of C2 and C2L knockdowns. HeLa cells were treated with siRNA 
directed against either C2 (top panel, left , lane 1) or non-specific siRNA (top panel, left, lanes 2-
5) and the protein levels were analyzed by western blotting. A loading control for the non-
specific knockdown was performed (indicated above lanes 2-5) to estimate the degree of C2 
knockdown which was estimated to be between 75% and 90%. Cells treated with siRNA against 
C2L (top panel, right, lane 1) or non-specific siRNA (top panel, right, lane 2) were analyzed for 
C2L transcript levels by RT-PCR and normalized to GAPDH. Extracts from cells treated with 
non-specific siRNA (bottom panel, lane 1), or two different siRNAs directed against either C2 
(bottom panel, lanes 2 and 3), C2L (bottom panel, lanes 4 and 5) or C3 (bottom panel, lanes 6 
and 7) were probed for C2 and C3 levels. Note that C2 levels are reduced ~50% in the C3 




In cells transfected with a non-specific siRNA, Mannosidase II localizes in the Golgi and 
demonstrates a compact or slightly extended tubular morphology in the perinuclear region 
(Figures 2.16 and 2.17). Knockdown of both C2L and C2 leads to a marked increase in 
fragmentation of the Mannosidase II signal (Figures 2.16 and 2.17). Interestingly, these punctae 





Figure 2.16 C2L and C2 knockdowns lead to Golgi fragmentation. Immunofluorescence was 
performed on HeLa cells following treatment with either non-specific siRNA (NS), C2L-directed 
siRNA (C2L) or C2-directed siRNA (C2). Localization was performed for Mannosidase II and 
GM130. Merged images include DAPI staining (blue) to reveal the nucleus. The increased 
punctate elements observed upon depletion of C2L and C2 represents the Golgi as punctate 
structures persist in co-localization with the Golgi markers.  







Figure 2.17 Punctate phenotype of the Golgi increases following C2L and C2 knockdowns. The 
fragmentation phenotype following the indicated knockdowns was quantitated for 128 (C2L 
knockdown), 312 (C2 knockdown) and 227 (non-specific) cells. Representative images used for 
scoring are shown. Note that punctate was defined as covering an area beyond the perinuclear 
region, while extended was largely confined to the perinuclear region but covering an area 
slightly larger than that in comparison to compact. 
 
 
To gain better insight into the nature of these punctae, we examined the effect of the 
knockdowns on the localization of the ERGIC marker ERGIC53. This protein shows both 
perinuclear and peripheral fluorescence in cells treated with a non-specific siRNA (Figures 2.16 
and 2.18). In both the C2L and C2 knockdowns there is a loss in the perinuclear ERGIC53 
signal with a concomitant increase in a punctate fluorescence that continues to co-localize with 
the two other Golgi markers (Figures 2.16 and 2.18). However, there remains ERGIC53 staining 
elsewhere in the cell periphery that does not co-localize with either of the Golgi markers 
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suggesting that Mannosidase II and GM130 are not accumulating in the ERGIC. Importantly, 
there is no accumulation of any of these markers in an ER-like compartment as would be 
expected for proteins that recycle to the ER but encounter a block in ERGIC formation. These 
results implicate C2 and C2L in the same or related trafficking pathways, and demonstrate that 
the integrity of the Golgi is severely compromised upon ablation of either protein.  
 
     
Figure 2.18 Elevated punctate phenotypes upon C2L and C2 knock down do not accumulate at 
ER-Golgi interface (ERGIC compartments). Immunofluorescence was performed whereby either 
C2L or C2 were knocked down via siRNA against the respective genes of interest. The ERCIG 




2.3.7 C2L cannot compensate for the loss of trs20 
   Although the results above suggest that both C2L and C2 are required for Golgi 
dynamics, the pairwise presence of both genes across species (Figures 2.1 and 2.2) and their 
overlapping expression patterns (Figure 2.4) suggest they may have distinct functions. To test 
this we asked whether C2 and C2L could compensate for the loss of the gene encoding the 
essential yeast C2 ortholog TRS20. We constructed a haploid yeast strain in which the genomic 
copy of TRS20 is disrupted (trs20Δ) but the cells are kept alive with a URA3-based plasmid 
containing TRS20. This plasmid can be counter-selected on plates containing the compound 5-
fluoroorotic acid (5-FOA). The trs20Δ strain was transformed with an empty vector, or a vector 
containing TRS20, YEL048c, C2 or C2L. As shown in Figure 2.19 only C2 and TRS20, but not 
C2L and YEL048c, could compensate for the loss of trs20 as evidenced by growth on plates 
containing 5-FOA. This is presumably not due to an inability of C2L to interact with the yeast 
TRAPP complex as we previously showed this interaction takes place (see Figure 2.9 and data 
not shown). This result confirms that C2 is the functional ortholog of Trs20p, consistent with an 
earlier study that used a stronger GAL1 promoter (Gecz et al., 2003). This result also further 
indicates that C2L cannot replace the function that C2 performs in the trs20Δ strain. Although 
yel048cΔ does not display any detectable growth phenotype (unpublished observation), the 
double mutant yel048cΔ /trs65Δ is lethal (see Table 2.2). However, we found that neither C2 nor 
C2L could complement this lethality (not shown). The inability of C2L to complement yel048cΔ 
is not entirely unexpected as the two proteins are more divergent than are C2 and TRS20 (see 
Figures 2.1 and 2.2). This result indicates that the ability of C2 to compensate for a trs20 





     
 
Figure 2.19 C2 and C2L are functionally distinct. A trs20Δ haploid strain kept alive with a 
URA3-based-TRS20 plasmid was transformed with either an empty vector, or a vector 
containing either TRS20 under its endogenous promoter, a high-copy vector containing 
YEL048c under its endogenous promoter, or either C2 or C2L under control of the ADH1 
























We describe a novel mammalian protein, C2L that interacts with the TRAPP complex in 
vitro and in vivo. We show that its yeast counterpart, YEL048c, encodes a protein that has 
strong genetic interactions with genes encoding TRAPP II subunits suggesting this protein may 
physically interact with yeast TRAPP II. Indeed, we report a co-fractionation of YEL048cp with 
TRAPP II by size exclusion chromatography and an interaction between this protein and TRAPP 
both in vivo and in vitro. Recombinant protein expression and purification suggest that C2L 
binds to the TRAPP complex on a side opposite to that of C2 and adds another level of 
complexity to the architecture of TRAPP. Should this model be validated, the inclusion of C2L 
imparts a remarkable symmetry along the C1-C4 axis. 
 
2.4.1 C2L as a marker for mammalian TRAPP II 
In mammalian cells C2L is found in the VLDM fraction but overexpression leads to its 
appearance additionally in the IDM fraction, membranes where C2L is not normally found but 
which do contain other TRAPP subunits. This suggests that C2L has the ability to interact with 
the TRAPP complex found in the IDM fraction. The identity of the VLDM fraction is presently 
unknown. Given the partial overlap of this fraction with EEA1, it is tempting to speculate that the 
VLDM membranes are similar to the endosome-like structures with which a portion of C3 was 
found to associate at the ultrastructural level (Yu et al., 2006).  
 
The two yeast TRAPP complexes are readily separated by size exclusion 
chromatography (Sacher et al., 2001). This is not the case in mammalian cells, suggesting that 
one of the complexes may be more labile or, alternatively, smaller subunits or interacting 
proteins dictate the distinction between the two complexes. The latter notion is supported by a 
recent report demonstrating the existence of multiple mammalian TRAPP complexes that can 
be distinguished by the subunit isoforms they contain (Kummel et al., 2008). Based on its 
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fractionation, interactions and effect on Golgi integrity, as well as the genetic and physical 
interactions between its yeast ortholog YEL048c and TRAPP II, we propose that C2L interacts 
with or is a component of a mammalian TRAPP II complex. Such a proposal implies distinct 
functions for C2 and C2L which is supported by their pairwise expression over multiple species 
and the ability of C2, but not C2L, to compensate for the loss of TRS20. An alternative 
interpretation of this latter result is the fact that C2 and C2L may be functionally redundant in 
mammals but divergent enough such that only C2 can compensate for the yeast TRS20 gene. 
While we cannot exclude such an explanation, we note that we have identified a C2-specific 
interactor, using a yeast two hybrid screen, that fails to interact with C2L (S. Hul and M.S., 
unpublished observation), further suggesting a functional distinction between these proteins. 
 
2.4.2 Possible function in membrane traffic 
The co-localization of Mannosidase II and GM130 with a portion of ERGIC53 in both 
C2L and C2 knockdown cells suggests that the Golgi is disintegrating. How, precisely, do C2L 
and C2 regulate Golgi integrity? It is not unreasonable to speculate that, like the yeast system, 
C2L in the context of mammalian TRAPP II regulates traffic to or through a late Golgi 
compartment. Likewise, the mammalian equivalent of TRAPP I may regulate traffic between the 
ERGIC and Golgi. The earliest stage after ERGIC biogenesis that we envision TRAPP I 
involved in is the transition between what has been referred to as the late intermediate 
compartment and the cis-Golgi (Marra et  al., 2001). This would again parallel the function of the 
highly conserved yeast TRAPP I complex that also accepts membranes (vesicles) at the cis-
Golgi. 
 
C3 was suggested to be involved in ERGIC biogenesis and proposed to be localized to 
transitional ER by immunofluorescence microscopy (Yu et al., 2006). Our studies suggest that 
C3 and other TRAPP subunits co-fractionate with markers for the Golgi and fractionate away 
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from the ERGIC marker protein ERGIC53. One explanation for this apparent discrepancy is the 
methodology used. Localization of TRAPP subunits to specific membranes by 
immunofluorescence microscopy is challenging, due to their large soluble pools. Removal of this 
pool by collection of membranes allowed us to visualize their co-fractionation on gradients with 
Golgi markers. Our fractionation results parallel those of the yeast system where TRAPP 
localizes to Golgi membranes (Sacher et al., 1998;Barrowman et al., 2000).  
 
The Golgi fragmentation phenotype that we observed in the C2L and C2 knockdown is 
very similar to that seen for the knockdown of a subunit of the COG vesicle-tethering complex 
that has also been shown to function in Golgi dynamics (Zolov and Lupashin, 2005 ;Shestakova 
et al., 2006). Although a C3 knockdown showed GM130 fragmentation (Yu et al., 2006), we 
have noted that this knockdown reduces the levels of C2 (Figure 2.15), indicating this may be 
an indirect effect of the C3 knockdown. In addition the Golgi enzyme galactosyltransferase 
redistributes to the ER upon C3 inactivation (Yu et al., 2006) in contrast to the punctate, 
GM130-associated localization we observed for Mannosidase II. This could reflect a role of C3 
in ERGIC biogenesis which may be specific to this subunit as recently suggested (Sacher et al., 
2008). 
 
Our studies suggest a site of interaction between C2L and the TRAPP complex. The 
simplest model (Figure 2.13) places C2L on the side of the complex opposite that of C2. 
Consistent with this notion are the findings that residues important for C2 binding to the complex 
are conserved in C2L (Figure 2.3) and yel048cΔ displays a synthetic genetic interaction with 
trs33Δ. We cannot yet exclude the possibility that isoforms of TRAPP containing either C2 or 
C2L bound to the C3-C5 interface form independently and associate during membrane transport 
events through the Golgi. Alternatively, sub-complexes of TRAPP, containing either C2L or C2, 
may associate to mediate distinct trafficking events. 
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2.4.3 Implications for SEDT 
The skeletal disorder SEDT has been shown to be caused by mutations in C2. Our 
expression analysis raises the question: how do C2.19 and C2L affect the molecular basis of 
SEDT? We provide evidence that C2.19 is expressed and translated. We also show that it is 
expressed in primary chondrocytes from femoral condyles derived from female patients. Since 
factors such as weight-bearing load and neighboring tissue are known to influence gene 
expression (Ben-Ze'ev et al., 1988;Raab-Cullen et al., 1994;Little et al., 1996) and since SEDT 
is a sex-linked disorder, a more detailed expression analysis of C2 compared to C2.19 in 
affected males is needed.  
 
We have shown that C2L is expressed in multiple mouse tissues and in human 
chondrocytes (Figure 2.4). Bioinformatic resources (e.g. http://www.genecards.org) similarly 
indicate broad expression of C2L in humans. With the same cautions mentioned above this may 
also point to a functional distinction between C2 and C2L. Like C2.19, this speculation also 
awaits analysis of SEDT patient chondrocytes. Sequence conservation of Asp47 between C2L 
and C2 implies that this residue, shown to be pathogenic in an SEDT patient, is important for 
the function of both proteins. Curiously, we have found that mutation of the Asp47 yeast 
equivalent in TRS20 does not lead to a recognizable phenotype under standard laboratory 










A trs20 mutation that mimics an SEDT-causing mutation blocks selective and non-
selective autophagy: A model for TRAPP III organization 
All of the work in this Chapter was recently published in the journal Traffic in July 2013. I am co-
first author of this manuscript and my contribution is as follows: Figures 3.1-3.8, 3.11, 3.13, 





The ability of a cell to properly localize its protein complement is critical for the cell to 
function correctly. Referred to as membrane transport, the process is mediated by vesicle 
carriers that move between various compartments. There are many factors involved in ensuring 
the fidelity of this process and defects in this trafficking process lead to numerous disorders 
(Aridor and Hannan, 2000 and 2002). Although strong defects in membrane traffic would be 
expected to result in embryonic lethality, more subtle mutations may lead to tissue-specific 
disorders. 
 
The overall process involves tethering factors, small GTP-binding proteins of the Rab 
family, coat proteins that encompass the transport vesicles and SNARE proteins that are 
involved in vesicle fusion with the target membrane (Cai et al., 2007a) . Intimate connections 
between each of these factors have been identified in various transport steps. In transport 
between the endoplasmic reticulum (ER) and Golgi in yeast, the tethering factor TRAPP I binds 
to the coat protein Sec23p, thus acting to bridge the vesicle and the target membrane (Cai et 
al., 2007b;Lord et al., 2011). In addition, as a guanine nucleotide exchange factor (GEF), 
TRAPP I activates the GTPase Ypt1p (Jones et al., 2000;Wang et al., 2000). Although a direct 
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link between TRAPP I and SNAREs has yet to be demonstrated, SNARE complex assembly is 
impaired in a bet3 mutant, a gene that encodes an essential TRAPP I subunit (Rossi et al., 
1995). Thus, as a tethering factor, TRAPP I serves to link all of these processes to ensure 
proper targeting of ER-derived transport vesicles. 
 
TRAPP I is composed of six distinct polypeptides (Bet5p, Bet3p, Trs20p, Trs23p, 
Trs31p, Trs33p) although the levels of Trs20p appear to be sub-stoichiometric in this complex 
(Sacher et al., 2001). Two related complexes called TRAPP II and III have also been described 
(Sacher et al., 2001;Lynch-Day et al., 2010). Each complex contains the TRAPP I core along 
with unique polypeptides: Trs65p, Tca17p, Trs120p and Trs130p for TRAPP II, and Trs85p for 
TRAPP III (Montpetit and Conibear 2009;Choi et al., 2011 ;Sacher et al., 2001;Lynch-Day et al., 
2010). TRAPP II has been implicated in traffic at the late Golgi, endocytosis and 
macroautophagy (Cai et al., 2005;Zou et al., 2013; Sacher et al., 2001) and TRAPP III has been 
shown to function in selective autophagy (Meiling-Wesse et al., 2005;Lipatova et al., 
2012a;Lynch-Day et al., 2010). Interestingly, Trs85p, the TRAPP III-specific subunit, has been 
implicated in ER-to-Golgi transport as well (Zou et al., 2012; Sacher et al., 2001). Since the 
TRAPP I core possesses Ypt1p GEF activity, both TRAPP II and III have also been shown to be 
capable of activating Ypt1p (Sacher et al., 2001;Lynch-Day et al., 2010). Indeed, Ypt1p has 
been implicated in the same membrane trafficking processes as TRAPP I, II and III (Jedd et al., 
1995;Bacon et al., 1989;Sclafani et al., 2010;Segev et al., 1988;Lipatova et al., 2012a;Lynch-
Day et al., 2010). 
 
In humans, mutations in TRAPPC2 (C2), the homolog of the yeast TRAPP I core protein 
Trs20p, have been linked to the skeletal disorder spondyloepiphyseal dysplasia tarda (SEDT) 
(Shaw et al., 2003). This X-linked disorder affects bone growth in the spine and the ends of long 
bones in the arms and legs. Patients are of short stature and develop dysplasia of joints in the 
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shoulders, hips and knees. The disorder appears to result from an inability of chondrocytes to 
secrete collagen (Tiller et al., 2001). Indeed, given the size of pro-collagen (~300nm) and the 
diameter of an ER-derived carrier (~60nm) it has been an unanswered question as to how pro-
collagen is transported between the ER and Golgi. Furthermore, understanding how a 
ubiquitously expressed protein such as C2 could lead to the phenotype seen in SEDT patients 
has been a major focus of researchers studying TRAPP. A recent report suggested that 
recruitment of C2 to ER exit sites by the pro-collagen receptor TANGO1 regulates the cycle of 
the GTPase Sar1, thus allowing carriers to achieve a size sufficient to accommodate the large 
pro-collagen molecule (Venditti et al., 2012). 
 
While elegant, we speculated that the model put forth regarding the role of C2 in pro-
collagen secretion may not explain the etiology of all SEDT mutations since yeast do not 
secrete collagen nor do they possess a readily identifiable homolog of the collagen receptor. 
Furthermore, C2-dependent Golgi fragmentation and collagen secretion are separable functions 
(Venditti et al., 2012;Scrivens et al., 2009), suggesting C2 may have several roles in the cell. 
Interestingly, an SEDT-causing missense mutation at D47 in C2 (C2D47Y) cannot suppress the 
lethality of a yeast trs20Δ mutation although wild type C2 can (Gecz et al., 2003). Since yeast 
do not produce collagen, this is an unexpected result if the sole function of C2 was in collagen 
transport. We therefore set out to characterize the interactions and function of the C2D47Y 
protein and its yeast homolog Trs20D46Y. Here we demonstrate an interaction between C2 and 
the SNARE protein Syntaxin 5 and show that this interaction is sensitive to the D47Y mutation. 
In yeast, Trs20D46Y is not involved in anterograde transport but is defective in endocytosis and 
both selective and non-selective autophagy, correlating with a destabilization of TRAPP III. We 
also show that the appearance of TRAPP III is dependent upon Atg9p and that the function of 
TRAPP III is influenced by palmitoylation of Bet3p, suggesting unexpected complexities in 
TRAPP III assembly and localization. 
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3.2 Materials and methods 
 
3.2.1 Yeast strains and molecular biological techniques 
All yeast strains were constructed using standard genetic techniques. TRS20 mutations 
were introduced by site-directed mutagenesis using High-Fidelity Polymerase (Roche) and 
expressed in yeast under the endogenous TRS20 promoter from a single-copy plasmid 
(pRS315 or pRS316). The C2D47Y mutation was constructed as above and cloned into the 
pRK5-myc plasmid facilitating detection of the mutant protein with anti-myc antibody. For yeast 
two-hybrid analysis, open reading frames were inserted into pGBKT7 or pGADT7 using either 
restriction enzyme cloning or Gateway cloning into modified, Gateway-compatible vectors 
(Scrivens et al., 2011). 
 
3.2.2 Yeast two-hybrid analysis 
Yeast cells (AH109 and Y187) were transformed with either pGBKT7 or pGADT7 
constructs. The cells were mated overnight on YPD plates and then replicated to selective 
medium (-Leucine/-Tryptophan, -Leucine/-Tryptophan/-Histidine ± 2 mM 3-aminotriazole, -
Leucine/-Tryptophan/-Histidine/-Adenine) to ensure that both plasmids were present and to test 
for an interaction. Growth was monitored daily for up to 8 days. 
 
3.2.3 Cell culture and immunoprecipitation 
HeLa and 293T cells were maintained in a humidified environment with 5% CO2 at 37°C. 
Transfections were performed using the Ca2PO4 method and 10 µg of plasmid DNA per 10 cm 
dish. In certain cases cells were treated with 10 µM N-ethylmaleimide (NEM) during the time 
course indicated in Figures 3.7 and 3.8.  
For immunoprecipitations, 500 mg of lysate prepared in lysis buffer (150 mM NaCl, 50 
mM Tris pH 7.2, 1 mM DTT, 1% Triton X-100, 0.5 mM EDTA, 1 mini-tablet of protease inhibitor 
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cocktail (Roche) per 10 mL) was incubated with 0.4 µg of anti-Syntaxin 5 antibody (Santa Cruz) 
overnight on ice. The sample was then incubated with a 10 µL bed volume of protein A-agarose 
beads for 60 min in the cold. The beads were washed 3 times with lysis buffer and eluted by 
boiling with 25 µL SDS-PAGE sample buffer. 
 
3.2.4 Yeast trafficking assays 
The assay for carboxypeptidase Y (CPY) transport and GFP-Snc1p localization were 
performed as previously described (Brunet et al., 2012). For the CPY assay the cells were 
shifted to 37°C for 60 min. 
For the general secretion assay, 2 OD600 units of cells were pre-shifted to 37°C for 30 
min. The cells were then pulse-labeled with 100 µCi 35S-methionine/cysteine for 15 min and 
chased with 10 mM unlabeled methionine and cysteine for 15 min. Before pelleting the cells 
NaN3/NaF was added to the culture to a final concentration of 0.5 mM. The cells were pelleted 
and the growth medium was precipitated with 10% trichloroacetic acid on ice. The pellet was 
dissolved in SDS-PAGE sample buffer and fractionated by SDS-PAGE. 
Calcofluor white (CFW) growth was monitored by spotting serial dilutions of cells on YPD 
± 10 µg/mL CFW and incubating the plates at 30°C. Growth was monitored daily for up to 5 
days. 
Processing of pre-Ape1p was performed by monitoring the forms of the protein using 
western analysis (Klionsky et al., 1992). Cells were grown overnight to an OD600 ≤ 1 in YPD and 
resuspended in prewarmed YPD medium at 37.5°C (for heat sensitive mutants) or 30°C for 1 h. 
For selective autophagy cells were immediately processed for lysis (see below). For 
macroautophagy cells were pelleted, washed in water and re-suspended in pre-warmed 
synthetic medium lacking nitrogen, incubated for 2-4 h at 37.5°C (for heat sensitive mutants) or 
30°C, and then processed for lysis. Localization of GFP-Ape1p was performed on fixed cells 
according to the GFP-Snc1p protocol above. 
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3.2.5 Preparation of yeast cell lysates 
Lysates for size exclusion chromatography were prepared as previously described 
(Brunet et al., 2012) and 2-5 mg of total protein was fractionated on a Superose 6 column. In 
some cases, 1% Triton X-100 was added to the lysis buffer and was included in the size 
exclusion column buffer. For pre-Ape1p processing, lysates were prepared by converting the 
cells to spheroplasts in medium containing 1.4 M sorbitol, 50 mM KPi pH 7.5, 36 mM β-
mercaptoethanol, 33 µg/mL zymolyase 100T for 30 min at 37.5°C. Spheroplasts were lysed in 
1% SDS, boiled and cleared by centrifugation. 
 
3.2.6 Optiprep gradient assay 
A yeast lysate from TRS85-HA cells was prepared in the absence of detergent and 
fractionated on a Superose 6 column as described (Brunet et al., 2012). Fractions containing 
TRAPP III were pooled and a portion was supplemented with 1% Triton X-100 before incubating 
on ice for 30 min. A sample (100 µL) was combined with size exclusion column buffer to a final 
volume of 300 µL and then loaded on top of a step Optiprep gradient composed of 1 mL 15%, 1 
mL 30%, 1 mL 40% 0.8 mL of 45% and 1.2 mL 54% Optiprep. The sample was centrifuged in 
an SW55 rotor at 36000 rpm for 16 h. Fractions were collected from the top of the tube and 
probed for Trs85p-HA with anti-HA antibody. 
 
3.2.7 Recombinant protein expression and in vitro binding 
Syntaxin 5 (amino acids 1-333) was recombined into pDEST15 (GST fusion vector) from 
a Gateway entry clone. C2 and C2D47Y were recombined into pDEST17 (His fusion vector) 
from Gateway entry clones. Protein was expressed by inducing with 1 mM IPTG in BL21 (DE3) 
cells overnight at 25°C. The protein was purified on glutathione-agarose resin or Ni2+-NTA resin 




In vitro binding assays contained 0.5 µM of GST-Syntaxin 5 with increasing amounts (0, 
0.1, 0.2, 0.5 µM) of His-tagged C2 wild type or D47Y. Samples were made up to a total volume 
of 250 µL with 1x binding buffer (10 mM HEPES pH 7.4, 25 mM NaCl, 115 mM KCl, 2 mM 
MgCl2, 0.1% Triton X-100) and left on ice at 4ºC for 1 h to allow binding. Pulldown employed 10 
µL glutathione agarose resin (GE Healthcare) in the cold for 1 h. Samples were washed 3x with 
binding buffer and eluted by boiling with SDS-PAGE sample buffer. Western blotting was 
performed using horseradish peroxide-conjugated anti-His antibody (Qiagen). 
 
3.2.8 Acyl-biotin exchange 
Biotinylation of acylated proteins was performed essentially as described (Hou et al., 
2005;Wan et al., 2007) with minor modifications. A wild type yeast lysate was prepared in the 
absence of detergent and fractionated on a Superose 6 column as described (Brunet et al., 
2012). Fractions containing TRAPP I, II and III were separately pooled and incubated at 4°C for 
30 min in 1% Triton X-100 with 25 mM N-ethylmaleimide. The proteins were precipitated two 
times using methanol/chloroform and resuspended in buffer A (2% SDS, 8 M urea, 100 mM 
NaCl, 50 mM Tris HCl, pH 7.4). Six volumes of a solution containing 1 M hydroxylamine and 
300 µM biotin-BMCC (Pierce) was added and incubated for 2 h at 4°C. The proteins were 
precipitated one time using methanol/chloroform, resuspended in PBS containing 0.1% Triton X-
100 and incubated with 15 µL of streptavidin-agarose beads (Sigma) for 1 h at room 
temperature. The beads were washed in PBS containing 0.5 M NaCl and 0.1% Triton X-100 
after which the proteins were eluted by boiling in a 3:1 mix of buffer A: 4x SDS-PAGE sample 







3.3 Results  
3.3.1 Binding of C2 to Syntaxin 5 is dependent upon the D47 residue in C2 
A recent study suggested that C2 participates in the export of pro-collagen by regulating 
the Sar1p GTPase cycle (Venditti et al., 2012). C2 is recruited to ER exit sites through an 
interaction with the collagen receptor Tango1. We reasoned that C2 has additional functions for 
the following reasons: (i) the yeast Saccharomyces cerevisiae does not have a recognizable 
Tango1 homolog nor a collagen-like molecule yet the yeast homolog of C2 (Trs20p) is encoded 
by an essential gene, and (ii) the role of C2 in collagen export and Golgi morphology can be 
separated based on the extent of C2 knockdown (Venditti et al., 2012;Scrivens et al., 2009). 
Since C2 is structurally related to longin-domain-containing SNARE proteins (Jang et al., 
2002;Tochio et al., 2001;Gonzalez et al., 2001) we speculated that it may interact with SNAREs 
involved in the early secretory pathway of mammalian cells. Using a yeast two-hybrid assay, we 
screened for interactions between C2 and the early secretory pathway SNAREs Syntaxin 5, 
membrin, Sec22b, Ykt6, Bet1 and GS28. As shown in Figure 3.1, we detected an interaction 
between C2 and Syntaxin 5. The interaction was mediated through the SNARE domain of 




Figure 3.1 C2 binds to Syntaxin 5. C2 was cloned into the yeast two hybrid vector pGBKT7 and 
the SNAREs indicated were cloned into pGADT7. The plasmids were transformed into AH109 
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and Y187 cells, mated and spotted as serial dilutions onto SD-Leu/-Trp and SD-Leu/-Trp/-His/-




Figure 3.2 C2 binds to the SNARE domain of Syntaxin 5 in addition to the full length protein. 
Full length Syntaxin 5, the SNARE domain (amino acids 263-333) or the amino-terminal domain 
(amino acids 1-262) of Syntaxin 5 were cloned into pGADT7 and tested for an interaction by 




This interaction was not simply due to the fact that C2 is a longin-domain-containing 
protein since C1 and C4, two other TRAPP components with longin domains, did not interact 





Figure 3.3 C2 interaction to Syntaxin 5 is specific. C2 in pGBKT7 was tested for its ability to 
interact with the indicated TRAPP proteins expressed in pGADT7 by yeast two hybrid. 
 
 
In an attempt to define the region of C2 that participates in the interaction with Syntaxin 
5 we found that the pathogenic missense mutation D47Y in C2 found in patients with SEDT 





Figure 3.4 SEDT-causing residue in C2 is critical for interaction with Syntaxin 5. C2 or the 
indicated mutants were inserted into pGBKT7 and tested for their ability to interact with Syntaxin 
5 cloned into pGADT7 by yeast two hybrid. 
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In order to confirm the interaction between C2 and Syntaxin 5, we performed in vitro 
binding studies with GST-tagged Syntaxin 5 and His-tagged C2. As shown in Figure 3.5, an 
interaction between the two proteins was detected in vitro. Consistent with the yeast two-hybrid 





Figure 3.5 C2-Syntaxin 5 interaction and its perturbation with C2-D47Y are also observed in 
vitro. Increasing amounts of His-tagged C2 or C2D47Y (0, 0.1, 0.2, 0.5 µM) were incubated with 
0.5 µM GST-tagged Syntaxin 5 as indicated in materials and methods. The bound C2 was 
detected by western analysis using anti-His IgG. An input representing 10% is shown. The lower 
panel shows a coomassie-stained gel of the bait proteins GST and GST-Syntaxin 5. 
 
 
As a third confirmation of this interaction we expressed myc-tagged C2 or C2D47Y in 
HeLa cells, immunoprecipitated Syntaxin 5 from the lysates prepared from the transfected cells 
and probed the immunoprecipitates for the presence of myc-C2. Consistent with the first two 
assays, we noted an interaction between Syntaxin 5 and C2 that was weakened by the D47Y 





Figure 3.6 C2-Syntaxin 5 interaction and its perturbation with C2-D47Y are demonstrated in cell 
culture. Lysates from HeLa cells transfected with myc-tagged C2 or C2D47Y were treated with 
anti-Syntaxin 5 IgG and the immunoprecipitates were probed for the presence of myc-C2 and 
Syntaxin 5 by western analysis using anti-myc or anti-Syntaxin 5 IgG. A portion (10%) of the 
input is also shown. 
 
 
Syntaxin 5 can be found as a component of a larger SNARE complex or free from other 
SNAREs (Williams et al., 2004). SNARE complex formation is increased by treatment of intact 
cells with N-ethyl maleimide (NEM) (Williams et al., 2004). In order to investigate whether C2 
binds to Syntaxin 5 in a SNARE complex, HeLa cells were transfected with C2-myc and cells 
were either untreated or treated with 10 µM NEM, a concentration sufficient to induce SNARE 
complex formation (N.S. and M.S., unpublished observation), with increasing times. Lysates 
prepared from the cells were immunoprecipitated with Syntaxin 5 antibody and probed for C2-




Figure 3.7 C2-Syntaxin 5 interaction increases in NEM-treated cells. HeLa cells were 
transfected with myc-tagged C2 and then treated for increasing times (indicated) with 10 µM 
NEM. Lysates were prepared and Syntaxin 5 was immunoprecipitated as in (Figure 3.6) (lanes 
2-5). Lysate in lane 1 was from a non-transfected culture and subjected to precipitation with 
protein A-agarose beads (serves as a negative control). The bound, tagged C2 was detected 
using anti-myc IgG and Syntaxin 5 was detected using anti-Syntaxin 5 IgG. A portion (10%) of 
the input is shown. 
 
 
The amount of co-precipitating C2 increased with increasing times of NEM treatment, 
suggesting that C2 binds to Syntaxin 5-containing SNARE complexes. Endogenous C2 was 





Figure 3.8 Endogenous C2-Syntaxin 5 interaction is elevated in NEM-treated cells. Non-
transfected HeLa cells were treated for increasing times (indicated) with 10 µM NEM. Lysates 
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were prepared and processed as in (Figure 3.7). Lysate in lane 1 was not incubated with IgG 
during the precipitation and only received protein A-agarose beads. Endogenous C2 was 
detected using anti-C2 IgG. A portion (10%) of the input is shown. 
 
 
3.3.2 The yeast mutant trs20D46Y does not prevent processing of carboxypeptidase Y 
The yeast homologs of C2 and Syntaxin 5 are Trs20p and Sed5p, respectively. The 
interaction demonstrated above suggested that Trs20p and Sed5p may also interact to mediate 
transport in the secretory pathway. However, we were unable to detect an interaction between 
the yeast homologs. The human D47 residue that plays a role in its interaction with Syntaxin 5 is 
conserved in the yeast Trs20 protein at the D46 residue. In order to study this conserved 
residue and its role in membrane traffic we focused on the more easily tractable yeast system. 
We first constructed trs20D46Y, a yeast mutant patterned after the pathogenic human C2D47Y 
mutation. Although this mutant was slightly heat sensitive, it was not as severely-compromised 
as trs20ts, a mutant that was constructed by random mutagenesis (Figure 3.9). In order to 
investigate whether trs20D46Y blocked early secretory protein traffic we performed a pulse-
chase experiment using the vacuolar hydrolase carboxypeptidase Y (CPY). This commonly 
used secretory marker protein is translated and inserted into the ER as a “p1” form. It then 
traffics to the Golgi where it migrates as a slower “p2” form before it is delivered to the vacuole 
as a faster-migrating “m” form (Stevens et al., 1982). As shown in Figure 3.10, neither 
trs20D46Y nor trs20ts displayed a defect in the processing of CPY. In addition, trs85Δ, a gene 
whose product has been reported to function in ER-to-Golgi transport but has more recently 
been implicated in selective autophagy, also processed CPY similar to wild type. These results 
suggest that TRS20 may not be required for ER-to-Golgi traffic. If this is the case, Trs20p may 
function either as a component of TRAPP II and/or III, complexes that function at the late Golgi 
and in autophagy, respectively. 
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Figure 3.9 Temperature sensitive phenotype observed in trs20D46Y is exacerbated in a 
TRA130-HA background. A yeast strain with trs20D46Y as the sole copy of TRS20 was spotted 
as a serial dilution on YPD plates and grown at either 30°C or 39°C. A trs20ts strain (Ben-Aroya 
et al., 2008) was also included. The same trs20 mutations were introduced into a yeast strain 




Figure 3.10 Trafficking of carboxypeptidase Y is unaffected in trs20D46Y. trs20D46Y does not 
block trafficking of CPY. Yeast strains indicated were pulsed with 35S-methionine for 4 min and 
chased with unlabeled methionine for the times indicated as described in materials and 
methods. CPY was immunoprecipitated using anti-CPY IgG, and the forms of CPY were 






3.3.3 The D46Y mutation in trs20 affects its interactions with TRAPP II and III proteins 
To begin to understand where Trs20p functions, we compared the interactions of Trs20p 
and Trs20D46Yp with all known components of the TRAPP complex using the yeast two-hybrid 
assay. As shown in Figure 3.11, Trs20p interacted with Trs31p, Bet3p, Trs85p, Trs120p and 
Trs130p (all other interactions were negative). The first two proteins are components of the 
TRAPP core and these interactions were seen in the crystal structure of both the yeast and 
mammalian complexes (Cai et al., 2008;Kim et al., 2006). Trs85p is a component of TRAPP III 
while Trs120p and Trs130p are found in the TRAPP II complex. These results are consistent 
with a recent report suggesting that the mammalian Trs20p homolog C2 interacts with both the 
Trs120p and Trs85p homologs C9 and C8, respectively (Zong et al., 2011). Interestingly, while 
the D46Y mutation in Trs20p did not affect the interaction with neither Bet3p nor Trs31p, it did 
weaken the interaction between Trs20p and the TRAPP II/III-specific components Trs85p, 
Trs120p and Trs130p (Figure 3.11). 
 
     
 
Figure 3.11 Genetic interactions affected by trs20D46Y. The open reading frames encoding 
TRS20 and trs20D46Y were cloned into pGBKT7, transformed into AH109 yeast cells, and 
mated to Y187 yeast that harbored pGADT7 containing the indicated TRAPP open reading 




We also used yeast genetic interactions to investigate the connection between TRS20 
and the TRAPP II and III complexes. Although trs20D46Y is mildly heat sensitive, the phenotype 
was more pronounced in the presence of HA-tagged Trs130p but not with HA-tagged Trs85p 
(Figure 3.9). Neither trs20D46Y nor trs20ts displayed genetic interactions with trs85Δ, although 




Figure 3.12 trs20D46Y does not display synthetic genetic interactions with trs65Δ or trs85Δ. The 
trs20D46Y mutation was introduced into a yeast strain in which the chromosomal copy of 
TRS65 (trs65) or TRS85 (trs85) was deleted and a copy of the respective wild type gene was 
maintained on a URA3-based plasmid. The plasmid was counter-selected on 5-fluoroorotic acid-
containing plates. 
 
Finally, using the more heat-sensitive trs20D46Y mutation in the TRS130-HA 
background, we found that, in addition to the expected suppression conferred by TRS20 and 
TRS130, TRS120 was capable of suppressing the temperature-sensitive growth phenotype 
(Figure 3.13). These results suggest that, although trs20D46Y does not have a strong growth 





Figure 3.13 The temperature sensitive phenotype of a trs20D46Y TRS130-HA yeast strain is 
bypassed by overexpression of two TRAPP II-specific subunits. A yeast strain (TRS130-HA 
trs20D46Y; see Figure 3.9) was transformed with a plasmid containing the indicated TRAPP 




3.3.4 trs20D46Y phenocopies trs85Δ in both Snc1p-GFP recycling and calcofluor white 
(CFW) hypersensitivity 
Since early secretory protein traffic was unaffected in trs20D46Y cells, we examined the 
cells for a general secretion defect. Included in these studies was the trs85Δ mutant since 
Trs20p showed a D46-dependent interaction with Trs85p (see Figure 3.11). Cells were pulsed 
with 35S-methionine and then chased with cold methionine and the culture supernatant was 
assayed for secreted proteins. As expected, sec18, a gene involved in virtually all membrane 
trafficking steps, blocked the production of secreted proteins compared to wild type (Figure 
3.14). In contrast, trs20D46Y appeared similar to wild type, suggesting that secretion is not 
defective in this mutant. A similar result was seen for trs85Δ (Figure 3.14) whereas trs130ts 
showed a partial block in secretion (not shown; see (13)). A partial block in secretion was also 





Figure 3.14 General secretion is not blocked in trs20D46Y. Yeast strains indicated were pulsed 
with 35S-methionine for 15 min and chased with unlabeled methionine for 15 min. The yeast 
were separated from the growth medium during a brief centrifugation and proteins in the growth 




Calcofluor white (CFW) sensitivity is often used as a measure of activity of the endocytic 
pathway (Valdivia et al., 2002). This compound binds to chitin in the yeast cell wall, enters the 
cell and ultimately results in cell death. A defect in endocytosis leads to elevated chitin levels in 
the cell wall and a hypersensitivity of the cells to CFW while a defect in anterograde traffic 
results in CFW resistance. In the case of trs20D46Y the cells were hypersensitive to CFW 




Figure 3.15 The endocytic pathway is compromised in trs20D46Y. The indicated yeast strains 




We next examined Snc1p-GFP localization in these cells. Snc1p is a SNARE protein 
that cycles between the Golgi and plasma membrane via the endocytic pathway. When fused to 
GFP, the protein localizes to the plasma membrane and to small buds in dividing cells (Figure 
3.16). Previous studies have shown an accumulation of internal structures in trs85Δ cells 
(Montpetit and Conibear, 2009; Brunet et al., 2012) (Figure 3.16). Similarly, we found internal, 
Snc1p-GFP-positive structures in trs20D46Y and trs20ts. Collectively, our results suggest that 
trs20D46Y affects post-Golgi trafficking. The similar phenotype seen in trs85Δ and the 
interaction between Trs20p and the TRAPP III-specific component Trs85p suggests Trs20p may 




Figure 3.16 Snc1p-GFP recycling is affected in trs20D46Y. Yeast strains were transformed with 
a plasmid containing GFP-Snc1p. The cells were fixed with paraformaldehyde and the 
localization of GFP-Snc1p was assessed by fluorescence microscopy. Accumulation of GFP-
Snc1p on internal structures is seen in 24±1%, 62±2%, 77±1% and 89±3% of wild type, trs20ts, 
trs20D46Y and trs85Δ cells, respectively (N=150 for each strain, performed in triplicate). The 




3.3.5 TRAPP III is destabilized in the trs20D46Y mutant 
To better understand the trafficking step(s) affected in trs20D46Y, we examined the 
assembly state of the TRAPP complexes. First, yeast lysates from wild type or trs20 mutants 
were probed for Trs20p, Trs23p (TRAPP I core protein), Trs130p-HA (TRAPP II subunit) and 
Trs85p-HA (TRAPP III subunit). As seen in Figure 3.17, Trs130p-HA levels were unaffected in 
trs20D46Y but were greatly reduced in trs20ts cells, suggesting destabilization of TRAPP II in 
the latter mutant. In addition, both mutants showed greatly reduced levels of Trs85p-HA. Only 
trs20ts, but not trs20D46Y, showed reduced Trs20p levels. Neither mutant displayed significant 
changes in the levels of Trs23p. These results suggest that the integrity of TRAPP III, but not 




Figure 3.17 Stability of several TRAPP components is reduced in trs20D46Y. TRS85 or 
TRS130 was tagged with a 3XHA epitope in wild type, trs20D46Y and trs20ts. Lysates prepared 
from these strains were probed with anti-HA IgG, anti-Trs20p, anti-Trs23p and anti-tubulin (as a 
loading control). 
 
To examine this, we fractionated lysates on a Superose 6 column that we previously 
showed efficiently separates TRAPP I, II and III (Choi et al., 2011;Brunet et al., 2012). The 
fractions from the column were probed with anti-Trs23p antibody. This protein is an integral 
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component of the TRAPP I core and, thus, is found in all three TRAPP complexes. As 
previously reported for wild type cells, Trs23p was detected in the fractions corresponding to 
TRAPP I, II and III (Figure 3.18). In the trs20D46Y mutant there was a striking loss in the Trs23p 
signal in only the TRAPP III fractions. In contrast to trs20D46Y, the Trs23p signal in both 
TRAPP II and III was reduced in trs20ts (Figure 3.18). Upon examination of Trs85p-HA, there 
was a decrease in this protein from the TRAPP peak in both trs20D46Y and trs20ts, consistent 
with the decrease in protein levels from whole cell lysates (Figure 3.18). The results from the 
Superose 6 column suggest that TRAPP III is selectively destabilized in the trs20D46Y mutant. 
This destabilization may be due to a weakened interaction between Trs20p and Trs85p in this 




Figure 3.18 The TRAPP III peak is affected in trs20D46Y. Lysates from the Trs85p-HA-tagged 
strains in Figure 3.17 were fractionated on a Superose 6 size exclusion column in 300 mM NaCl 
and fractions were probed with anti- Trs23p (top panel) or anti-HA IgGto detect Trs85p-HA 
(lower panel). The location of the TRAPP I, II and III fractions are indicated as are the 
fractionation of molecular size standards. 
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3.3.6 Autophagy is defective in the trs20D46Y mutant 
Based on the destabilization of TRAPP III, a complex involved in autophagy, we tested 
whether trs20D46Y affected autophagy. Growing cells in the presence or absence of a nitrogen 
allows one to distinguish between the selective Cytosol-to-vacuole (Cvt) autophagic pathway 
(+nitrogen) and the non-selective macroautophagy pathway (-nitrogen). We first probed for the 
marker protein Ape1p which uses the Cvt pathway in the presence of nitrogen but is transported 
to the vacuole in a non-selective manner in the absence of nitrogen (Scott et al., 1996). The 
processing of Ape1p is detected by examining the levels of the precursor form of the protein and 
the processed form that appears as a faster-migrating species by SDS-PAGE using an Ape1p 
antibody. Consistent with the destabilization of TRAPP III in trs20D46Y, Ape1p processing in 
the presence of nitrogen was completely blocked when compared to wild type (Figure 3.19, +N 
panel). In accordance with previous studies, trs85Δ and atg1Δ (genes that are critical for 
autophagy) also showed blocks in the Cvt pathway (Lynch-Day et al., 2010;Meiling-Wesse et 
al., 2005) as did trs20ts (Figure 3.19). In the absence of nitrogen, when Ape1p is processed by 
non-selective macroautophagy, a significant amount of mature Ape1p was detected in 
trs20D46Y, trs20ts and trs85Δ with small amounts of the precursor form also present, 
suggesting a defect in non-selective autophagy (Figure 3.19 -N panel). 
 
To more carefully assess whether trs20D46Y affects macroautophagy, we examined the 
processing of GFP-Atg8p. Upon uptake into the vacuole under nitrogen starvation conditions, 
this fusion protein is cleaved, liberating GFP. This processing can be detected by western 
analysis. As seen in Figure 3.19, trs20D46Y as well as trs20ts displayed a defect in GFP-Atg8p 
processing in nitrogen starved medium (-N). A similar defect was also seen for trs85Δ, 
consistent with previous studies (Zou et al., 2013; Meiling-Wesse et al., 2005). Collectively, our 
results demonstrate that trs20D46Y affects both the selective (Cvt) and non-selective 






Figure 3.19 Both selective and non-selective autophagy are affected in trs20D46Y. The 
indicated yeast strains were grown in nitrogen rich (+N) or nitrogen starvation (-N) medium as 
described in materials and methods. Equal amounts of protein were fractionated by SDS-PAGE 
and analyzed by western analysis using anti-Ape1p IgG or anti-GFP (to monitor GFP-Atg8p 
processing) as indicated. 
 
 
To further confirm autophagic defects in trs20D46Y, we examined the localization of 
Ape1p-GFP. In wild type cells, a single punctum of fluorescence is often detected that 
represents Ape1p in the preautophagosomal structure (PAS) (Shintani et al., 2002) (Figure 
3.20). Interestingly, trs20D46Y showed a single but much larger punctum of Ape1p-GFP 
fluorescence suggesting the protein accumulates in the PAS. This is consistent with the 
autophagic defect seen by western analysis above. Furthermore, trs85Δ and trs20ts also 
displayed a similar phenotype of a single, but much larger, punctum of fluorescence (Figure 
3.20). A single, large punctum such as that seen in trs20D46Y and trs85Δ has been reported in 





Figure 3.20 The appearance of Ape1p-GFP is affected in trs20D46Y. The strains indicated 
were transformed with GFP-Ape1p, fixed and visualized by fluorescence microscopy. The scale 
bar is 2 µm. Note the larger size of the GFP-Ape1p punctum in the mutants compared to wild 
type. 
 
3.3.7 Trs20p and Tca17p have differing functions 
Trs20p and its mammalian homolog C2 are phylogenetically and structurally related to a 
newly-identified TRAPP interacting protein called Tca17p in yeast (TRAPPC2L in higher 
eukaryotes) (Cai et al., 2008;Kim et al., 2006;Jang et al., 2002; Scrivens et al., 2009) (Protein 
Data Bank ID 3PR6). We therefore examined the interaction profile of Tca17p and the 
biochemical consequences in yeast of tca17Δ to that seen for Trs20p and trs20D46Y. By yeast 
two hybrid analysis, and in accordance with our previously reported genetic interaction 
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(Scrivens et al., 2009), when compared to the three TRAPP subunits whose interactions were 
affected by Trs20D46Yp (i.e. Trs85p, Trs120p and Trs130p), we found that Tca17p only 




Figure 3.21 Tca17p interacts with Trs130p, but not with Trs120p or Trs85p. The open reading 
frame encoding TCA17 was cloned into pGBKT7, transformed into AH109 yeast cells, and 
mated to Y187 yeast that harbored pGADT7 containing the open reading frame for either 
TRS130, TRS120 or TRS85. Growth on SD-Leu/-Trp/-His/-Ade indicates that Tca17p binds to 
only Trs130p.  
 
In addition, size exclusion chromatography showed that tca17Δ altered the integrity of 
the TRAPP II peak but did not alter the integrity of the TRAPP III peak (Figure 3.22) (Choi et al., 
2011). Finally, in contrast to trs20D46Y, tca17Δ did not block the processing of Ape1p in rich 
medium nor of GFP-Atg8p in starvation medium (Figure 3.19). While this latter result is in 
contradiction to that recently reported for tca17ts (Zou et al., 2013), it is noteworthy that our 
mutant is a simple tca17 deletion as compared to tca17ts which also includes modifications to 
TRS120 and TRS130. In combination with our previous results showing that human C2, but not 
human C2L, could suppress trs20Δ (Scrivens et al., 2009), we suggest that Tca17p and Trs20p, 






Figure 3.22 Deletion of TCA17 affects TRAPP II but does not affect TRAPP I and TRAPP III. 
Lysate prepared from tca17Δ or trs85Δ was fractionated on a Superose 6 size exclusion column 
in 300 mM NaCl. The peaks for TRAPP I, II and III are indicated. Also shown is the same wild 
type blot shown in Figure 3.18 for comparison. The Trs23p signal in the TRAPP II fractions is 
missing but remains in the TRAPP III fractions.  
 
 
3.3.8 The molecular size of TRAPP III depends upon membranes and Atg9p 
The composition of TRAPP III differs from that of TRAPP I by the addition of a single 
subunit, Trs85p. However, the molecular size of TRAPP III (>1MDa) is much greater than that of 
TRAPP I (~200kDa), and this difference cannot be accounted for by this single 85 kDa protein. 
A previous study did not identify any other polypeptides in this complex and oligomerization was 
also ruled out (Choi et al., 2011) (S.B. and M.S., unpublished observation). Suspecting that the 
large molecular size of TRAPP III was due to association with membranes, we examined the 
fractionation of Trs23p and Trs85p-HA in lysates prepared using Triton X-100. While Trs85p-HA 
shifted to a fraction with a smaller molecular size near TRAPP I, Trs23p spread out between the 
fractions spanning TRAPP III to II (Figure 3.23). This spreading of the Trs23p peak in Triton X-
100 was independent of Trs85p since a similar pattern was seen in trs85Δ treated with the 
detergent (Figure 3.23). Such an effect was previously noted for Trs130p in a tca17Δ strain 
(Choi et al., 2011). Since Trs23p is absent from the TRAPP III fractions in trs85Δ prepared 
without detergent (Figure 3.22), this result suggests that the fractionation of Trs23p seen in the 
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presence of Triton X-100 is likely due to changes to TRAPP II. Our results indicate that, in the 
absence of detergent, TRAPP III is associated with Triton X-100-soluble membranes. 
Consistent with this notion, TRAPP III penetrated an Optiprep gradient further in the absence, 




Figure 3.23 The molecular size of TRAPP III is dependent upon membranes. Lysate was 
prepared from TRS85-HA or trs85Δ strains with 300 mM NaCl/1% Triton X-100. The lysates 
were fractionated on a Superose 6 size exclusion column. The fractions were probed for Trs23p 
and Trs85p-HA as indicated. 
 
  
Figure 3.24 Trs85p-HA is bound to membranes. Pooled fractions from a Superose 6 column 
enriched in TRAPP III derived from a TRS85-HA strain that was not treated with Triton X-100 
were loaded on top of an Optiprep step gradient prepared as described in materials and 
methods. The top-loaded sample was either left untreated or incubated with 1% Triton X-100 
before centrifugation on the gradient. Fractions were collected from the top of the gradient and 
probed for Trs85p-HA. 
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We next set out to identify a putative TRAPP III receptor on autophagic membranes by 
screening atgΔ mutants for changes in the fractionation pattern of TRAPP III on a size exclusion 
column. Our studies led us to focus on atg9Δ. In whole cell lysates, the levels of Trs85p-HA, but 
not Trs23p, were dramatically reduced upon nitrogen starvation in atg9Δ (Figure 3.25, compare 
+/- nitrogen). Correspondingly, there was a decrease in the appearance of Trs85p-HA in the 
TRAPP III peak in nitrogen-starved atg9Δ cells relative to non-starved cells (Figure 3.26). 
Remarkably, Trs23p was also reduced in the TRAPP III fractions (Figure 3.26). This result is 
similar to that seen for trs20D46Y (see Figure 3.18) in which the levels of Trs85p-HA, but not 
Trs23p, are reduced yet the amounts of both proteins are reduced in TRAPP III. We next 
examined Atg17p since this protein has been reported to recruit Atg9p to autophagic 
membranes (Sekito et al., 2009). In a nitrogen-starved atg17Δ strain, we did not detect a 
significant decrease in the levels of neither Trs85p-HA nor of Trs23p (Figure 3.25) and there 
were no differences in the fractionation of these proteins in the TRAPP III peak (Figure 3.26) 
compared to non-starved cells. Collectively, our results suggest that the recruitment of TRAPP 
III during non-selective, but not during selective autophagy, requires Atg9p, and that an 




Figure 3.25 Starvation-induced reduction in the levels of Trs85p-HA in atg9 Δ. Lysate in 300 
mM NaCl was prepared from wild type, atg9Δ, atg17Δ, atg9Δ TRS85-HA or atg17Δ /TRS85-HA 
grown in YPD (+) or nitrogen starvation medium (-). Lysates were probed for either Trs23p, 






Figure 3.26 Starvation-induced disappearance of TRAPP III in atg9Δ. A total of 5 mg of lysate 
from the cells in (Figure 3.25) was fractionated on a Superose 6 column and probed for Trs23p 





3.3.9 Palmitoylated Bet3p is enriched in TRAPP III 
TRAPP III appears to be membrane associated while TRAPP I is more easily separated 
from membranes since fractionation of the latter on a size exclusion column is not affected by 
detergent. What can account for this difference? The TRAPP I core subunit Bet3p was shown to 
be lipid-modified by either palmitoylation or myristoylation (Kim et al., 2005b;Turnbull et al., 
2005). The modified cysteine residue at position 80 in the yeast protein is highly conserved yet, 
surprisingly, mutation of this residue does not lead to any observable growth phenotype. We 
speculated that lipid-modified Bet3p may partially account for the association of the TRAPP III 
complex with PAS membranes. If this is the case, bet3C80S, a mutant that prevents Bet3p 
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palmitoylation (Kummel et al., 2006;Kim et al., 2005b;Turnbull et al., 2005), may block 
autophagy. Indeed, compared to wild type, bet3C80S displayed both a defect in Ape1p 
processing in the presence, but not the absence, of nitrogen and a starvation-induced block in 
GFP-Atg8p processing upon nitrogen starvation (Figure 3.27). In addition, bet3C80S also 
displayed an enlarged Ape1p-GFP punctum similar to that seen for trs85Δ and trs20D46Y 
(Figure 3.20). This suggests that palmitoylation of Bet3p is involved in the efficient functioning of 




Figure 3.27 Both selective and non-selective autophagy are affected in bet3C80S. Lysates from 
wild type, bet3C80S and atg1Δ were prepared from cultures grown in YPD (+N) or nitrogen 
starvation (-N) medium as described in materials and methods and analyzed by western 






Figure 3.28 Lipidated Bet3p is predominantly found in TRAPP III.  A wild type lysate was 
fractionated on a Superose 6 column and the peak of TRAPP I, II and III were pooled 
individually and subjected to acyl-biotin exchange as described in materials and methods. A 
portion of each input fraction, to enable normalization to Bet3p, along with the entire precipitate 
from the streptavidin-agarose beads was subjected to western analysis using anti-Bet3p serum 
and quantitated using Image J. Error bars indicate standard deviation. 
 
 
Given the result above we speculated that palmitoylated Bet3p would be enriched in 
TRAPP III. To test this notion, a wild type lysate was fractionated by size exclusion 
chromatography and the fractions containing TRAPP I, II and III were pooled separately and 
subjected to acyl-biotin exchange. In this assay, acyl chains on proteins are exchanged for a 
biotin moiety which can then bind to streptavidin-agarose beads. Precipitation of proteins onto 
the beads indicates that the proteins were initially acylated. As shown in Figure 3.28, after 
normalization to Bet3p levels in the input, acylated Bet3p was greatly enriched in TRAPP III. 
Our results suggest that acylated Bet3p is important for the function and/or localization of the 







Here we demonstrate that the mammalian TRAPP protein C2 binds to the SNARE 
protein Syntaxin 5. This interaction is weakened by the pathogenic D47Y mutation in C2 and led 
us to speculate that a yeast mutation patterned after this mutation in the C2 homolog Trs20p 
would affect early secretory pathway traffic. Instead this mutant (trs20D46Y) did not display 
anterograde trafficking defects but was defective in the selective (Cvt) and non-selective 
autophagy pathways. In addition, trs20D46Y, atg9Δ and bet3C80S mutants revealed 
complexities in the organization and function of the TRAPP III complex that is involved in these 
pathways. It should be stressed that, although the trs20 mutants examined in this study did not 
display trafficking defects in the early secretory pathway, other residues in this protein may in 
fact impinge on this process. 
 
3.4.1 Complexities in TRAPP III assembly and function 
The subunit composition of TRAPP III differs from TRAPP I by just a single protein 
(Trs85p in TRAPP III), yet the molecular size of TRAPP III is much greater than that of TRAPP I 
(see Figures 3.17-3.18 and 3.23-3.26) (Choi et al., 2011;Brunet et al., 2012) and this is not due 
to oligomerization of Trs85p/TRAPP III (Choi et al., 2011) (S.B. and M.S., unpublished 
observation). We found that the levels of the TRAPP III-specific protein Trs85p-HA, but not the 
TRAPP I core protein Trs23p, were greatly diminished in trs20D46Y as well as in atg9Δ, but 
unaffected in atg17Δ. The former two mutants showed reduced levels of both Trs85p-HA and 
Trs23p in the TRAPP III fractions. Our results imply that, during macroautophagy, the 
recruitment of TRAPP III to autophagic membranes is dependent upon Atg9p (Figure 3.29, A). 
Our data do not address which, if any, subunit of TRAPP III interacts directly with Atg9p 
although a recent report suggested that Trs85p, but not other TRAPP I core subunits, binds 
directly to Atg9p (Kakuta et al., 2012). If this is the case, our results with trs20D46Y suggest that 
recruitment of the TRAPP I core to the Atg9p-Trs85p unit is mediated by Trs20p and particularly 
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by its conserved D46 residue. Our data leave open the possibility that the TRAPP I core may be 
recruited to membranes distinct from those containing Trs85p in which case their interaction to 
form TRAPP III may contribute to tethering (Figure 3.29, B). This would be similar to the 
mechanism of exocyst complex-mediated tethering in which vesicles are tethered to the plasma 
membrane via interactions between exocyst components on separate membranes (Boyd et al., 
2004). Since the levels of Trs85p-HA and the appearance of Trs85p-HA and Trs23p in TRAPP 
III were not affected under rich growth conditions in atg9Δ, recruitment of TRAPP III to 
autophagic membranes during selective autophagy must be dependent on an as yet 












Figure 3.29 Model for the organization and assembly of TRAPP III. Assembly of TRAPP III is 
dependent upon an interaction between Trs20p and Trs85p and is mediated by the conserved 
D46 residue in Trs20p. Assembled TRAPP III is then recruited to autophagic membranes in an 
Atg9p-dependent manner (A). This may be mediated by a direct interaction between Trs85p and 
Atg9p as recently suggested (Kakuta et al., 2012). Alternatively, Trs85p and Trs23p may be 
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recruited to separate membranes, and their interaction to form TRAPP III is mediated by the 
same Trs20p-Trs85p interaction described above (B). Note that the involvement of Atg9p in this 
scenario is based on a recent study (Kakuta et al., 2012). Although TRAPP III assembly in the 
Cvt pathway is also mediated by a Trs20p-Trs85p interaction, recruitment to autophagic 
membranes does not appear to require Atg9p and some as yet unknown factor (denoted as ?) 
may be involved (C). In both cases (Cvt and macroautophagy) lipidation of Bet3p in TRAPP III 
increases the functional efficiency of the TRAPP III complex (denoted by TRAPP III*). The steps 
that are blocked by the various mutants used in this study are indicated by red lines. 
 
 
Our results provide a clue as to the role of trs20D46Y in autophagy. Based on Ape1p 
processing in rich medium, this mutant affects the Cvt pathway. While there was only a minor 
defect in Ape1p processing under nitrogen-starved conditions, examination of GFP-Atg8p under 
these conditions indicated that non-selective autophagy was also strongly affected. Such a 
phenotype of a mild defect of Ape1p processing but a strong defect in GFP-Atg8p processing in 
starvation conditions has been reported for the TRAPP mutant trs85Δ as well as for vac8Δ 
(Cheong et al., 2005;Zou et al., 2013; Meiling-Wesse et al., 2005). In the latter mutant, 
autophagic bodies were reduced in both number and size. Our results, therefore, suggest that in 
trs20D46Y Cvt vesicles fail to form. However, in nitrogen-starved conditions, while some 
autophagosomes may form, their size is likely abnormally small. 
 
What is the role of Bet3p lipidation in TRAPP III function? The enrichment of lipidated 
Bet3p in TRAPP III and the fact that TRAPP III remains membrane-associated in bet3C80S 
(S.B. and M.S., unpublished observation), suggests that lipidation alone cannot account for 
TRAPP III membrane attachment. It is tempting to speculate that lipidated Bet3p may localize 
the complex to a membrane sub-domain of authophagic vesicles. It is noteworthy that acylation 
of proteins is one mechanism that directs their intracellular localization (Moreau et al., 
2011;Roskoski, 2003). Alternatively, lipidation of Bet3p/C3 has been postulated to alter its 
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structure (Kummel et al., 2006 and 2010;Turnbull et al., 2005), which may promote binding to 
these specialized membrane regions or increase the efficiency of TRAPP III function (Figure 
3.29, D). 
 
3.4.2 Trs20p as an adaptor protein 
When compared to tca17Δ, our results with trs20D46Y suggest that Trs20p can act as 
an adaptor protein for the TRAPP II-specific subunit Trs120p and the TRAPP III-specific subunit 
Trs85p. This adaptor function of Trs20p is similar to that reported for the mammalian homolog 
C2 (Scrivens et al., 2009). Since Trs85p and Trs120p do not reside in the same complex, their 
interaction with Trs20p is not mutually exclusive. The fact that the D46Y mutation in Trs20p 
weakens both interactions suggests that these two TRAPP subunits interact with Trs20p in a 
similar fashion. The suggestion that Trs120p binds directly to Trs20p is in disagreement with the 
recently published electron microscopic structure of the TRAPP II complex, which suggested 
that Trs20p was in direct contact with Trs130p while Trs120p was on a side of the complex 
opposite to that of Trs20p (Yip et al., 2010; see Figure 1.9). While our results leave this 
possibility open, we do not believe this to be the case for the following reasons. The interaction 
between Trs20p and Trs130p is much weaker than that between Trs20p and Trs120p (M.S., 
unpublished observation). In addition, the similarity in structure between Trs20p and Tca17p 
leaves open the possibility that some Trs20p interactions occur due to the similar structure 
between these two proteins and do not take place in vivo. Indeed, Tca17p was found to bind 
only to Trs130p which is consistent with a previous study showing that Tca17p binds to the 
amino-terminus of Trs130p (Choi et al., 2011) and our earlier result showing a strong genetic 
interaction between TCA17 and TRS130 (Scrivens et al., 2009). We suggest that Tca17p may 
be the TRAPP subunit that interacts with Trs130p while Trs20p acts as an adaptor to allow 
either Trs85p or Trs120p to interact with the TRAPP I core complex. It remains unclear how 
Tca17p interacts with the TRAPP I core and how it is excluded from TRAPP III. 
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3.4.3 Implications for SEDT 
The C2D47Y mutation was identified in a patient with spondyloepiphyseal dysplasia 
tarda (SEDT) (Shaw et al., 2003). A recent study suggested that C2 (called Sedlin) regulates 
the Sar1p GTPase cycle at ER exit sites to allow ER-derived carriers to grow to a size that can 
accommodate large cargo such as collagen (Venditti et al., 2012). It is the transport of pro-
collagen that is believed to be defective in SEDT patients. Although we could not detect an 
interaction between Trs20p and the yeast Syntaxin 5 homolog Sed5p, it is possible that the 
mammalian Trs20p homolog C2 evolved the ability to interact with Syntaxin 5. In this case, pro-
collagen release from the Golgi in patients with the C2D47Y mutation may not be affected but 
fusion of the megacarriers with the Golgi would be defective. Alternatively, Syntaxin 5 has been 
implicated in membrane traffic steps beyond the ER-to-Golgi portion of the secretory pathway 
including the endocytic pathway (Xu et al., 2002;Tai et al., 2004)  and pro-collagen transport in 
patients with the C2D47Y mutation may be blocked at these later stages. It is noteworthy that 
defects in endocytosis could indirectly block anterograde transport, suggesting that the C2D47Y 
mutation may have an indirect effect on pro-collagen transport. At present, it is difficult to 
envision how a defect in autophagy could affect pro-collagen transport. Studies on the role of 
mammalian C2 in both endocytosis and autophagy will help address these possibilities. 
 








Binding of TRAPP to the tethering factor p115 affects its membrane association in the 
presence of an SEDT-causing mutant TRAPPC2D47Y 
In Chapter 3, I presented evidence that there is a direct association between the TRAPP 
complex and the ER-Golgi fusion protein Syntaxin 5. In the following chapter, I will demonstrate 
further results, yet to be published, involving  the stated TRAPP-SNARE interaction and in the 
course of this study I will demonstrate a novel association between two tethering factors TRAPP 
and p115.   
 
4.1 Introduction 
The first interaction between a vesicle and target membrane is called “tethering”, a 
process mediated by a group of heterogeneous proteins known as tethering factors. Tethering 
factors are divided into two groups: multisubunit complexes and long coiled-coil proteins, and 
some of these proteins reside at the Golgi. The tethering factor p115 was originally identified 
through an intra-Golgi transport assay and was revealed to be essential in capturing coat 
protein I (COPI) transport vesicles on Golgi membranes (Clary and Rothman, 1990). 
Subsequent studies on the yeast p115 homolog Uso1p pointed to its involvement in ER-to-Golgi 
trafficking mediated by the coat protein II (COPII) coat. Additionally, the temperature sensitive 
uso1-1 mutant was unable to support trafficking to the Golgi apparatus (Allan et al., 2000;Beard 
et al., 2005;Alvarez et al., 2001;Nakajima et al., 1991).  Thus, p115/Uso1p has been implicated in 
interactions with both COPI- and COPII- coated vesicles and mediates different trafficking steps. 
Structural studies of p115 have documented two large N-terminal globular homology (H1-2) 
domains, also known as globular head region (GHR), which precede the central extended 
coiled-coiled domains (CC1 – CC4), followed by an acidic tail (AD) (Sapperstein, et al., 1995) 
(Figure 4.1). Golgi-SNARE proteins are also among the direct binding partners of p115 and their 
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interaction is mapped to the coiled-coil regions of p115, facilitating SNARE complex formation 
by directing anterograde transport of COPII vesicles towards the Golgi apparatus (Beard et al., 
2005; Xu et al., 2004). A recent in vivo study in Caenorhabditis elegans has elegantly shed light 
on the simultaneous involvement of two SNARE-binding domains (CC1 and CC4) in the 
tethering event (Grabski et al., 2012a).   
 
 
Figure 4.1 Multiple interactions in p115 with several proteins of the secretory machinery. 
Coiled-coil domains one and four (CC1 and CC4) directly bind to a number of SNARE proteins 
(left panel). Distinct combinations of these SNAREs make three different complexes of four 
SNARE proteins (right panel); complexes 1, 2, and 3 are symbolized by *, §, and ǂ, 
respectively. *Complex 1 has been reported to be involved early in the secretory pathway in 
homotypic fusion of COPII vesicles with ERGIC (Xu et al., 2000). § Complex 2 is implicated in 
tethering of anterograde transport carrier with cis-Golgi (Zhang et al., 2001). ǂ Complex 3 plays 
a role in intra-Golgi trafficking (Xu and Hay, 2004). Note that CC4 region does not bind to 




Homotypic fusion of COPII coated vesicles is believed to be mediated between the 
globular head region of p115 and Rab1a, with these interactions leading to the generation of 
vesicular tubular clusters (VTCs) (Beard et al., 2005). Sequential actions involved in COPII 
tethering occur as follows: (1) The TRAPP I complex associates via Bet3p/C3 with a component 
of COPII, Sec23p/Sec23 (Cai et al., 2007b), on the nascent vesicle; (2) Ypt1p/Rab1 is activated 
by the TRAPP I complex, serving as a Ypt1p/Rab1 GEF (Jones et al., 2000; Wang et al., 2000) 
which in turn recruits its effector, Uso1p/p115, to the COPII vesicle; and (3) The captured 
vesicle is brought toward the target Golgi membrane (Allan et al., 2000), although in mammals it 
is less clear whether the target membrane is ERGIC (VTCs) or Golgi. A recent study in yeast 
indicates that sequential Sec23p-Sec24p interactions first with TRAPP and then with a Golgi 
resident kinase Hrr25p that competes with TRAPP I to bind to Sec23p-Sec24p establishes the 
directionality of vesicle trafficking (Lord et al., 2011).  
 
 The tethering protein p115 is a cytoplasmic protein that cycles on and off of membranes 
(Brandon et al., 2006) and a cytosolic p115 dimer is recruited to the membrane through the 
small GTPase Rab1 (Brandon et al., 2006; Allan et al., 2000) and is implicated in SNARE 
complex formation in order to promote subsequent membrane bilayer fusion (Shorter et al., 
2002; Allan et al., 2000; Puthenveedu et al., 2004; Bentley et al., 2006; Gmach and Wimmer, 
2001). In support of this, GDI-mediated extraction of Ypt1p in yeast results in Uso1p 
dissociation from membranes (Cao et al., 1998). Moreover, membrane targeting of p115 is 
regulated by accessibility of free SNARE binding as persistence of the assembled SNARE 
complex due to mutation in SNARE-dissociation factors NSF or α-SNAP, prolongs p115 
membrane residency (Bentley et al., 2006; Brandon et al., 2006). However, it is currently 
unknown whether the TRAPP complex affects membrane recruitment of p115. Here I present 
evidence that an SEDT-causing mutation of TRAPPC2 leads to stronger association of p115 
with membranes. In addition I demonstrate that a TRAPP-Syntaxin 5 interaction (shown in 
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Chapter 3) is associated with COPII-coated vesicles. The association occurs in brefeldin A- 






















4.2 Materials and Methods 
Methods listed below are unique to this chapter. All other methods can be found in the methods 
sections of Chapters 2, 3 and 5. 
 
4.2.1 Preparation of total cell lysates 
Lysates from HeLa cells for size exclusion chromatography were prepared as previously 
described in Chapter 2 and a total protein of 2-5 mg was fractionated on a Superose 6 column. 
High molecular weight fractions corresponding to TRAPP were identified by western blotting 
analysis and pooled together. The same was done for low molecular weight monomeric 
fractions. These fractions were subjected to co-immunoprecipitation (see Chapter 2) using 2 µL 
of Syntaxin 5 (18C8) antibody and probed with rabbit, home-made anti-C2 1:1000, mouse anti-
p115 (1:1000, kind gift from Dr. Paul Melancon) and for positive and negative controls rabbit 
anti-Syntaxin 5 (1:1000, Santa Cruz) and rabbit anti-Sam68 (1:1000). In co-IP experiments, 
SNARE antibodies were anti-Bet1, anti-membrin, anti-Syntaxin 5 and anti-GS28 were generous 
gifts from Dr. James Rothman. In certain experiments cells were treated with BFA (10 µg/mL 30 
minutes prior to harvesting) or NEM (see Chapter 2). Co-IPs were as above and probed with 
anti-Sec23 (1:1000, rabbit) courtesy of Dr. Randy Schekman. NEM-treated HeLa cells used for 
co-IP experiments were as described in Chapter 2. Immunofluorescence microscopy was 
performed as in Chapter 5. 
 
4.2.2 Membrane and soluble fractionations  
HeLa cells were grown in 10 cm dishes to 50-60% confluency at the time of transfection. 
Cells were then transfected with 10 µg of plasmid either with or without the Syntaxin 5 open 
reading frame and co-transfected either with myc-tagged C2 or C2 D47Y-myc. 48 hours post 
transfection, medium was removed and cells were collected by scraping. Samples were washed 
twice in wash buffer (140 mM NaCl, 10 mM EDTA, 25 mM Tris, and 30 mM KCl). Cells were 
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resuspended in homogenizing buffer (25 mM NaCl, 1 mM EGTA, 25 mM Tris ,and 30 mM KCl) 
and lysed by 10 passes with a dounce homogenizer and then through a 26 and 21 G needle, 
each with 10 strokes. After a brief spin to remove cell debris (3000g, 5 minutes), the postnuclear 
supernatant was centrifuged for 1 hour at 100,000g in an SW55Ti rotor. A volume of 700 µL of 
supernatant was removed (S fraction) and the pellet (P fraction) was washed with wash buffer. 
The supernatant received 700 µL of 2X Laemmli buffer while the pellet was resuspended in 


















4.3.1 Novel association between p115 and TRAPP is enhanced by SNARE complex 
formation  
A recent review article by Yu and Liang (2012) on the TRAPP complex suggests the 
involvement of p115 once TRAPP has been released from an incoming vesicle. In order to 
reveal spatiotemporal relationships between key players in capturing vesicles, as well as further 
investigating the significance of the C2-Syntaxin 5 interaction (a novel association found in the 
course of this study; see Chapter 3),  I performed co-IP experiments wherein Syntaxin 5 
simultaneously precipitated both p115 and C2 (Figure 4.2). This result is in accordance with 
previous models suggesting the possibility of multiple tethers being involved in tethering 
vesicles (Kim et al., 2006). More interestingly, the association of TRAPP and p115 to Syntaxin 5 
are both enhanced when the cells are treated with NEM, a reagent that prevents the 
disassembly of the four helix bundle of the SNARE complex, suggesting that these tethering 
factors bridge the cargo to the target membrane while also facilitating formation of SNARE 
complexes for the later fusion event (Figure 4.2). 
 
   
 
Figure 4.2 Syntaxin 5 associates with both p115 and C2. Immunoprecipitation of Syntaxin 5 
reveals a novel association between p115 and TRAPP. Like the TRAPP complex, p115 
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association to Syntaxin 5 is increased by NEM and assessed by western analysis using 
antibodies against p115 and C2. During a time course of 60 minutes, HeLa cells were treated 
with 10 µM NEM. Total cell lysate represents 10% of the input lysate utilised in co-IP. 
 
While Syntaxin 5 immuno-isolations (Figures 4.2) suggest p115 could also associate 
with TRAPP and Syntaxin 5 in distinct complexes, we considered the possibility that p115 and 
TRAPP are Syntaxin 5 protein partners and constituents of a single complex.  To address this, 
anti-C2 was used to precipitate endogenous p115 along with Syntaxin 5. As shown in Figure 4.3 
this antibody was able to precipitate both Syntaxin 5 and p115.Taken together with the results in 
Figure 4.2, it is possible that all three proteins (Syntaxin 5, C2 and p115) are components of a 




Figure 4.3 p115 and Syntaxin 5 are C2 binding partners that are associated together. HEK 293 
cells were immunoprecipitated using C2 IgG and then subjected to western blot analysis to 
detect p115 (top panel), Syntaxin5 (middle panel) and C2 (bottom panel). Total cell lysate 
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indicates 10% of input used in the co-IP. Syntaxin 5 migrates at three different sizes: 30, 34, 
and 40 kDa (shown by pink arrows). 
 
 
4.3.2 Unlike Syntaxin 5, p115 associates with C2-containing TRAPP complex and 
not with the monomeric form of C2 
Since the two protein partners C2 and Syntaxin 5 are part of their own protein complex 
and can be also found in free/monomeric form (Sacher et  al., 2000; Williams et al., 2004), the 
C2-Syntaxin 5 interaction may occur in the presence of their cognate  protein complexes or in 
their monomeric forms. To distinguish between these possibilities, size exclusion 
chromatography was employed to separate TRAPP complexes from their monomeric 
components. Cell fractions corresponding to multimeric and monomeric forms were collected 
and subjected to immunoprecipitation with endogenous Syntaxin 5 antibody. While the C2 and 
Syntaxin 5 interaction was confirmed in both forms of C2 (with a preference for association with 
the complex form) (Figure 4.4; and shown in the inset), interestingly, an association of p115 with 
the complex form of C2 and not with its monomeric form was observed (compare lanes 3 and 
4). This suggests that TRAPP and p115, two tethering factors, together may facilitate the 
capture of the t-SNARE Syntaxin 5. This is consistent with the subcellular distribution of p115, 
Syntaxin 5 and TRAPP (ERGIC, cis-Golgi and intra-Golgi compartments). 
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Figure 4.4 p115 and C2 associate with Syntaxin 5. Multimeric subunits of TRAPP complex 
interacts with an essential putative ER-Golgi tethering factor p115 along with ER-Golgi t-SNARE 
Syntaxin 5 in HEK293 cells. Total cell lysates are 10% of lysate subjected to co-IP (lanes 1 and 
2). At higher exposure (shown on the right side of the C2 blot), a band for the monomeric form 
of C2 appears, but not for p115. Sam68 antibody is used as a negative control. Multimeric and 
monomeric populations are collected from fractions of high and low molecular weights 
respectively corresponding to TRAPP complex and monomers of TRAPP subunits and 
subsequently were used in co-IP (lanes 3 and 4). 
 
 
4.3.3 Association of C2 with multiple Syntaxin 5-containing SNARE complexes 
As previously mentioned (Figure 4.1), Syntaxin 5 is part of three distinct SNARE 
complexes. Thus, in order to assess whether a free form of Syntaxin 5 is associating with the 
TRAPP complex or interacting with its cognate SNARE complexes, immunoprecipitation 
analysis was performed using antibodies raised against SNARE proteins and probed for the 
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TRAPP complex component C2 as well as Syntaxin 5 (Figure 4.5). Immuno-isolation of 
Syntaxin 5 demonstrated that Bet1, membrin, Syntaxin 5 and GS28 were coprecipitated with 
C2. Bet1, membrin and Syntaxin 5 (Xu et al., 2000) are part of complex 1, acting in homotypic 
COPII vesicle fusion while GS28, Bet1 and Syntaxin 5 (Xu et al., 2000) constitute complex 2, 
proposed to be serving at the cis-Golgi interface. These data suggest that Syntaxin 5 interacts 
with TRAPP as part of a SNARE complex. Furthermore, TRAPP might be involved in multiple 




Figure 4.5 ER-Golgi SNARE complexes containing Syntaxin 5 coprecipitates with TRAPP. 
HeLa cells were lysed then the moncolonal Syntaxin 5 antibody was used to isolate 
endogenous ER-Golgi SNAREs (Bet1, membrin, Syntaxin 5, and GS28) along with a 
component of the TRAPP complex C2. Syntaxin 5 migrates at three different sizes: 30, 34, and 
40 kDa (shown by pink arrows; green star is thought to be a degradation product). 10% of the 




4.3.4 TRAPP interacts with Syntaxin 5 while COPII vesicles are still coated 
Coat depolymerisation was once thought to occur immediately upon COPII vesicle 
biogenesis. However subsequent studies indicated that coat proteins remains after budding. In 
support of this notion, TRAPP I (C3) was shown to directly interact with COPII subunit Sec23 
(Cai et al., 2007b). Thus, this notion prompted me to determine whether TRAPP association to 
ER-Golgi SNAREs occurs in presence of transport vesicle coat proteins (shown in Figure 4.6). 
To test this idea, HeLa cells were treated with and without the fungal metabolite brefeldin A 
(BFA), which is known to disrupt the Golgi architecture (Klausner et al., 1992). Western blot 
analysis indicates that immunoprecipitation of anti-Syntaxin 5 not only pulls down C2 but it is 
also able to precipitate COPII component Sec23 (Figure 4.6).  
 
These associations with Syntaxin 5 are BFA-resistant (Figure 4.6). In agreement with 
previous reports, C3 localization is also resistant to BFA  (Yu et al., 2006). Since BFA induces 
dramatic morphological alterations in several intracellular compartments (Pelham, 1991), the 
BFA-resistance of C2 and Syntaxin 5 association with COPII suggests that this interaction might 
occur at BFA-resistant compartments such as ER exit site (ERES) or ERGIC and precludes the 
compartment sensitive to BFA treatment such as the cis-Golgi. Therefore, I postulate that 
TRAPP can act at the center of the membrane trafficking process by linking the components of 
the COPII machinery, small GTP-binding protein as well as membrane fusion at an early stage 
of the secretory pathway. 
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Figure 4.6 Syntaxin 5 binds to TRAPP and Sec23.  This association is not disrupted in 
presence of BFA treatment. Prior to lysate preparation, HeLa cells were treated with or without 
BFA (10 µg/mL) and lysates were subjected to co-IP using Syntaxin 5 and probed for Sec23, 
Syntaxin 5 and C2.    
 
 
4.3.5 SEDT-causing mutant C2D47Y enhances p115 membrane association  
I then turned my attention to the membrane association and dissociation of tethering 
factor p115. The rationale for these experiments was that if p115 membrane targeting is 
regulated by Rab1 and SNARE complexes, then TRAPP may affect the cycle of on and off 
membrane dynamics of p115 due to its association with SNAREs. To test this hypothesis, C2-
myc or the SEDT-causing C2D47Y-myc was overexpressed in HEK293 cells with or without 
Syntaxin 5 (Figure 4.7). Soluble and membrane fractions were separated by centrifugation and 
after loading equal amounts of total cell lysates in each set, the membrane- and soluble-
associated form of p115 were assessed using p115 antibody. Interestingly, p115 membrane 
association was perturbed when the pathogenic D47Y-myc was overproduced (lanes 7-12); 
indicating that efficient cycling of membrane and cytosolic p115 is dependent upon C2. It further 
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suggests the membrane association of p115 in C2 D47Y-myc is antagonised by overexpression 




Figure 4.7 Membrane association of p115 requires C2. HeLa cells were transiently transfected 
with C2-myc with or without Syntaxin 5 (lanes 1-6); or X-linked SEDT causing mutation 
C2D47Y-myc in combination with or without Syntaxin 5 (lanes 7-12). Post-transfected cells were 
disrupted and subjected to cell fractionation. Membrane (pellet) and soluble fractions were 





4.3.6 C2 and p115 both have similar cellular distribution in human fibroblast cells 
Because defining the localization of C2 using our home-made anti-C2 antibody was 
difficult in cultured cells such as HeLa and HEK293, primary cultures of skin fibroblasts were 
used (see Chapter 5). Interestingly, C2 and p115 staining showed a similar subcellular 
distribution (Figure 4.8).  Co-localization is consistent with C2 and p115 association shown in 




Figure 4.8 Co-localization of C2 and p115. Endogenous C2 and p115 co-localize in human 








4.4 Discussion  
 I previously showed that C2 binds to Syntaxin 5 (Chapter 3). Here I demonstrate a novel 
association between TRAPP and the ER-Golgi tethering factor p115. Syntaxin 5 antibody pulls 
down increasing amounts of p115 and C2 upon NEM treatment. Additionally, I presented 
evidence that these Syntaxin 5 binding partners are associating together. Further investigation 
is required to determine whether C2 and p115 are constituents of different Syntaxin 5-containing 
complexes or present in the same complex. In order to further characterize the state to which 
the C2-Syntaxin 5-p115 associates, I carried out gel filtration chromatography to discriminate 
TRAPP complexes from its monomeric species. The result indicated that p115 only associates 
with TRAPP in its complex form and not to its monomeric component C2.  
 
I subsequently presented evidence in which Syntaxin 5 interacts with the TRAPP 
complex along with its cognate SNARE complexes (Figure 4.5). TRAPP may be involved in 
multiple processes in conjunction with three distinct SNARE complexes. The experiments were 
carried out with available antibodies against SNARE proteins and further examination is 
required to investigate the association of TRAPP with SNARE complexes (particularly using 
SNAREs specific to complex 2 and 3, Ykt6 and GS15, respectively). 
 
Previous studies determined that TRAPP interacts with the COPII component Sec23 in 
yeast and mammals. Interestingly, while TRAPP binds to Syntaxin 5-containing SNAREs, the 
COPII subunit Sec23 also attached to a TRAPP-SNARE complex (Figure 4.6). Additionally, it 
was demonstrated that TRAPP-SNARE association to COPII is resistant to BFA treatment. 
Thus C2-Syntaxin 5-Sec23 association can potentially take place at ERES and/or ERGIC 
compartments. Along the same line, disruption of ERES using nocodazole or blockage of Sar1 




 Lastly, I have shown the SEDT-causing C2D47Y mutation enhances the membrane-
bound fraction of p115 (Figure 4.7). This finding is significant since it reveals that the 
mechanism of p115 membrane retention involves C2. Considering the fact that p115 only 
associates with C2-containing TRAPP complex (Figure 4.4), it highlights a novel function of the 
TRAPP complex performed through the C2 subunit. p115 with its proposed function as a 
“flypaper” capturing free SNAREs (Grabski et al., 2012b) might facilitate the C2-Syntaxin 5 
association and both TRAPP and p115 might be under the influence of SNARE proteins to be 
recruited to ERGIC and/or the Golgi membranes. Below I propose a preliminary model based on 









Figure 4.9 Schematic representation of the early secretory pathway. Traffic initiates at ER exit 
sites where COPII vesicles bud. (1) The TRAPP complex via its C3 subunit interacts with COPII 
vesicles (Yu et al., 2006). (2) Subsequently, TRAPP GEF activity results in activation of the 
small GTPase Rab1a (Yamasaki et al., 2009). (3) Activated Rab1a induces p115 recruitment 
onto COPII vesicles. (4) ERGIC formation results from homotypic fusion of COPII vesicles in a 
p115- and SNARE-dependent manner (Xu and Hay, 2004). Currently, it is not clear how 
anterograde trafficking of COPII vesicles, once fused with ERGIC membranes, continues its 
joinery toward the cis- Golgi. However there is evidence to suggest that during ERGIC 
maturation a number of proteins, in sequential transport stages, are recruited to this 
compartment thus providing acquisition of COPI vesicles onto the ERGIC. For instance, (5) 
TRAPP II via the C9 subunit interacts with components of minus-end-directed dynein to move 
these vesicles towards the cis- Golgi and the microtubule organizing center (Zong et al., 2012). 
(6) Rab1b recruits the Arf GEF GBF1 and activation of Arf1 GTPase is followed by COPI 
recruitment onto the ERGIC (Garcia et al., 2011). It is worth mentioning that GBF1, but not 
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Rab1b, recruitment is BFA-sensitive. Dashed lines indicate COPI vesicles originating from 
ERGIC recycling back to the ER to return ER-resident proteins. The relationship between 
ERGIC and the Golgi is not clear, however live cell microscopy showed that cargo is not diluted 
upon reaching the Golgi (Presley et al., 1997), indicating that ERGIC membranes fuse to each 
other as opposed to fusion of ERGIC to pre-existing Golgi. The positions depicted for TRAPP II 
and TRAPP III are not known. However in Chapter 2 I have presented data suggesting that a 



















Recessive TRAPPC11 mutations cause a disease spectrum of limb girdle muscular 
dystrophy and myopathy with infantile hyperkinetic movements and intellectual disability 
In the following chapter I will discuss our discoveries into the function of TRAPPC11, 
some of which have been incorporated in a publication in the American Journal of Human 
Genetics (Bogershausen et al., 2013). The genetic component of this work was conducted by 
our collaborators from Alberta who used homozygosity mapping in combination with exome 
sequencing in two affected siblings from a Hutterite family to find that the candidate gene is 
mutated in TRAPPC11. Two additional Syrian families with a TRAPPC11 point mutation, though 
in a different region (C-terminus) compared to the Hutterite mutation, were also found and the 
results will be briefly discussed. My contribution to the figures is as follows: Figures 5.1- 5.15 
were conducted by myself and live cell imaging was performed by myself and Gabriel Lapointe. 
Figures presented in this chapter are all published except for Figures 5.7, 5.14 and 5.15 and I 
am co-first author on this manuscript.    
 
5.1 Introduction 
Intellectual disability (ID) is defined as an intelligence quotient <70 and significant 
limitations in two or more adaptive skills identified in childhood and is found in 1-3% of the 
general population (Kaufman et al., 2010).  ID is etiologically heterogeneous with genetic and 
non-genetic causes and can be found as the sole clinical feature in non-syndromic ID or as part 
of a syndrome with other clinical manifestations. Over the past decade much effort has gone 
into unravelling the genetic complexity of ID such that ID is now one of the most genetically 
heterogeneous disorders. Autosomal recessive, autosomal dominant and X-linked inheritance 
patterns have all been documented and over 100 responsible genes have been identified, yet 
the underlying cause of ID is found in only 15% of patients (de Ligt et al., 2012). Disruption of a 
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number of cellular and embryological processes have been linked to ID and include metabolism, 
transcription (including epigenetic modifications), translation, neuronal development and 
maturation (including transcription factors), development, intracellular signalling, as well as 
intracellular trafficking (van Bokhoven, 2011;Kaufman et al., 2010). We report on the clinical, 
molecular, and cellular phenotype of a novel ID pathway demonstrating that altered vesicle 
trafficking downstream of the Golgi results in a syndrome that includes intellectual disability, 




















5.2 Materials and Methods 
All experiments conducted in this chapter used skin primary fibroblast cells from control 
and patients (2:II-6 and 2:II-8). Cells were plated on 6-well dishes with coverslips in a 37°C 
incubator unless otherwise mentioned. 
 
5.2.1 Fluorescence microscopy  
Cells were grown to 60-70% confluency in Dulbecco’s modified Eagle’s medium (DMEM) 
containing 10% fetal bovine serum (FBS). For treatment with microtubule the disrupting agent 
(Figure 5.15), 10 µM of Nocodazole (gift from Dr. Alisa Piekny) was added to the cells for 1 
hour. Cells were then washed with ice-cold phosphate-buffered saline (PBS), and fixed for 20 
minutes at room temperature with freshly prepared 4% paraformaldehyde (PFA). Cells were 
then permeabilized with ice-cold methanol for 4 minutes at -20°C and washed thoroughly in 
PBS. Cells were subjected to one hour blocking solution (2% FBS, 2% bovine serum albumin 
(BSA), and 0.2% fish skin gelatin) at room temperature. Diluted primary antibodies were used 
as follows: GM130/ MLO7 at 1:250 (rabbit, kind gift of Dr. Martin Lowe); Mannosidase II at 1:300 
(rabbit, kind gift of Dr. Kelley Mormen); EEA1 at 1:400 (mouse, BD Biosciences 610456); 
LAMP1 at 1:150 (rabbit, ab24170); Rab9 at 1:300 (mouse, ab2810), TGN46 at 1:150 (rabbit, 
AB16052). Immunostaining was conducted as described (Scrivens et al., 2011). All images 
were acquired on a Leica TCS SP2 laser scanning confocal microscope at 63X magnification 
except for Figure 5.3 which represents an epifluorescence image using a Zeiss Axioplan 
microscope. 
 
5.2.2 Preparation of total cell lysates 
Lysate for size exclusion chromatography was prepared with lysis buffer (150 mM NaCl, 
0.5 mM EDTA, 50 mM Tris, pH 7.2, 1% Triton X-100, 1 mM dithiothreitol [DTT], one tablet of 
EDTA-free protease inhibitor) and a total protein of 2 mg were fractionated on a Superose 6 
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column. For western blot analysis the lysate was prepared as above and probed with 
TRAPPC11 antibody. Samples were heated for 2 minutes at 95°C with Laemmli sample buffer 
prior to loading on an SDS-polyacrylamide gel. Coimmunoprecipitations were conducted as 
previously described (Scrivens et al., 2011). 
 
5.2.3 Transferrin trafficking assay 
Cells were grown on a 6-well dish with coverslips. One hour prior to initiating the 
trafficking assay, cells were placed in serum free-DMEM. Subsequently cells were allowed to 
internalize Alexa-Fluor-448-EGF or Alexa-Fluor-546-transferrin (Tfn) (both courtesy of Dr. Peter 
McPherson) at 10 µg/mL for 15 and 30 minutes. Samples were prepared, for fluorescence 
microscopy as stated above.   
 
5.2.4 ts045-VSV-G-GFP trafficking assay 
Cells were infected by adenovirus (a generous gift from Dr. Martin Lowe) encoding a 
temperature-sensitive mutant of the vesicular stomatitis virus glycoprotein fused with GFP 
(ts045-VSV-G-GFP) and the cells were followed either in real time or fixed at specific times 
(Figure 5.1).  
 
5.2.4.1 Preparation of ts045-VSV-G-GFP virus 
  HEK293 cells at 70% confluencey were prepared in collagen-coated 75 cm bottles. A 50 
µL aliquot of ts045-VSV-G-GFP diluted with 2 mL DMEM (supplemented with 5% FBS) was 
added to the cells and incubated for 1 hour at 37 °C. At the end of 1 hour, 13 mL of DMEM + 
5% FBS were added to the infected cells. After 4 days, the cells and culture supernatant were 
recovered in a 50 mL falcon tube. 6 cycles of freeze and thaw were applied using liquid N2. The 




5.2.4.2 ts045-VSV-G-GFP trafficking assay 
Human skin fibroblasts were incubated with 50 µL of virus solution for each well in a 6-
well dish for 1 hour at 37°C with occasional tilting. Following 1 hour of infection, 2 mL of DMEM 
+ 10% FBS was added to the cells. The following day (~18 hours post-infection) the cells were 
transferred to a 40°C incubator for 6 hours to ensure that the ts045-VSV-G-GFP was retained in 
the ER. At the end of 6 hours, 10 µg/mL cycloheximide was added and rapidly transferred to a 
32°C incubator to allow the release of trafficking. One coverslip was immediately fixed (0 time 
point). For the remainder of the coverslips, cells were fixed and prepared for immunostaining 
with the Golgi medial marker ManII at the time points indicated below.  The Golgi was then 
counter stained using a medial Golgi marker and co-localization with ts045-VSV-G-GFP was 




Figure 5.1 Schematic representation of the ts045-VSV-G-GFP trafficking assay. Cells were 
infected and allowed to express the GFP-tagged ts045-VSV-G. This was followed by a 6 hour 
incubation at restrictive temperature. After cycloheximide addition, the cells were shifted to 
permissive temperature and fixed and stained with the Golgi medial marker ManII at the 





5.3 Results  
5.3.1 Mutation in TRAPPC11 causing a partial deletion in the highly-conserved foie 
gras domain 
Two families with a total of five affected children were independently examined due to 
longstanding histories of moderate ID, ataxia and muscle weakness. These families are all of 
Hutterite ancestry (Hostetler et al., 1985;Boycott et al., 2008) and have remained largely 
genetically isolated from one another.  Although the two families were not closely related, a 
founder mutation with an autosomal recessive mode of inheritance was suspected because of 
the Hutterite's history of genetic isolation.  One family consists of two affected brothers 
(designated as 2:II-6 and 2:II-8) and their affected first cousin from the Hutterites of Alberta, in 
which the phenotypes of the two brothers at both the molecular and cellular levels will be 
presented in this chapter. The other family consists of two affected siblings (one male, one 
female) from the Hutterites of South Dakota.  
 
As young adults all affected individuals now have obvious mild to moderate intellectual 
disability. As young children, they all had significant evidence of a hyperkinetic movement 
disorder. Age of walking was delayed and although the hyperkinetic movements have improved, 
all patients continue to have gross and fine motor difficulties. Mild muscle weakness with 
persistently elevated creatine kinase (CK) levels suggested an associated myopathy with non-
specific myopathic changes uncovered by muscle biopsy.  
 
TRAPPC11 (hereafter C11) is a 32-exon gene and the first pathogenic mutation to be 
reported for C11 was identified in two brothers from Huteritte families by means of 
homozygosity mapping and exome sequencing. RT-PCR revealed that this mutation 
(C.1287+5G>A) results in mis-splicing and an in-frame deletion of 58 amino acids (372-429) 
comprising both exons 11 and 12, in the highly conserved foie gras domain of C11 (Figure 5.2). 
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Once the candidate gene was revealed to be C11, primary skin fibroblasts from the two affected 
brothers and from a healthy volunteer were obtained and cultured in our laboratory. My work in 
this portion of my thesis revolved around further biological and functional characterization of 





Figure 5.2 The foie gras domain of C11 is highly conserved. Multiple sequence alignment of 
C11 (adapted from R. Lamont) indicating conservation of this region across evolution, 
suggesting a critical role might be attributed to C11 in normal cellular function. A schematic of 
the C11 protein, indicating the highly-conserved foie gras domain and the region deleted due to 




C11 (transport protein particle complex 11) has been shown to play a role in vesicle 
trafficking to the membrane in both human and Drosophila cells (Scrivens et al., 2011; Wendler 
et al., 2010;) and was recently characterized as a component of TRAPP (transport protein 
particle), a multisubunit complex implicated in vesicle-mediated membrane trafficking (Yu and 
Liang, 2012;Sacher et al., 2008). C11 participates in numerous interactions with other TRAPP 
complex family members, most notably C2, C2L, C6, C10 and C12 (Scrivens et al., 2011).  
Mutations in TRAPP complex members, C2 and C9, result in X-linked spondyloepiphyseal 
dysplasia tarda and non-syndromic ID, respectively (Gedeon et al., 1999; Mir et al., 2009; 
Najmabadi et al., 2007). Loss of function mutations in the zebrafish homolog of C11 have been 
found in the foie gras mutant, characterized by hepatomegaly from steatohepatitis and eye 
development defects (Sadler et al., 2005 ;Gross et al., 2005 ). We do not observe any liver or 
eye phenotypes in our patients; however, this may reflect complete loss of function in the 
zebrafish model compared to the presumed hypomorphic nature of the in-frame deletion 
identified in our patients.  
 
5.3.2 Golgi organization is under influence of the intact TRAPP complex  
Since small interfering RNA-mediated (siRNA) knockdown of C11 leads to Golgi 
fragmentation (Scrivens et al., 2011), we examined the state of the Golgi in primary fibroblasts 
from the two brothers from family 1 (herein referred to as patients 2:II-6 and 2:II-8). Compared 
to control fibroblasts, the Golgi in both patients appeared more fragmented using the marker 
proteins GM130 (Figures 5.3) and Mannosidase II (ManII; data not shown). Quantitation of the 
fragmented phenotype indeed showed a higher percentage of cells with a fragmented Golgi 
(Figure 5.4), consistent with results from previous C11 knockdown experiments. Three-
dimensional reconstruction of the Golgi confirmed that the fragmentation was due to fewer 




Figure 5.3 The Golgi integrity is dependent upon C11. Immunofluorescence of the Golgi 
apparatus and nucleus by GM130 and DAPI, respectively, in primary skin fibroblasts from 






Figure 5.4 Quantification of Golgi morphology. Quantification of the Golgi morphology was 
performed using the same criteria as in Figure 2.17. Also shown is a three dimensional (3D) 
reconstruction of the Golgi apparatus using confocal z stack images generated in control and 
patient cells (2:II-8) by Fiji software. A minimum of 300 cells for each sample was quantified 




5.3.3 Partial deletion of the foie gras domain results in C11 protein instability and 
perturbed assembly of the TRAPP complex  
To assess the effect of the C11 in-frame deletion on the TRAPP complex, C11 was 
immunoprecipitated from lysates prepared from control and patient cells and probed for the 
TRAPP complex member C2 that co-precipitates with C11. Although equal amounts of C2 are 
present in the starting material, patient cells showed significantly less C2 co-precipitating with 
C11 (Figure 5.5), suggesting that C11 is either unstable or that the levels of C11-C2-containing 
TRAPP complexes are reduced. Consistent with the former notion, western blot analysis of 




Figure 5.5 Loss of interaction of C11 with C2 in affected patient cells.  Inputs (10%) were 
loaded (lanes 1-3) and equal amounts of total lysates in control and affected individuals were 




   
 
Figure 5.6 Partial deletion of the foie gras domain affects C11 stability. Total cellular level of 
C11 was estimated in control and affected (2:II-6, 2:II-8) individuals. GAPDH was used as a 
loading control. Note the loss of full-length C11 immunoreactivity and the appearance of 
presumably truncated versions of C11.  
 
 
As a further confirmation that TRAPP assembly is compromised in the presence of this 
C11 mutation, we examined the fractionation of TRAPP in lysates prepared from affected and 
non-affected individuals using size exclusion chromatography. Consistent with Figure 5.6, a 
single band for C11 at fractions 16-19, where the mammalian TRAPP complex fractionates, was 
seen in the control sample while the affected individuals (2:II-6 and 2:II-8) exhibited multiple 
bands. In addition a subtle shift which begins trailing off in fractions 17 to 22 was also noted. 
Consistent with the fractionation of a C11 knock down observed in our previous publication 
(Scrivens et al., 2011), a subtle shift for the C2 protein was also seen  (Figure 5.7). This 





Figure 5.7 Partial deletion of the foie gras domain results in a perturbation of the TRAPP 
complex. Lysates from affected and unaffected individuals were fractionated on a Superose 6 
column and fractions were probed for C2 and C11. Note the difference in fractions 16-19, where 
the TRAPP complex fractionates, between control and affected individual samples. 
 
 
5.3.4 Partial deletion of the foie gras domain results in impaired exit from the Golgi  
Scrivens et al. (2011) have shown that siRNA knockdown of C11 leads to Golgi 
fragmentation and perturbed membrane trafficking between the endoplasmic reticulum (ER) and 
the Golgi (Scrivens et al., 2011). Thus, we investigated if patient cells also displayed a block in 
transport between these two compartments. We used the ts045-VSVG -GFP (VSV-G) marker to 
investigate transport along the secretory pathway. This commonly used marker protein mis-folds 
at elevated temperatures (40°C) and is retained in the ER. Upon shifting to lower temperature 
(32°C) and in the presence of the protein synthesis inhibitor cycloheximide, the ER-restricted 
material exits and is transported to the Golgi and ultimately to the cell surface (Bergmann et al., 
149 
 
1983). The kinetics of this transport is well documented with appearance of the protein in the 
Golgi within minutes of release, where it can reside for up to 40 minutes before transport to the 
cell surface (Hirschberg et al., 1998). To determine the effect of the C11 mutation on ER-Golgi 
trafficking, we assessed VSV-G localization at fixed intervals in patient and control fibroblasts, in 
conjunction with the Golgi marker ManII.  After incubation at 40°C, VSV-G is found exclusively 
in the ER in both control and patient cells, displaying the typical diffuse, reticular pattern (Figure 
5.8). Co-localization of VSV-G with the Golgi marker ManII is clearly seen after 30 minutes 
following release from the ER at 32°C in both control and patient cells (Figure 5.8). After 120 
minutes, however, virtually all of the VSV-G is found on the cell surface of control cells while a 
significant amount of VSV-G remains in the Golgi of patient cells (Figure 5.8).   
 
Live-cell imaging confirmed delayed VSV-G exit from the Golgi in patient cells, 
pronounced from approximately 90 minutes, consistent with the findings of the timed intervals 
above (http://www.cell.com/AJHG/supplemental/S0002-9297(13)00273-5).  In the movie 
additional information was gained since vesicles or carriers moving in several directions and not 
fusing with the PM were observed. The delay of VSV-G exit from the Golgi in patient cells 
suggests that generalized trafficking of molecules through the Golgi may be delayed in patient 





Figure 5.8 Transport of ts045-VSV-G-GFP is markedly reduced in patient cells lacking a portion 
of the foie gras domain. Note the white boxed area in patient cells at 120 minutes where ts045-
VSV-G-GFP colocalized with the Golgi marker ManII, while in the control samples the ts045-
VSV-G-GFP had reached the surface of the cells and none is colocalizing with the Golgi marker. 
The scale bar represents 10 µm. 
 
 
5.3.5 Partial deletion of the foie gras domain from C11 does not interfere with 
internalization and early recycling pathways  
Delayed exit from the Golgi could arise from a defect in anterograde traffic from the 
Golgi to the cell surface or indirectly from defects in the endocytic pathway that would fail to 
retrieve material from the Golgi needed for anterograde traffic. To determine if the trafficking 
defect observed in patient cells was due to defects in the endocytic pathway, we examined the 
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uptake of fluorescently-tagged transferrin (Figure 5.9) and EGF (data not shown) from the cell 
medium, but did not observe any uptake defects.  
(A) 
   
(B) 
      
 
Figure 5.9 Partial loss of the foie gras domain does not affect transferrin uptake. (A) 
Internalization can occur by means of clathrin (Step 1) or clathrin-independent pathways. Tf-Tf 
receptor (TfR) complexes are present in both static and dynamic populations of early 
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endosomes (EE) (Step 2). Alternatively, EGF-EGF receptor complexes exist in dynamic EE 
which mature into lysosomes (Step 3). Tf-TfR complexes return to the cell surface from both 
forms of EE called fast recycling (Step 4), or after transit through recycling endosome known as 
slow recycling (Step 5). (B) Early recycling and internalization are normal in fibroblast patient 
cells. After a 15 minute incubation at 37°C with fluorescently-tagged surface ligand, transferrin 
did not display any alteration in patient cells compared to controls neither in internalization nor in 




5.3.6 Partial deletion of the foie gras domain from C11 interferes with late 
endosome/lysosomal trafficking 
Having ruled out a defect in the early endocytic pathway, we next examined markers for 
other structures in the endocytic pathway including TGN46, Rab9, EEA1, and LAMP1. Staining 
patient cells for LAMP1, a marker of late endosomes/lysosomes, identified a striking difference 
in the localization pattern compared to control cells (Figure 5.10). LAMP1 in control cells was 
concentrated in puncta throughout the cell with the occasional deposition in a perinuclear region 
(24±1% of control cells (N=189)). Conversely, fibroblasts from patients displayed prominent 
perinuclear staining for LAMP1 in a high proportion of cells (78±2% and 87±3% of cells in 
patients 2:II-6 and 2:II-8, respectively (N=189 for all cases)) (Figure 5.11).  
 
Immunostaining of patient cells as well as immunoblotting of patient cell lysates showed 
a reduced level of LAMP1 compared to control (Figures 5.10 and 5.12). Interestingly, as 
opposed to the broad molecular size seen in control cells, LAMP1 from patient cells was 
concentrated in the higher molecular size region, suggesting it may be more highly glycosylated 
(Figure 5.12).  A similar phenotype was also observed for the related protein LAMP2, although 
the levels of the protein do not appear to be dramatically reduced as LAMP1 (Figure 5.12). 
Hyperglycosylation could result from either an increased residence time of LAMP1 and LAMP2 
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in the Golgi, in accordance with the VSV-G results above, or mis-localization of Golgi-resident 
glycosylation enzymes such that LAMP1 and LAMP2 continue to be glycosylated outside of the 
Golgi. In contrast, no obvious changes were observed in the distribution of the early endosomal 
marker EEA1 in patient fibroblasts (Figure 5.10).  
 
     
 
Figure 5.10 Distribution of late endosomes/lysosomes, but not early endosomes, is altered in 
patient cells.  Immunofluorescence was performed using antibodies against early and late Golgi 
markers EEA1 and LAMP1, respectively, in control and affected primary fibroblast cells. Note 





   
 
 
Figure 5.11 LAMP1 perinuclear foci are dramatically increased in patient cells. Quantification of 




Figure 5.12 Altered protein and glycosylation levels of LAMP1 and LAMP2 in cells lacking a 
portion of the foie gras domain. Equal amounts of lysates were prepared from control and 
patient (2:II-6 and 2:II-8) fibroblasts. With respect to LAMP1 and LAMP2, bands with a diffuse 
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appearance are typical of highly glycosylated proteins. There are two differences in lysates of 
patient cells compared to control cells: (1) decreased level of the lysosomal membrane proteins 
LAMP1 and LAMP2, and (2) slower migration of LAMP1 and LAMP2, indicative of extensive 
glycosylation. 
 
Given the fragmented nature of the membranes of cis- and medial- Golgi stack assessed 
by GM130 and ManII (refer to Figures 5.3 and 5.8, respectively), it was expected that the trans 
side of the Golgi would also be fragmented in the patient cells. Surprisingly, in addition to a 
TGN-fragmented phenotype shown by TGN46, perinuclear foci, similar to that observed for 
LAMP1 staining, were noted (Figure 5.13). Co-localization with Rab9 suggests these 
perinuclear foci may be bona fide late endosomes (Figure 5.13). In contrast, Rab9 signal is 
observed as a punctate staining seen throughout the cytoplasm in the control sample. This 




Figure 5.13 Perinuclear foci in LAMP1-positive organelles also co-localize with Rab9 and 
TGN46 markers. Skin fibroblasts were double labeled with LAMP1 and Rab9 or Rab9 and 
TGN46.  Intriguingly, patient fibroblasts immunostained with both late endosomal and TGN 
156 
 
markers reveal perinuclear foci similar to that observed with LAMP1 antibody. The scale bar 
represents 10 µm. 
 
 
5.3.7 LAMP1 perinuclear foci co-localise with γ-tubulin 
Given the requirement for both LAMP1 and LAMP2 in lysosomal motility along 
microtubules (Huynh et al., 2007), together with the perinuclear foci found in the LAMP1-,  
Rab9-, and TGN46- positive organelles, we speculated that if the concentrated perinuclear 
region is clustered around the microtubule organizing centre (MTOC) minus-end, these foci 
should co-localise  with the microtubule nucleation member γ–tubulin. Indeed, LAMP1-positive 





Figure 5.14 LAMP1 foci co-localize with γ-tubulin. Double immunostaining of primary skin 




  5.3.8 LAMP1 perinuclear foci formation is dependent upon microtubules 
To evaluate if juxtanuclear LAMP1 is reliant on microtubules, both patient and control 
samples were treated with the microtubule destabilizing drug nocodazole. While the LAMP1 
staining remained unaltered in control cells, juxtanuclear foci in patient samples treated with 




Figure 5.15 LAMP1 foci are dependent upon microtubules. Nocodazole treatment of affected 
(2:II-8) and unaffected (control) samples resulted in elimination of perinuclear foci of patient 







5.4 Discussion  
Retention of the human growth hormone marker protein GFP-FM4-hGH in the Golgi of 
HeLa cells following knockdown of C11 was previously reported (Wendler et al., 2010). In 
addition, ablation of C11 by small interfering RNA was reported to result in accumulation of 
VSV-G in a brefeldin A-resistant compartment, interpreted to be related to the ERGIC (ER-Golgi 
intermediate compartment) (Scrivens et al., 2011). Our finding that partial deletion of the foie 
gras domain of C11 leads to defects in a post-Golgi compartment may be explained by the fact 
that only a portion of the protein is missing and represents a milder defect compared to 
knockdown of the entire protein. It is noteworthy that a recent study implicated the TRAPP 
complex in retrograde traffic originating at the cell surface, however, the precise cellular location 
where TRAPP acts in this pathway was not addressed (Moreau et al., 2011). Our present study 
suggests that a C11-containing TRAPP complex is involved in the formation and/or movement 
of late endosomes/lysosomes and implicates the foie gras domain of C11 in this process. A 
prominent perinuclear staining of LAMP1 has been observed in cells depleted of Rab9, leading 
to the suggestion that effector molecules required for late endosomal transport are not recruited 
in the absence of this GTPase (Ganley et al., 2004). In addition, Rab7 and the lipid composition 
of membranes has been implicated in the motility of late endosomes/lysosomes (Lebrand et al., 
2002). It will be of interest to examine the relationship between a C11-containing TRAPP 
complex and various GTPases involved in late endosome dynamics. Interestingly, reduced 
LAMP1 levels and Golgi fragmentation have also been observed in Syrian patients with a 
missense mutation in C11 (p.Gly980Arg) presenting with limb-girdle muscular dystrophy. This 
mutation shows a weakened interaction with several TRAPP proteins including C2, C2L, C6a, 
and C13. 
 
Finally, a link to autophagy should also be considered. It has been suggested that 
lysosomal myopathies result from a buildup of autophagosomes (Malicdan et al., 2008). Given 
159 
 
recent studies suggesting the yeast TRAPP III complex is involved in autophagy (Zou et al., 
2012;Lynch-Day et al., 2010;) and a study that suggests depletion of C11 leads to a reduction in 
autophagosome formation (Behrends et al., 2010), it will also be important to determine the 
molecular connection between autophagy and the phenotype we describe here. 
 
Using whole exome sequencing we have identified a mutation in C11, resulting in a 
splicing defect that creates an in-frame deletion in five patients with ID, hyperkinetic 
movements, myopathy and ataxia from two Hutterite families. Functional studies using patient 
fibroblasts demonstrated a defect in vesicle trafficking through the Golgi. This finding represents 
the second TRAPP complex gene associated with ID and provides evidence for the involvement 















           Discussion 
In Chapter 6, I will discuss the significance and implications of the results of the 
experiments that I conducted over the course of my PhD work. I also will outline questions that 
remain unanswered. I speculate further on the models that I introduced in Chapters 4 and 5 and 
I will propose future experiments. Finally, I will discuss possible explanations for the phenotype 
seen in C11 patients. 
 
6.1 Tca17p and its related protein Trs20p exists in the same TRAPP complex  
In Chapter 2 of this dissertation subsequent to the identification of YEL048cp, a new 
component of the TRAPP II complex now termed Tca17p, we suggested that Tca17p is located 
on a side of TRAPP opposite to that of Trs20p. The arrangement of Tca17p was based on in 
vitro binding as well as recombinant reconstitution of a TRAPP sub-complex.  With respect to 
the core subunits of the TRAPP complex, Tca17p interacted with Trs33p-Bet3p as well as with 
Trs31p-Bet3p, the equivalent interface to which Trs20p binds. However Trs20p only interacted 
with Trs31p-Bet3p. The interaction of Tca17p with the Trs33p-Bet3p side of the complex was 
also observed in Dr. Elizabeth Conibear’s laboratory. Since Trs20p only interacts with one side 
of the complex, and since Trs20p and Tca17p co-exist in the same complex, strongly suggest 
that these two proteins likely bind to opposite ends of the complex. The most likely explanation 
as to why Tca17p binds to Trs31p-Bet3p is that it is structurally similar to Trs20p (compare 
structure coordinates 1H3Q and 3PR6). This result was also observed in mammals for the 
proteins C2 and C2L.  
 
More recently a physical interaction of Tca17p with TRAPP II-specific subunits (Trs65p, 
Trs120p and Trs130p) was described by yeast two-hybrid, and Tca17p was shown to directly 
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interact with the N-terminus of Trs130p (Choi et al., 2011). Given the proposed position of 
Trs130p deduced by electron microscopy of purified yeast TRAPP II (Yip et al., 2010) (Figure 
1.9), Trs130p is located a substantial distance away from Trs33p-Bet3p, thus it is difficult to 
imagine how Tca17p can physically interact with Trs33p-Bet3p as well as with Trs130p. The 
comparably distant location of Trs33p-Bet3p to that of Trs130p is reminiscent of Trs31p-Bet3p 
to that of Trs120p, both of which interact with Trs20p (Taussig et al., 2013;Kim et al., 2005a). As 
stated in Chapter 1, although a number of laboratories have reported a direct interaction 
between Trs20p and Trs120p and their mammalian counterparts C2 and C9, yeast TRAPP II 
might assemble into a higher-order structure composed of multiple TRAPP II complexes that 
disassemble in the course of purification of yeast TRAPP II, thus the structure and the 
orientations of the larger specific components of TRAPP II (Trs120p and Trs130p), relative to 
the smaller subunits of the core TRAPP complex requires further investigation.  
 
6.2 TRAPP proteins are present on two distinct membranes 
As discussed in Chapter 2, we detected C2L, along with other subunits of TRAPP, on 
very light density membranes (VLDM) (Figure 2.14). VLDM is the only fraction that endogenous 
C2L shares with other TRAPP components because C2L is not found on Golgi membranes 
where other TRAPP proteins are present. There are two possible explanations for the existence 
of TRAPP on two different membranes: (1 ) light density membranes may represent Golgi to 
which TRAPP components are tethered. Interestingly, our data described in Chapter 3 
suggested that the yeast TRAPP I core recruited to autophagic membranes is distinct from that 
of Trs85p-containing membranes (Figure 3.29). We postulated that this is similar to the 
mechanism of exocyst tethering of vesicles at the cell surface through interactions between 
components present on both vesicles and the plasma membrane. This might explain how the 
TRAPP complex assembles, an open question in the field, and whether the TRAPP complex 
assembles on membranes or in the cytosol. Thus the elucidation of the identity of VLDM could 
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help to explain the functional mechanism of the TRAPP complex. (2) Alternatively, light density 
membranes potentially come from COPII-coated vesicles. To test this, membrane isolation 
followed by equilibrium-gradient centrifugation, similar to that performed in Chapter 2, with 
different gradients (to obtain better resolution of the light density membranes) could be carried 
out. To this end, the inhibitor of COPII-coat assembly, H89, could be used to determine whether 
COPII-coated vesicles are the source of the C2L-containing VLDM.  
 
6.3 TRAPP complexes and their implication in specific and non-specific autophagy 
Several researchers have described the significant role played by the TRAPP complexes 
(TRAPP II and TRAPP III) in both Cvt and non-selective autophagy. There are numerous Atg 
proteins and components of intracellular machinery that act either in only one or in both of these 
pathways. In Chapter 3, we showed that TRAPP III, in addition to its role in non-specific 
autophagy, is involved in the proper localization of the Cvt complex to the PAS (Figures 3.19 
and 3.20). We have also deciphered a model for TRAPP III assembly via interaction between 
the conserved D46 residue of Trs20p and Trs85p (Figure 3.29) which was supported by the 
recently-published EM structure of TRAPP III (Tan et al., 2013). In addition to Atg11p (Shintani 
et al., 2002), the multi tethering complex GARP has also been reported to be important for 
proper delivery of the Cvt complex to PAS, and its function is indispensable for autophagy 
(Reggiori et al., 2003). A recurring hypothesis is that membrane sources for Cvt and bulk 
autophagy pathways are distinct from one another.  However it remains to be determined what 
the molecular machinery is that converts the specific/Cvt form of autophagy to non-specific/bulk 
autophagy. In this regard, hyperphosphorylation of Atg13p and the formation of a trimer of 
Atg17p-Atg29-Atg31p were hypothesized to be critical for favouring biogenesis of Cvt vesicles 




TRAPP III GEF activity acting on Ypt1p results in activation of Ypt1p, and Ypt1p-GTP 
has been recently been shown to associate with the Atg1p kinase. Intriguingly, the association 
between these two proteins is preserved in the absence and presence of nutrients. However, 
under starvation conditions the binding Ypt1p-GTP to Atg1p is enhanced. Along the same lines 
of evidence, overexpression of Ypt1p-GTP increases autophagy, which further supports the 
idea that there is a stronger association of the two proteins during nutrient deprivation (Wang et 
al., 2013). Interestingly Lipatova et al. ( 2012) examined the effects of Ypt1p in the regulation of 
selective autophagy, and under nutrient-rich conditions. Ypt1p-GTP interacted with the Cvt-
specific subunit Atg11p. Thus, I propose that given the specific behaviour of activated Ypt1p, in 
terms of its interaction with two important Atg components (Atg1p and Atg11p), one implicated 
in bulk autophagy and the other in selective autophagy, that Ypt1p is an ideal candidate to study 
the molecular mechanism of transition between the two pathways. It is critical to map out the 
regions on Ypt1p sequences to which the two binding partners Atg1p and Atg11p associate and 
to better understand their binding affinity towards Ypt1p under vegetative and starvation 
conditions. This could indicate whether Ypt1p serves as a turning point in induction of selective 
and non-selective autophagy.  
 
The possible role of yeast and mammalian TRAPP complexes in autophagy has been 
described. However, involvement of mammalian TRAPP in the Cvt pathway has not been 
studied.  In yeast, Atg19p is a cargo receptor in the Cvt pathway that also binds to membrane-
associated Atg8p-PE and promotes formation of Cvt vesicles (Noda et al., 2008). Like Atg8p, 
the mammalian homolog LC3 contains an evolutionarily conserved WXXL binding pocket critical 
for the Cvt pathway and not for bulk autophagy (Noda et al 2008). This region is responsible for 
interaction with the mammalian adaptor protein p62/SQSTM1 that then binds to ubiquitinated 
cargos.  Interestingly, C8 harbours the WXXL motif and it is worth investigating, using various 
protein-protein interaction methods, whether under vegetative conditions the WXXL motif of C8 
164 
 
can associate with LC3. Nevertheless, while researchers are working to understand the 
molecular mechanism regulating autophagy, elucidation of the function of TRAPP complexes in 
this fundamental physiological process will be as fascinating as the discovery of this tethering 
complex. 
 
6.4 The TRAPP complex and the ER-Golgi intermediate compartment (ERGIC) 
C3 is required for homotypic fusion of COPII vesicles leading to ERGIC biogenesis (Yu 
et al., 2006). Our laboratory determined that siRNA-mediated depletion of C11 caused retention 
of secretory proteins in a BFA-resistant compartment thought to be the ERGIC compartment. In 
Chapter 4, the association of C2-Syntaxin 5 in the presence of the COPII component Sec23 
was observed, and the interaction was not affected by BFA treatment (Figure 4.6). BFA 
treatment of cells causes Golgi structural collapse and the distribution of puncta that colocalize 
with the ERGIC (Lippincott-Schwartz et al., 1989), suggesting that the ERGIC, not the cis-Golgi, 
could be the site of Sec23-C2-Syntaxin 5 association. Interestingly, Syntaxin 5 and the SM 
protein Sly1 were reported to be involved in homotypic fusion of COPII vesicles and thus 
biogenesis of ERGIC (Xu and Hay, 2004).  
 
It has been shown that once the ERGIC has been generated, an Arf GEF (GBF1) is 
recruited to ERGIC by Rab1 and in turn GBF1 activates the Arf1 GTPase, and both of these 
events are sensitive to BFA treatment (Garcia et al., 2011) (Figure 6.1). The fact that Sec23-C2-
Syntaxin 5 association was resistant to BFA treatment suggests that the coat-tether-SNARE 
interaction must have occurred prior to Arf GTPase and/or GBF1 recruitment.The ERGIC 
depleting inhibitor H89 could be used to confirm the subcellular location where COPII-TRAPP-
SNARE association takes place. If it is at the ERGIC, a compartment that has not yet been 
identified in yeast, it could explain why a physical interaction between their yeast counterparts 




Figure 6.1 Schematic representation of ERGIC maturation. 
 
6.5 Implications of SEDT  
The tethering factor COG has been proposed to regulate the assembly of SNARE 
complexes, since the localization and stability of Golgi SNAREs are perturbed in cells with a 
defect in the COG complex (Laufman et al., 2011). As stated in Chapter 4, p115 cycles on and 
off membranes of Golgi and ERGIC, and the ER-Golgi SNARE protein GS28 colocalizes with 
p115 on the ERGIC (Brandon et al., 2006). In a series of elegant experiments, which included 
the use of fluorescence recovery after photobleaching (FRAP), the time required for the 
recovery of p115 onto the membrane was precisely measured. Interestingly, an inactive mutant 
form of NSF (NSF E329Q), which inhibits SNARE complex disassembly, increased the FRAP 
half time of p115 compared to that of wild type cells (20 vs 13 seconds) (Figure 6.2) (Bentley et 
al., 2006). In other words, the persistence of SNARE complex assembly in the cells treated with 
NSF E329Q decreased p115 membrane association, thus indicating that p115 membrane 
association is related to SNARE disassembly. In Chapter 4, I have also demonstrated that p115 
membrane association in the SEDT-causing mutant C2D47Y is dramatically increased (Figure 
4.7). In addition, in Chapter 3, I have shown that the C2D47Y interaction with Syntaxin 5 is 
reduced (Figures 3.4- 3.6), implying that the C2D47Y mutant could compromise p115 cycling 
through the disassembly of SNARE complexes. Interestingly the GTPase that TRAPP acts on, 
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Rab1, also influences the cycle of its effector p115, as the dominant negative form of Rab1 
(Rab1 N121I) shortens FRAP of p115 to 8 seconds (see Figure 6.2). The cycling of p115 is 
summarized below:   
 
 
Figure 6.2 Schematic representation of p115 cycling between membrane and cytosol. 
 
C2 is thought to be involved in the regulation of numerous intracellular processes from 
membrane trafficking to controlling gene expression as reflected by the vast number of its 
interacting partners. A link between membrane transport and cartilage development began to 
emerge when patients with a degenerative skeletal disorder causing SEDT were found to have 
mutations in the C2 gene (Gedeon et al., 1999;Sacher, 2003). Currently, more than 40 different 
mutations in C2 have been reported to cause SEDT (Jeyabalan et al., 2010). To shed light on 
the etiology of SEDT, it will be useful to identify the protein interactions, among the many protein 
partners, that are impaired when C2 is mutated.  
 
  These proteins include intermolecular associations within the TRAPP complex such as 
C8, C9 (Zong et al., 2011), and C10 (my unpublished observations) which are also observed 
with their yeast counterparts (Figure 3.11;Taussig et al., 2013). While disruption of these 
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interactions caused by the C2D47Y mutation might compromise the dynamics of TRAPP 
complexes (TRAPP II/III), other protein partners of C2 are not part of the TRAPP complex, 
including Sar1-GTP and TANGO1. This is of interest as TANGO1 is the collagen receptor and 
recruits C2 to the ERES. ER-export of collagen is perturbed upon C2 depletion (Venditti et al., 
2012). It would be interesting to examine collagen exit from the ER in the context of C2D47Y 
where its interaction with Syntaxin 5 is perturbed. The C2-Syntaxin 5 interaction is not observed 
in budding yeast, which does not produce collagen, and it is possible that in higher eukaryotes 
the TRAPP complex has gained the latter interaction to fulfil a novel function during the course 
of evolution. There is a strong possibility that in the C2D47Y mutant and in the intellectual 
disability-causing C9 truncation mutation the formation of TRAPP II and TRAPP III might be 
impaired. However it is difficult to know the consequences of the above dissociations in yeast. 
Thus far the only protein partner of C2 beyond the components of the TRAPP complex that 
does not bind to the C2D47Y SEDT-causing mutant is Syntaxin 5.  
 
6.6 Models for the function of C11  
Microscopic and biochemical analyses revealed a dramatic decrease and extensive 
glycosylation in cellular levels of LAMP1 in the presence of a mutation of C11 (Figures 5.10 and 
5.12). There are several explanations for the observed phenotype. First, LAMP1 turnover might 
have been comprised in the affected individuals. It has been shown that the lysosomal 
hydrolase neuraminidase acts on sialic acid of LAMP1, which is a regulator of LAMP1 half-life 
and its subcellular distribution. Given the aberrant glycosylation of LAMP1 in patient samples, 
we speculate that alteration of the pattern of glycosylation, presumably sialylation which mostly 
occurs in the trans-Golgi, could explain why the expression level of LAMP1 is diminished, thus 




Second, as stated in Chapter 5, recycling transport between endosomal compartments 
occurs via slow or fast recycling pathways. The slow circuit transits through recycling 
endosomes. Recycling endosomes accumulate around the microtubule organizing centre 
(MTOC) (Maxfield and McGraw, 2004), and the marker for recycling endosomes, Rab11, is 
found as a perinuclear focus similar to that seen for  LAMP1 staining observed in the C11 
patients lacking the foie gras domain. Thus we speculate that while a portion of cellular LAMP1 
declines possibly by degradation, a second fraction of LAMP1 is distributed to perinuclear foci. 
Either the state of glycosylation or alteration of protein-protein interactions induced by partial 
deletion of the foie gras domain possibly redirects LAMP1-Rab9-TGN46- positive vesicles 
towards recycling endosomes.  
 
Finally our proposal that compromised TRAPP function interferes with microtubule-
mediated transport of the late endosomal/lysosomal compartment towards the MTOC is 
supported by experiments in which overexpression of multiple TRAPP components causes the 
microtubule minus end-directed component of dynactin p150 to move away from the MTOC 
(Zong et al., 2012). FYCO1 is one of the many Rab7 effectors decorating vesicles of late 
endosomes and lysosomes (Pankiv et al., 2010). FYCO1 via interaction with LC3 promotes 
anterograde transport of plus end-directed vesicles along microtubules. On the other hand, 
activated Rab7 also interacts with RILP and ORP1L to recruit the dynein-dynactin complex to 
the late endosome/ lysosomes (Johansson et al., 2007) (Figure 6.3 bottom boxed area). LAMP1 
foci are observed in the partial deletion of foie gras domain of C11, which implies that wild-type 
C11 functions in favor of the plus end-directed kinesin motor machinery. Therefore, it would be 
worthwhile to examine whether the foie gras domain interacts with kinesin or alternatively 






Figure 6.3 Model in favor of the TRAPP complex playing a role in plus end-directed 
anterograde (toward cell periphery) transport of late endosomal/lysosomal vesicles along 
microtubules (see text for details). 
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